id	sid	tid	token	lemma	pos
dti-3177	1	1	dti	dti	PROPN
dti-3177	1	2	drug	drug	PROPN
dti-3177	1	3	target	target	NOUN
dti-3177	1	4	insights	insight	NOUN
dti-3177	1	5	2024	2024	NUM
dti-3177	1	6	;	;	PUNCT
dti-3177	1	7	18	18	NUM
dti-3177	1	8	:	:	SYM
dti-3177	1	9	70	70	NUM
dti-3177	1	10	-	-	SYM
dti-3177	1	11	77	77	NUM
dti-3177	1	12	issn	issn	PROPN
dti-3177	1	13	1177	1177	NUM
dti-3177	1	14	-	-	SYM
dti-3177	1	15	3928	3928	NUM
dti-3177	1	16	|	|	ADV
dti-3177	1	17	doi	doi	NOUN
dti-3177	1	18	:	:	PUNCT
dti-3177	1	19	10.33393	10.33393	NUM
dti-3177	1	20	/	/	SYM
dti-3177	1	21	dti.2024.3177	dti.2024.3177	ADJ
dti-3177	1	22	original	original	ADJ
dti-3177	1	23	research	research	NOUN
dti-3177	1	24	article	article	NOUN
dti-3177	1	25	drug	drug	NOUN
dti-3177	1	26	target	target	NOUN
dti-3177	1	27	insights	insight	NOUN
dti-3177	1	28	issn	issn	VERB
dti-3177	1	29	1177	1177	NUM
dti-3177	1	30	-	-	SYM
dti-3177	1	31	3928	3928	NUM
dti-3177	1	32	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-3177	1	33	©	©	PROPN
dti-3177	1	34	2024	2024	NUM
dti-3177	1	35	the	the	DET
dti-3177	1	36	authors	author	NOUN
dti-3177	1	37	.	.	PUNCT
dti-3177	2	1	this	this	DET
dti-3177	2	2	article	article	NOUN
dti-3177	2	3	is	be	AUX
dti-3177	2	4	published	publish	VERB
dti-3177	2	5	by	by	ADP
dti-3177	2	6	aboutscience	aboutscience	NOUN
dti-3177	2	7	and	and	CCONJ
dti-3177	2	8	licensed	license	VERB
dti-3177	2	9	under	under	ADP
dti-3177	2	10	creative	creative	ADJ
dti-3177	2	11	commons	common	NOUN
dti-3177	2	12	attribution	attribution	NOUN
dti-3177	2	13	-	-	PUNCT
dti-3177	2	14	noncommercial	noncommercial	ADJ
dti-3177	2	15	4.0	4.0	NUM
dti-3177	2	16	international	international	NOUN
dti-3177	2	17	(	(	PUNCT
dti-3177	2	18	cc	cc	NOUN
dti-3177	2	19	by	by	ADP
dti-3177	2	20	-	-	PUNCT
dti-3177	2	21	nc	nc	PROPN
dti-3177	2	22	4.0	4.0	NUM
dti-3177	2	23	)	)	PUNCT
dti-3177	2	24	.	.	PUNCT
dti-3177	3	1	commercial	commercial	ADJ
dti-3177	3	2	use	use	NOUN
dti-3177	3	3	is	be	AUX
dti-3177	3	4	not	not	PART
dti-3177	3	5	permitted	permit	VERB
dti-3177	3	6	and	and	CCONJ
dti-3177	3	7	is	be	AUX
dti-3177	3	8	subject	subject	ADJ
dti-3177	3	9	to	to	ADP
dti-3177	3	10	publisher	publisher	NOUN
dti-3177	3	11	’s	’s	PART
dti-3177	3	12	permissions	permission	NOUN
dti-3177	3	13	.	.	PUNCT
dti-3177	4	1	full	full	ADJ
dti-3177	4	2	information	information	NOUN
dti-3177	4	3	is	be	AUX
dti-3177	4	4	available	available	ADJ
dti-3177	4	5	at	at	ADP
dti-3177	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-3177	4	7	enhancement	enhancement	NOUN
dti-3177	4	8	of	of	ADP
dti-3177	4	9	apoptosis	apoptosis	NOUN
dti-3177	4	10	in	in	ADP
dti-3177	4	11	caco-2	caco-2	NUM
dti-3177	4	12	,	,	PUNCT
dti-3177	4	13	hep	hep	NOUN
dti-3177	4	14	-	-	PUNCT
dti-3177	4	15	g2	g2	PROPN
dti-3177	4	16	,	,	PUNCT
dti-3177	4	17	and	and	CCONJ
dti-3177	4	18	ht29	ht29	PROPN
dti-3177	4	19	cancer	cancer	NOUN
dti-3177	4	20	cell	cell	NOUN
dti-3177	4	21	lines	line	NOUN
dti-3177	4	22	following	follow	VERB
dti-3177	4	23	exposure	exposure	NOUN
dti-3177	4	24	to	to	ADP
dti-3177	4	25	toxoplasma	toxoplasma	NOUN
dti-3177	4	26	gondii	gondii	NOUN
dti-3177	4	27	peptides	peptide	NOUN
dti-3177	4	28	firooz	firooz	VERB
dti-3177	4	29	shahrivar	shahrivar	PROPN
dti-3177	4	30	1	1	NUM
dti-3177	4	31	,	,	PUNCT
dti-3177	4	32	javid	javid	PROPN
dti-3177	4	33	sadraei	sadraei	PROPN
dti-3177	4	34	1	1	NUM
dti-3177	4	35	,	,	PUNCT
dti-3177	4	36	majid	majid	PROPN
dti-3177	4	37	pirestani	pirestani	ADJ
dti-3177	4	38	1	1	NUM
dti-3177	4	39	,	,	PUNCT
dti-3177	4	40	ehsan	ehsan	PROPN
dti-3177	4	41	ahmadpour	ahmadpour	PROPN
dti-3177	4	42	2,3	2,3	NUM
dti-3177	4	43	1department	1department	NUM
dti-3177	4	44	of	of	ADP
dti-3177	4	45	parasitology	parasitology	NOUN
dti-3177	4	46	,	,	PUNCT
dti-3177	4	47	faculty	faculty	NOUN
dti-3177	4	48	of	of	ADP
dti-3177	4	49	medical	medical	ADJ
dti-3177	4	50	sciences	science	NOUN
dti-3177	4	51	,	,	PUNCT
dti-3177	4	52	tarbiat	tarbiat	PROPN
dti-3177	4	53	modares	modares	PROPN
dti-3177	4	54	university	university	PROPN
dti-3177	4	55	,	,	PUNCT
dti-3177	4	56	tehran	tehran	PROPN
dti-3177	4	57	iran	iran	PROPN
dti-3177	4	58	2immunology	2immunology	PROPN
dti-3177	4	59	research	research	NOUN
dti-3177	4	60	center	center	NOUN
dti-3177	4	61	,	,	PUNCT
dti-3177	4	62	tabriz	tabriz	PROPN
dti-3177	4	63	university	university	PROPN
dti-3177	4	64	of	of	ADP
dti-3177	4	65	medical	medical	ADJ
dti-3177	4	66	sciences	science	NOUN
dti-3177	4	67	,	,	PUNCT
dti-3177	5	1	tabriz	tabriz	NOUN
dti-3177	5	2	iran	iran	PROPN
dti-3177	5	3	3infectious	3infectious	NUM
dti-3177	5	4	and	and	CCONJ
dti-3177	5	5	tropical	tropical	ADJ
dti-3177	5	6	diseases	disease	NOUN
dti-3177	5	7	research	research	NOUN
dti-3177	5	8	center	center	NOUN
dti-3177	5	9	,	,	PUNCT
dti-3177	5	10	tabriz	tabriz	PROPN
dti-3177	5	11	university	university	PROPN
dti-3177	5	12	of	of	ADP
dti-3177	5	13	medical	medical	ADJ
dti-3177	5	14	sciences	science	NOUN
dti-3177	5	15	,	,	PUNCT
dti-3177	5	16	tabriz	tabriz	NOUN
dti-3177	5	17	iran	iran	PROPN
dti-3177	5	18	abstract	abstract	ADJ
dti-3177	5	19	objective	objective	NOUN
dti-3177	5	20	:	:	PUNCT
dti-3177	5	21	cancer	cancer	NOUN
dti-3177	5	22	or	or	CCONJ
dti-3177	5	23	neoplasm	neoplasm	NOUN
dti-3177	5	24	is	be	AUX
dti-3177	5	25	a	a	DET
dti-3177	5	26	cosmopolitan	cosmopolitan	ADJ
dti-3177	5	27	catastrophe	catastrophe	NOUN
dti-3177	5	28	that	that	PRON
dti-3177	5	29	results	result	VERB
dti-3177	5	30	in	in	ADP
dti-3177	5	31	more	more	ADJ
dti-3177	5	32	than	than	ADP
dti-3177	5	33	20	20	NUM
dti-3177	5	34	million	million	NUM
dti-3177	5	35	new	new	ADJ
dti-3177	5	36	cases	case	NOUN
dti-3177	5	37	and	and	CCONJ
dti-3177	5	38	10	10	NUM
dti-3177	5	39	million	million	NUM
dti-3177	5	40	deaths	death	NOUN
dti-3177	5	41	every	every	DET
dti-3177	5	42	year	year	NOUN
dti-3177	5	43	.	.	PUNCT
dti-3177	6	1	some	some	DET
dti-3177	6	2	factors	factor	NOUN
dti-3177	6	3	lead	lead	VERB
dti-3177	6	4	to	to	ADP
dti-3177	6	5	carcinogenesis	carcinogenesis	NOUN
dti-3177	6	6	like	like	ADP
dti-3177	6	7	infectious	infectious	ADJ
dti-3177	6	8	diseases	disease	NOUN
dti-3177	6	9	.	.	PUNCT
dti-3177	7	1	parasites	parasite	NOUN
dti-3177	7	2	like	like	ADP
dti-3177	7	3	toxoplasma	toxoplasma	NOUN
dti-3177	7	4	gondii	gondii	NOUN
dti-3177	7	5	,	,	PUNCT
dti-3177	7	6	by	by	ADP
dti-3177	7	7	its	its	PRON
dti-3177	7	8	components	component	NOUN
dti-3177	7	9	,	,	PUNCT
dti-3177	7	10	could	could	AUX
dti-3177	7	11	modulate	modulate	VERB
dti-3177	7	12	the	the	DET
dti-3177	7	13	cancer	cancer	NOUN
dti-3177	7	14	system	system	NOUN
dti-3177	7	15	by	by	ADP
dti-3177	7	16	inducing	induce	VERB
dti-3177	7	17	apoptosis	apoptosis	NOUN
dti-3177	7	18	.	.	PUNCT
dti-3177	8	1	the	the	DET
dti-3177	8	2	objective	objective	NOUN
dti-3177	8	3	of	of	ADP
dti-3177	8	4	this	this	DET
dti-3177	8	5	investigation	investigation	NOUN
dti-3177	8	6	is	be	AUX
dti-3177	8	7	to	to	PART
dti-3177	8	8	assess	assess	VERB
dti-3177	8	9	the	the	DET
dti-3177	8	10	potential	potential	NOUN
dti-3177	8	11	of	of	ADP
dti-3177	8	12	peptides	peptide	NOUN
dti-3177	8	13	derived	derive	VERB
dti-3177	8	14	from	from	ADP
dti-3177	8	15	t.	t.	NOUN
dti-3177	8	16	gondii	gondii	NOUN
dti-3177	8	17	in	in	ADP
dti-3177	8	18	combating	combat	VERB
dti-3177	8	19	cancer	cancer	NOUN
dti-3177	8	20	by	by	ADP
dti-3177	8	21	examining	examine	VERB
dti-3177	8	22	their	their	PRON
dti-3177	8	23	effects	effect	NOUN
dti-3177	8	24	on	on	ADP
dti-3177	8	25	caco-2	caco-2	NUM
dti-3177	8	26	,	,	PUNCT
dti-3177	8	27	hep	hep	NOUN
dti-3177	8	28	-	-	PUNCT
dti-3177	8	29	g2	g2	PROPN
dti-3177	8	30	,	,	PUNCT
dti-3177	8	31	and	and	CCONJ
dti-3177	8	32	ht29	ht29	PROPN
dti-3177	8	33	cell	cell	NOUN
dti-3177	8	34	lines	line	NOUN
dti-3177	8	35	.	.	PUNCT
dti-3177	9	1	materials	material	NOUN
dti-3177	9	2	and	and	CCONJ
dti-3177	9	3	methods	method	NOUN
dti-3177	9	4	:	:	PUNCT
dti-3177	9	5	candidate	candidate	NOUN
dti-3177	9	6	peptide	peptide	NOUN
dti-3177	9	7	by	by	ADP
dti-3177	9	8	its	its	PRON
dti-3177	9	9	similarity	similarity	NOUN
dti-3177	9	10	to	to	PART
dti-3177	9	11	anticancer	anticancer	NOUN
dti-3177	9	12	compounds	compound	NOUN
dti-3177	9	13	was	be	AUX
dti-3177	9	14	predicted	predict	VERB
dti-3177	9	15	through	through	ADP
dti-3177	9	16	the	the	DET
dti-3177	9	17	computer	computer	NOUN
dti-3177	9	18	-	-	PUNCT
dti-3177	9	19	based	base	VERB
dti-3177	9	20	analysis	analysis	NOUN
dti-3177	9	21	/	/	SYM
dti-3177	9	22	platform	platform	NOUN
dti-3177	9	23	.	.	PUNCT
dti-3177	10	1	the	the	DET
dti-3177	10	2	impact	impact	NOUN
dti-3177	10	3	of	of	ADP
dti-3177	10	4	the	the	DET
dti-3177	10	5	peptide	peptide	NOUN
dti-3177	10	6	on	on	ADP
dti-3177	10	7	cell	cell	NOUN
dti-3177	10	8	viability	viability	NOUN
dti-3177	10	9	,	,	PUNCT
dti-3177	10	10	cell	cell	NOUN
dti-3177	10	11	proliferation	proliferation	NOUN
dti-3177	10	12	,	,	PUNCT
dti-3177	10	13	and	and	CCONJ
dti-3177	10	14	gene	gene	NOUN
dti-3177	10	15	expression	expression	NOUN
dti-3177	10	16	was	be	AUX
dti-3177	10	17	evaluated	evaluate	VERB
dti-3177	10	18	through	through	ADP
dti-3177	10	19	the	the	DET
dti-3177	10	20	utilization	utilization	NOUN
dti-3177	10	21	of	of	ADP
dti-3177	10	22	mtt	mtt	NOUN
dti-3177	10	23	assay	assay	VERB
dti-3177	10	24	,	,	PUNCT
dti-3177	10	25	flow	flow	NOUN
dti-3177	10	26	cytometry	cytometry	NOUN
dti-3177	10	27	,	,	PUNCT
dti-3177	10	28	and	and	CCONJ
dti-3177	10	29	real	real	ADJ
dti-3177	10	30	-	-	PUNCT
dti-3177	10	31	time	time	NOUN
dti-3177	10	32	polymerase	polymerase	NOUN
dti-3177	10	33	chain	chain	NOUN
dti-3177	10	34	reaction	reaction	NOUN
dti-3177	10	35	(	(	PUNCT
dti-3177	10	36	pcr	pcr	NOUN
dti-3177	10	37	)	)	PUNCT
dti-3177	10	38	methodologies	methodology	NOUN
dti-3177	10	39	.	.	PUNCT
dti-3177	11	1	results	result	NOUN
dti-3177	11	2	:	:	PUNCT
dti-3177	11	3	the	the	DET
dti-3177	11	4	cell	cell	NOUN
dti-3177	11	5	viability	viability	NOUN
dti-3177	11	6	rate	rate	NOUN
dti-3177	11	7	exhibited	exhibit	VERB
dti-3177	11	8	a	a	DET
dti-3177	11	9	significant	significant	ADJ
dti-3177	11	10	decrease	decrease	NOUN
dti-3177	11	11	(	(	PUNCT
dti-3177	11	12	p	p	X
dti-3177	11	13	<	<	X
dti-3177	11	14	0.001	0.001	NUM
dti-3177	11	15	)	)	PUNCT
dti-3177	11	16	across	across	ADP
dti-3177	11	17	all	all	DET
dti-3177	11	18	cell	cell	NOUN
dti-3177	11	19	lines	line	NOUN
dti-3177	11	20	when	when	SCONJ
dti-3177	11	21	exposed	expose	VERB
dti-3177	11	22	to	to	ADP
dti-3177	11	23	a	a	DET
dti-3177	11	24	concentration	concentration	NOUN
dti-3177	11	25	of	of	ADP
dti-3177	11	26	≤160	≤160	PROPN
dti-3177	11	27	μg	μg	PROPN
dti-3177	11	28	.	.	PROPN
dti-3177	12	1	within	within	ADP
dti-3177	12	2	the	the	DET
dti-3177	12	3	48	48	NUM
dti-3177	12	4	-	-	PUNCT
dti-3177	12	5	hour	hour	NOUN
dti-3177	12	6	timeframe	timeframe	NOUN
dti-3177	12	7	,	,	PUNCT
dti-3177	12	8	the	the	DET
dti-3177	12	9	half	half	ADJ
dti-3177	12	10	maximal	maximal	ADJ
dti-3177	12	11	inhibitory	inhibitory	ADJ
dti-3177	12	12	concentration	concentration	NOUN
dti-3177	12	13	(	(	PUNCT
dti-3177	12	14	ic50	ic50	PROPN
dti-3177	12	15	)	)	PUNCT
dti-3177	12	16	for	for	ADP
dti-3177	12	17	ht29	ht29	PROPN
dti-3177	12	18	and	and	CCONJ
dti-3177	12	19	hep	hep	NOUN
dti-3177	12	20	-	-	ADJ
dti-3177	12	21	g2	g2	PROPN
dti-3177	12	22	cell	cell	NOUN
dti-3177	12	23	lines	line	NOUN
dti-3177	12	24	was	be	AUX
dti-3177	12	25	determined	determine	VERB
dti-3177	12	26	to	to	PART
dti-3177	12	27	be	be	AUX
dti-3177	12	28	107.2	107.2	NUM
dti-3177	12	29	and	and	CCONJ
dti-3177	12	30	140.6	140.6	NUM
dti-3177	12	31	μg	μg	NOUN
dti-3177	12	32	/	/	SYM
dti-3177	12	33	ml	ml	NOUN
dti-3177	12	34	,	,	PUNCT
dti-3177	12	35	respectively	respectively	ADV
dti-3177	12	36	.	.	PUNCT
dti-3177	13	1	notably	notably	ADV
dti-3177	13	2	,	,	PUNCT
dti-3177	13	3	a	a	DET
dti-3177	13	4	marked	mark	VERB
dti-3177	13	5	decrease	decrease	NOUN
dti-3177	13	6	in	in	ADP
dti-3177	13	7	the	the	DET
dti-3177	13	8	expression	expression	NOUN
dti-3177	13	9	levels	level	NOUN
dti-3177	13	10	of	of	ADP
dti-3177	13	11	bcl2	bcl2	PROPN
dti-3177	13	12	and	and	CCONJ
dti-3177	13	13	apaf1	apaf1	NOUN
dti-3177	13	14	genes	gene	NOUN
dti-3177	13	15	was	be	AUX
dti-3177	13	16	observed	observe	VERB
dti-3177	13	17	in	in	ADP
dti-3177	13	18	both	both	CCONJ
dti-3177	13	19	the	the	DET
dti-3177	13	20	hep	hep	NOUN
dti-3177	13	21	-	-	PUNCT
dti-3177	13	22	g2	g2	PROPN
dti-3177	13	23	and	and	CCONJ
dti-3177	13	24	ht29	ht29	PROPN
dti-3177	13	25	cell	cell	NOUN
dti-3177	13	26	lines	line	NOUN
dti-3177	13	27	.	.	PUNCT
dti-3177	14	1	conclusion	conclusion	NOUN
dti-3177	14	2	:	:	PUNCT
dti-3177	14	3	these	these	DET
dti-3177	14	4	findings	finding	NOUN
dti-3177	14	5	indicate	indicate	VERB
dti-3177	14	6	that	that	SCONJ
dti-3177	14	7	the	the	DET
dti-3177	14	8	t.	t.	ADJ
dti-3177	14	9	gondii	gondii	PROPN
dti-3177	14	10	peptide	peptide	NOUN
dti-3177	14	11	affected	affect	VERB
dti-3177	14	12	cancer	cancer	NOUN
dti-3177	14	13	cell	cell	NOUN
dti-3177	14	14	mortality	mortality	NOUN
dti-3177	14	15	and	and	CCONJ
dti-3177	14	16	led	lead	VERB
dti-3177	14	17	to	to	ADP
dti-3177	14	18	changes	change	NOUN
dti-3177	14	19	in	in	ADP
dti-3177	14	20	the	the	DET
dti-3177	14	21	expression	expression	NOUN
dti-3177	14	22	of	of	ADP
dti-3177	14	23	genes	gene	NOUN
dti-3177	14	24	associated	associate	VERB
dti-3177	14	25	with	with	ADP
dti-3177	14	26	apoptosis	apoptosis	NOUN
dti-3177	14	27	.	.	PUNCT
dti-3177	15	1	keywords	keyword	NOUN
dti-3177	15	2	:	:	PUNCT
dti-3177	15	3	anticancer	anticancer	NOUN
dti-3177	15	4	,	,	PUNCT
dti-3177	15	5	neoplasm	neoplasm	NOUN
dti-3177	15	6	,	,	PUNCT
dti-3177	15	7	parasite	parasite	NOUN
dti-3177	15	8	,	,	PUNCT
dti-3177	15	9	peptides	peptide	NOUN
dti-3177	15	10	,	,	PUNCT
dti-3177	15	11	real	real	ADJ
dti-3177	15	12	-	-	PUNCT
dti-3177	15	13	time	time	NOUN
dti-3177	15	14	pcr	pcr	NOUN
dti-3177	15	15	,	,	PUNCT
dti-3177	15	16	toxoplasmosis	toxoplasmosis	NOUN
dti-3177	15	17	received	receive	VERB
dti-3177	15	18	:	:	PUNCT
dti-3177	15	19	june	june	PROPN
dti-3177	15	20	24	24	NUM
dti-3177	15	21	,	,	PUNCT
dti-3177	15	22	2024	2024	NUM
dti-3177	15	23	accepted	accept	VERB
dti-3177	15	24	:	:	PUNCT
dti-3177	15	25	july	july	PROPN
dti-3177	15	26	11	11	NUM
dti-3177	15	27	,	,	PUNCT
dti-3177	15	28	2024	2024	NUM
dti-3177	15	29	published	publish	VERB
dti-3177	15	30	online	online	ADV
dti-3177	15	31	:	:	PUNCT
dti-3177	15	32	september	september	PROPN
dti-3177	15	33	30	30	NUM
dti-3177	15	34	,	,	PUNCT
dti-3177	15	35	2024	2024	NUM
dti-3177	15	36	corresponding	correspond	VERB
dti-3177	15	37	author	author	NOUN
dti-3177	15	38	:	:	PUNCT
dti-3177	15	39	javid	javid	PROPN
dti-3177	15	40	sadraei	sadraei	PROPN
dti-3177	15	41	email	email	NOUN
dti-3177	15	42	:	:	PUNCT
dti-3177	15	43	sadraeij@modares.ac.ir	sadraeij@modares.ac.ir	ADJ
dti-3177	15	44	phase	phase	NOUN
dti-3177	15	45	,	,	PUNCT
dti-3177	15	46	and	and	CCONJ
dti-3177	15	47	(	(	PUNCT
dti-3177	15	48	iii	iii	X
dti-3177	15	49	)	)	PUNCT
dti-3177	15	50	sporozoites	sporozoite	NOUN
dti-3177	15	51	,	,	PUNCT
dti-3177	15	52	which	which	PRON
dti-3177	15	53	are	be	AUX
dti-3177	15	54	distinctive	distinctive	ADJ
dti-3177	15	55	of	of	ADP
dti-3177	15	56	the	the	DET
dti-3177	15	57	sexual	sexual	ADJ
dti-3177	15	58	stage	stage	NOUN
dti-3177	15	59	in	in	ADP
dti-3177	15	60	felids	felid	NOUN
dti-3177	15	61	and	and	CCONJ
dti-3177	15	62	found	find	VERB
dti-3177	15	63	in	in	ADP
dti-3177	15	64	oocysts	oocyst	NOUN
dti-3177	15	65	in	in	ADP
dti-3177	15	66	feline	feline	ADJ
dti-3177	15	67	feces	fece	NOUN
dti-3177	15	68	(	(	PUNCT
dti-3177	15	69	3	3	NUM
dti-3177	15	70	)	)	PUNCT
dti-3177	15	71	.	.	PUNCT
dti-3177	16	1	various	various	ADJ
dti-3177	16	2	pathways	pathway	NOUN
dti-3177	16	3	have	have	AUX
dti-3177	16	4	been	be	AUX
dti-3177	16	5	reported	report	VERB
dti-3177	16	6	for	for	ADP
dti-3177	16	7	the	the	DET
dti-3177	16	8	infection	infection	NOUN
dti-3177	16	9	of	of	ADP
dti-3177	16	10	intermediate	intermediate	ADJ
dti-3177	16	11	hosts	host	NOUN
dti-3177	16	12	:	:	PUNCT
dti-3177	16	13	ingestion	ingestion	NOUN
dti-3177	16	14	of	of	ADP
dti-3177	16	15	oocysts	oocyst	NOUN
dti-3177	16	16	-	-	PUNCT
dti-3177	16	17	contaminated	contaminate	VERB
dti-3177	16	18	fruits	fruit	NOUN
dti-3177	16	19	,	,	PUNCT
dti-3177	16	20	vegetables	vegetable	NOUN
dti-3177	16	21	,	,	PUNCT
dti-3177	16	22	or	or	CCONJ
dti-3177	16	23	water	water	NOUN
dti-3177	16	24	,	,	PUNCT
dti-3177	16	25	consumption	consumption	NOUN
dti-3177	16	26	of	of	ADP
dti-3177	16	27	raw	raw	ADJ
dti-3177	16	28	or	or	CCONJ
dti-3177	16	29	uncooked	uncooked	ADJ
dti-3177	16	30	meat	meat	NOUN
dti-3177	16	31	containing	contain	VERB
dti-3177	16	32	tissue	tissue	NOUN
dti-3177	16	33	cysts	cyst	NOUN
dti-3177	16	34	,	,	PUNCT
dti-3177	16	35	congenital	congenital	ADJ
dti-3177	16	36	transmission	transmission	NOUN
dti-3177	16	37	,	,	PUNCT
dti-3177	16	38	blood	blood	NOUN
dti-3177	16	39	transfusion	transfusion	NOUN
dti-3177	16	40	,	,	PUNCT
dti-3177	16	41	and	and	CCONJ
dti-3177	16	42	organ	organ	NOUN
dti-3177	16	43	transplantation	transplantation	NOUN
dti-3177	16	44	.	.	PUNCT
dti-3177	17	1	although	although	SCONJ
dti-3177	17	2	transmission	transmission	NOUN
dti-3177	17	3	through	through	ADP
dti-3177	17	4	the	the	DET
dti-3177	17	5	ingestion	ingestion	NOUN
dti-3177	17	6	of	of	ADP
dti-3177	17	7	non	non	ADJ
dti-3177	17	8	-	-	ADJ
dti-3177	17	9	pasteurized	pasteurized	ADJ
dti-3177	17	10	milk	milk	NOUN
dti-3177	17	11	or	or	CCONJ
dti-3177	17	12	milk	milk	NOUN
dti-3177	17	13	products	product	NOUN
dti-3177	17	14	has	have	AUX
dti-3177	17	15	been	be	AUX
dti-3177	17	16	documented	document	VERB
dti-3177	17	17	,	,	PUNCT
dti-3177	17	18	it	it	PRON
dti-3177	17	19	is	be	AUX
dti-3177	17	20	not	not	PART
dti-3177	17	21	common	common	ADJ
dti-3177	17	22	(	(	PUNCT
dti-3177	17	23	4	4	NUM
dti-3177	17	24	)	)	PUNCT
dti-3177	17	25	.	.	PUNCT
dti-3177	18	1	it	it	PRON
dti-3177	18	2	is	be	AUX
dti-3177	18	3	obvious	obvious	ADJ
dti-3177	18	4	that	that	SCONJ
dti-3177	18	5	felines	feline	NOUN
dti-3177	18	6	as	as	ADP
dti-3177	18	7	definitive	definitive	ADJ
dti-3177	18	8	hosts	host	NOUN
dti-3177	18	9	can	can	AUX
dti-3177	18	10	become	become	VERB
dti-3177	18	11	infected	infect	VERB
dti-3177	18	12	through	through	ADP
dti-3177	18	13	carnivorous	carnivorous	ADJ
dti-3177	18	14	behavior	behavior	NOUN
dti-3177	18	15	or	or	CCONJ
dti-3177	18	16	ingestion	ingestion	NOUN
dti-3177	18	17	of	of	ADP
dti-3177	18	18	sporulated	sporulate	VERB
dti-3177	18	19	oocysts	oocyst	NOUN
dti-3177	18	20	(	(	PUNCT
dti-3177	18	21	5	5	NUM
dti-3177	18	22	)	)	PUNCT
dti-3177	18	23	.	.	PUNCT
dti-3177	19	1	cancer	cancer	NOUN
dti-3177	19	2	is	be	AUX
dti-3177	19	3	referred	refer	VERB
dti-3177	19	4	as	as	ADP
dti-3177	19	5	a	a	DET
dti-3177	19	6	composite	composite	NOUN
dti-3177	19	7	of	of	ADP
dti-3177	19	8	diseases	disease	NOUN
dti-3177	19	9	acquired	acquire	VERB
dti-3177	19	10	by	by	ADP
dti-3177	19	11	the	the	DET
dti-3177	19	12	development	development	NOUN
dti-3177	19	13	of	of	ADP
dti-3177	19	14	neoplastic	neoplastic	ADJ
dti-3177	19	15	cells	cell	NOUN
dti-3177	19	16	(	(	PUNCT
dti-3177	19	17	6	6	NUM
dti-3177	19	18	)	)	PUNCT
dti-3177	19	19	.	.	PUNCT
dti-3177	20	1	it	it	PRON
dti-3177	20	2	contributes	contribute	VERB
dti-3177	20	3	symptoms	symptom	NOUN
dti-3177	20	4	like	like	ADP
dti-3177	20	5	eluding	elude	VERB
dti-3177	20	6	growth	growth	NOUN
dti-3177	20	7	suppressors	suppressor	NOUN
dti-3177	20	8	,	,	PUNCT
dti-3177	20	9	empowering	empower	VERB
dti-3177	20	10	proliferative	proliferative	ADJ
dti-3177	20	11	signaling	signal	VERB
dti-3177	20	12	,	,	PUNCT
dti-3177	20	13	withstanding	withstand	VERB
dti-3177	20	14	cell	cell	NOUN
dti-3177	20	15	death	death	NOUN
dti-3177	20	16	,	,	PUNCT
dti-3177	20	17	promoting	promote	VERB
dti-3177	20	18	the	the	DET
dti-3177	20	19	ability	ability	NOUN
dti-3177	20	20	to	to	PART
dti-3177	20	21	replicate	replicate	VERB
dti-3177	20	22	indefinitely	indefinitely	ADV
dti-3177	20	23	,	,	PUNCT
dti-3177	20	24	activating	activate	VERB
dti-3177	20	25	angiogenesis	angiogenesis	NOUN
dti-3177	20	26	,	,	PUNCT
dti-3177	20	27	prompting	prompt	VERB
dti-3177	20	28	invasion	invasion	NOUN
dti-3177	20	29	and	and	CCONJ
dti-3177	20	30	metastasis	metastasis	NOUN
dti-3177	20	31	,	,	PUNCT
dti-3177	20	32	genome	genome	NOUN
dti-3177	20	33	vulnerability	vulnerability	NOUN
dti-3177	20	34	,	,	PUNCT
dti-3177	20	35	reconstructing	reconstruct	VERB
dti-3177	20	36	energy	energy	NOUN
dti-3177	20	37	metabolism	metabolism	NOUN
dti-3177	20	38	,	,	PUNCT
dti-3177	20	39	and	and	CCONJ
dti-3177	20	40	evading	evade	VERB
dti-3177	20	41	destruction	destruction	NOUN
dti-3177	20	42	by	by	ADP
dti-3177	20	43	the	the	DET
dti-3177	20	44	immune	immune	ADJ
dti-3177	20	45	system	system	NOUN
dti-3177	20	46	as	as	ADV
dti-3177	20	47	well	well	ADV
dti-3177	20	48	(	(	PUNCT
dti-3177	20	49	7	7	NUM
dti-3177	20	50	)	)	PUNCT
dti-3177	20	51	.	.	PUNCT
dti-3177	21	1	there	there	PRON
dti-3177	21	2	are	be	VERB
dti-3177	21	3	more	more	ADJ
dti-3177	21	4	than	than	ADP
dti-3177	21	5	20	20	NUM
dti-3177	21	6	million	million	NUM
dti-3177	21	7	newly	newly	ADV
dti-3177	21	8	diagnosed	diagnose	VERB
dti-3177	21	9	cases	case	NOUN
dti-3177	21	10	of	of	ADP
dti-3177	21	11	cancer	cancer	NOUN
dti-3177	21	12	and	and	CCONJ
dti-3177	21	13	almost	almost	ADV
dti-3177	21	14	10	10	NUM
dti-3177	21	15	million	million	NUM
dti-3177	21	16	deaths	death	NOUN
dti-3177	21	17	attributed	attribute	VERB
dti-3177	21	18	to	to	ADP
dti-3177	21	19	this	this	DET
dti-3177	21	20	disease	disease	NOUN
dti-3177	21	21	every	every	DET
dti-3177	21	22	year	year	NOUN
dti-3177	21	23	(	(	PUNCT
dti-3177	21	24	8)	8)	NUM
dti-3177	21	25	.	.	PUNCT
dti-3177	22	1	multiple	multiple	ADJ
dti-3177	22	2	factors	factor	NOUN
dti-3177	22	3	play	play	VERB
dti-3177	22	4	a	a	DET
dti-3177	22	5	introduction	introduction	NOUN
dti-3177	22	6	toxoplasma	toxoplasma	NOUN
dti-3177	22	7	gondii	gondii	NOUN
dti-3177	22	8	is	be	AUX
dti-3177	22	9	the	the	DET
dti-3177	22	10	most	most	ADV
dti-3177	22	11	widespread	widespread	ADJ
dti-3177	22	12	protozoan	protozoan	NOUN
dti-3177	22	13	parasite	parasite	NOUN
dti-3177	22	14	that	that	PRON
dti-3177	22	15	gained	gain	VERB
dti-3177	22	16	its	its	PRON
dti-3177	22	17	reputation	reputation	NOUN
dti-3177	22	18	by	by	ADP
dti-3177	22	19	seropositive	seropositive	ADJ
dti-3177	22	20	analysis	analysis	NOUN
dti-3177	22	21	.	.	PUNCT
dti-3177	23	1	it	it	PRON
dti-3177	23	2	has	have	AUX
dti-3177	23	3	been	be	AUX
dti-3177	23	4	found	find	VERB
dti-3177	23	5	that	that	SCONJ
dti-3177	23	6	more	more	ADJ
dti-3177	23	7	than	than	ADP
dti-3177	23	8	30%-50	30%-50	NUM
dti-3177	23	9	%	%	NOUN
dti-3177	23	10	of	of	ADP
dti-3177	23	11	the	the	DET
dti-3177	23	12	world	world	NOUN
dti-3177	23	13	’s	’s	PART
dti-3177	23	14	population	population	NOUN
dti-3177	23	15	is	be	AUX
dti-3177	23	16	positive	positive	ADJ
dti-3177	23	17	for	for	ADP
dti-3177	23	18	t.	t.	NOUN
dti-3177	23	19	gondii	gondii	NOUN
dti-3177	23	20	(	(	PUNCT
dti-3177	23	21	1	1	NUM
dti-3177	23	22	)	)	PUNCT
dti-3177	23	23	.	.	PUNCT
dti-3177	24	1	felids	felid	NOUN
dti-3177	24	2	are	be	AUX
dti-3177	24	3	known	know	VERB
dti-3177	24	4	to	to	PART
dti-3177	24	5	be	be	AUX
dti-3177	24	6	the	the	DET
dti-3177	24	7	definitive	definitive	ADJ
dti-3177	24	8	host	host	NOUN
dti-3177	24	9	in	in	ADP
dti-3177	24	10	which	which	PRON
dti-3177	24	11	the	the	DET
dti-3177	24	12	sexual	sexual	ADJ
dti-3177	24	13	stage	stage	NOUN
dti-3177	24	14	takes	take	VERB
dti-3177	24	15	place	place	NOUN
dti-3177	24	16	.	.	PUNCT
dti-3177	25	1	terrestrial	terrestrial	ADJ
dti-3177	25	2	and	and	CCONJ
dti-3177	25	3	aquatic	aquatic	ADJ
dti-3177	25	4	mammals	mammal	NOUN
dti-3177	25	5	as	as	ADV
dti-3177	25	6	well	well	ADV
dti-3177	25	7	as	as	ADP
dti-3177	25	8	birds	bird	NOUN
dti-3177	25	9	act	act	VERB
dti-3177	25	10	as	as	ADP
dti-3177	25	11	intermediate	intermediate	ADJ
dti-3177	25	12	hosts	host	NOUN
dti-3177	25	13	during	during	ADP
dti-3177	25	14	the	the	DET
dti-3177	25	15	asexual	asexual	ADJ
dti-3177	25	16	stage	stage	NOUN
dti-3177	25	17	(	(	PUNCT
dti-3177	25	18	2	2	NUM
dti-3177	25	19	)	)	PUNCT
dti-3177	25	20	.	.	PUNCT
dti-3177	26	1	three	three	NUM
dti-3177	26	2	developmental	developmental	ADJ
dti-3177	26	3	stages	stage	NOUN
dti-3177	26	4	have	have	AUX
dti-3177	26	5	been	be	AUX
dti-3177	26	6	distinguished	distinguish	VERB
dti-3177	26	7	to	to	PART
dti-3177	26	8	infect	infect	VERB
dti-3177	26	9	the	the	DET
dti-3177	26	10	cell	cell	NOUN
dti-3177	26	11	:	:	PUNCT
dti-3177	26	12	(	(	PUNCT
dti-3177	26	13	i	i	NOUN
dti-3177	26	14	)	)	PUNCT
dti-3177	26	15	tachyzoite	tachyzoite	PROPN
dti-3177	26	16	,	,	PUNCT
dti-3177	26	17	which	which	PRON
dti-3177	26	18	rapidly	rapidly	ADV
dti-3177	26	19	multiplies	multiply	VERB
dti-3177	26	20	and	and	CCONJ
dti-3177	26	21	occurs	occur	VERB
dti-3177	26	22	in	in	ADP
dti-3177	26	23	the	the	DET
dti-3177	26	24	acute	acute	ADJ
dti-3177	26	25	phase	phase	NOUN
dti-3177	26	26	of	of	ADP
dti-3177	26	27	the	the	DET
dti-3177	26	28	infection	infection	NOUN
dti-3177	26	29	,	,	PUNCT
dti-3177	26	30	(	(	PUNCT
dti-3177	26	31	ii	ii	NOUN
dti-3177	26	32	)	)	PUNCT
dti-3177	26	33	bradyzoite	bradyzoite	PROPN
dti-3177	26	34	,	,	PUNCT
dti-3177	26	35	a	a	DET
dti-3177	26	36	form	form	NOUN
dti-3177	26	37	of	of	ADP
dti-3177	26	38	slow	slow	ADJ
dti-3177	26	39	multiplication	multiplication	NOUN
dti-3177	26	40	that	that	PRON
dti-3177	26	41	characterizes	characterize	VERB
dti-3177	26	42	the	the	DET
dti-3177	26	43	chronic	chronic	ADJ
dti-3177	26	44	https://doi.org/10.33393/dti.2024.3177	https://doi.org/10.33393/dti.2024.3177	PROPN
dti-3177	26	45	https://doi.org/dti.2022.2522	https://doi.org/dti.2022.2522	PROPN
dti-3177	26	46	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NUM
dti-3177	26	47	https://orcid.org/0000-0001-6941-6360	https://orcid.org/0000-0001-6941-6360	NOUN
dti-3177	26	48	https://orcid.org/0000-0003-3312-765x	https://orcid.org/0000-0003-3312-765x	VERB
dti-3177	26	49	https://orcid.org/0000-0003-0046-4772	https://orcid.org/0000-0003-0046-4772	NOUN
dti-3177	26	50	https://orcid.org/0000-0003-1202-6147	https://orcid.org/0000-0003-1202-6147	PROPN
dti-3177	26	51	shahrivar	shahrivar	PROPN
dti-3177	26	52	et	et	PROPN
dti-3177	26	53	al	al	PROPN
dti-3177	26	54	drug	drug	PROPN
dti-3177	26	55	target	target	NOUN
dti-3177	26	56	insights	insight	NOUN
dti-3177	26	57	2024	2024	NUM
dti-3177	26	58	;	;	PUNCT
dti-3177	26	59	18	18	NUM
dti-3177	26	60	:	:	SYM
dti-3177	26	61	71	71	NUM
dti-3177	26	62	©	©	PROPN
dti-3177	26	63	2024	2024	NUM
dti-3177	26	64	the	the	DET
dti-3177	26	65	authors	author	NOUN
dti-3177	26	66	.	.	PUNCT
dti-3177	27	1	published	publish	VERB
dti-3177	27	2	by	by	ADP
dti-3177	27	3	aboutscience	aboutscience	NOUN
dti-3177	27	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-3177	27	5	pivotal	pivotal	ADJ
dti-3177	27	6	role	role	NOUN
dti-3177	27	7	in	in	ADP
dti-3177	27	8	causing	cause	VERB
dti-3177	27	9	carcinogenesis	carcinogenesis	NOUN
dti-3177	27	10	like	like	ADP
dti-3177	27	11	lifestyle	lifestyle	NOUN
dti-3177	27	12	,	,	PUNCT
dti-3177	27	13	genes	gene	NOUN
dti-3177	27	14	,	,	PUNCT
dti-3177	27	15	and	and	CCONJ
dti-3177	27	16	the	the	DET
dti-3177	27	17	microenvironment	microenvironment	NOUN
dti-3177	27	18	.	.	PUNCT
dti-3177	28	1	moreover	moreover	ADV
dti-3177	28	2	,	,	PUNCT
dti-3177	28	3	it	it	PRON
dti-3177	28	4	is	be	AUX
dti-3177	28	5	widely	widely	ADV
dti-3177	28	6	recognized	recognize	VERB
dti-3177	28	7	that	that	SCONJ
dti-3177	28	8	infectious	infectious	ADJ
dti-3177	28	9	diseases	disease	NOUN
dti-3177	28	10	play	play	VERB
dti-3177	28	11	a	a	DET
dti-3177	28	12	significant	significant	ADJ
dti-3177	28	13	role	role	NOUN
dti-3177	28	14	in	in	ADP
dti-3177	28	15	the	the	DET
dti-3177	28	16	development	development	NOUN
dti-3177	28	17	of	of	ADP
dti-3177	28	18	various	various	ADJ
dti-3177	28	19	types	type	NOUN
dti-3177	28	20	of	of	ADP
dti-3177	28	21	cancers	cancer	NOUN
dti-3177	28	22	.	.	PUNCT
dti-3177	29	1	these	these	DET
dti-3177	29	2	diseases	disease	NOUN
dti-3177	29	3	are	be	AUX
dti-3177	29	4	responsible	responsible	ADJ
dti-3177	29	5	for	for	ADP
dti-3177	29	6	approximately	approximately	ADV
dti-3177	29	7	25%-50	25%-50	NUM
dti-3177	29	8	%	%	NOUN
dti-3177	29	9	of	of	ADP
dti-3177	29	10	all	all	DET
dti-3177	29	11	cancer	cancer	NOUN
dti-3177	29	12	cases	case	NOUN
dti-3177	29	13	(	(	PUNCT
dti-3177	29	14	9	9	NUM
dti-3177	29	15	)	)	PUNCT
dti-3177	29	16	.	.	PUNCT
dti-3177	30	1	notably	notably	ADV
dti-3177	30	2	,	,	PUNCT
dti-3177	30	3	viral	viral	ADJ
dti-3177	30	4	infections	infection	NOUN
dti-3177	30	5	such	such	ADJ
dti-3177	30	6	as	as	ADP
dti-3177	30	7	papilloma	papilloma	NOUN
dti-3177	30	8	virus	virus	NOUN
dti-3177	30	9	have	have	AUX
dti-3177	30	10	been	be	AUX
dti-3177	30	11	linked	link	VERB
dti-3177	30	12	to	to	ADP
dti-3177	30	13	cervical	cervical	ADJ
dti-3177	30	14	cancer	cancer	NOUN
dti-3177	30	15	,	,	PUNCT
dti-3177	30	16	while	while	SCONJ
dti-3177	30	17	bacterial	bacterial	ADJ
dti-3177	30	18	infections	infection	NOUN
dti-3177	30	19	like	like	ADP
dti-3177	30	20	helicobacter	helicobacter	NOUN
dti-3177	30	21	pylori	pylori	NOUN
dti-3177	30	22	have	have	AUX
dti-3177	30	23	been	be	AUX
dti-3177	30	24	associated	associate	VERB
dti-3177	30	25	with	with	ADP
dti-3177	30	26	gastric	gastric	ADJ
dti-3177	30	27	cancer	cancer	NOUN
dti-3177	30	28	.	.	PUNCT
dti-3177	31	1	additionally	additionally	ADV
dti-3177	31	2	,	,	PUNCT
dti-3177	31	3	parasitic	parasitic	ADJ
dti-3177	31	4	infections	infection	NOUN
dti-3177	31	5	,	,	PUNCT
dti-3177	31	6	including	include	VERB
dti-3177	31	7	schistosoma	schistosoma	ADJ
dti-3177	31	8	haematobium	haematobium	NOUN
dti-3177	31	9	,	,	PUNCT
dti-3177	31	10	have	have	AUX
dti-3177	31	11	been	be	AUX
dti-3177	31	12	found	find	VERB
dti-3177	31	13	to	to	PART
dti-3177	31	14	be	be	AUX
dti-3177	31	15	connected	connect	VERB
dti-3177	31	16	to	to	ADP
dti-3177	31	17	urinary	urinary	ADJ
dti-3177	31	18	bladder	bladder	NOUN
dti-3177	31	19	cancer	cancer	NOUN
dti-3177	31	20	.	.	PUNCT
dti-3177	32	1	the	the	DET
dti-3177	32	2	strong	strong	ADJ
dti-3177	32	3	correlation	correlation	NOUN
dti-3177	32	4	between	between	ADP
dti-3177	32	5	infectious	infectious	ADJ
dti-3177	32	6	diseases	disease	NOUN
dti-3177	32	7	and	and	CCONJ
dti-3177	32	8	cancer	cancer	NOUN
dti-3177	32	9	underscores	underscore	VERB
dti-3177	32	10	the	the	DET
dti-3177	32	11	importance	importance	NOUN
dti-3177	32	12	of	of	ADP
dti-3177	32	13	preventive	preventive	ADJ
dti-3177	32	14	measures	measure	NOUN
dti-3177	32	15	and	and	CCONJ
dti-3177	32	16	early	early	ADJ
dti-3177	32	17	detection	detection	NOUN
dti-3177	32	18	in	in	ADP
dti-3177	32	19	reducing	reduce	VERB
dti-3177	32	20	the	the	DET
dti-3177	32	21	burden	burden	NOUN
dti-3177	32	22	of	of	ADP
dti-3177	32	23	these	these	DET
dti-3177	32	24	malignancies	malignancy	NOUN
dti-3177	32	25	.	.	PUNCT
dti-3177	33	1	in	in	ADP
dti-3177	33	2	this	this	DET
dti-3177	33	3	way	way	NOUN
dti-3177	33	4	,	,	PUNCT
dti-3177	33	5	some	some	DET
dti-3177	33	6	parasites	parasite	NOUN
dti-3177	33	7	act	act	VERB
dti-3177	33	8	as	as	SCONJ
dti-3177	33	9	the	the	DET
dti-3177	33	10	inducers	inducer	NOUN
dti-3177	33	11	or	or	CCONJ
dti-3177	33	12	promoters	promoter	NOUN
dti-3177	33	13	of	of	ADP
dti-3177	33	14	the	the	DET
dti-3177	33	15	cancers	cancer	NOUN
dti-3177	33	16	and	and	CCONJ
dti-3177	33	17	others	other	NOUN
dti-3177	33	18	inhibit	inhibit	VERB
dti-3177	33	19	the	the	DET
dti-3177	33	20	factors	factor	NOUN
dti-3177	33	21	that	that	PRON
dti-3177	33	22	could	could	AUX
dti-3177	33	23	modulate	modulate	VERB
dti-3177	33	24	tumorigenesis	tumorigenesis	NOUN
dti-3177	33	25	.	.	PUNCT
dti-3177	34	1	so	so	ADV
dti-3177	34	2	far	far	ADV
dti-3177	34	3	,	,	PUNCT
dti-3177	34	4	investigations	investigation	NOUN
dti-3177	34	5	show	show	VERB
dti-3177	34	6	that	that	SCONJ
dti-3177	34	7	components	component	NOUN
dti-3177	34	8	of	of	ADP
dti-3177	34	9	parasites	parasite	NOUN
dti-3177	34	10	are	be	AUX
dti-3177	34	11	able	able	ADJ
dti-3177	34	12	to	to	PART
dti-3177	34	13	modulate	modulate	VERB
dti-3177	34	14	the	the	DET
dti-3177	34	15	cancer	cancer	NOUN
dti-3177	34	16	system	system	NOUN
dti-3177	34	17	by	by	ADP
dti-3177	34	18	inducing	induce	VERB
dti-3177	34	19	apoptosis	apoptosis	NOUN
dti-3177	34	20	(	(	PUNCT
dti-3177	34	21	10	10	NUM
dti-3177	34	22	)	)	PUNCT
dti-3177	34	23	.	.	PUNCT
dti-3177	35	1	studies	study	NOUN
dti-3177	35	2	have	have	AUX
dti-3177	35	3	shown	show	VERB
dti-3177	35	4	that	that	SCONJ
dti-3177	35	5	t.	t.	NOUN
dti-3177	35	6	gondii	gondii	NOUN
dti-3177	35	7	is	be	AUX
dti-3177	35	8	able	able	ADJ
dti-3177	35	9	to	to	PART
dti-3177	35	10	break	break	VERB
dti-3177	35	11	tumor	tumor	NOUN
dti-3177	35	12	immune	immune	ADJ
dti-3177	35	13	tolerance	tolerance	NOUN
dti-3177	35	14	and	and	CCONJ
dti-3177	35	15	arouse	arouse	VERB
dti-3177	35	16	potent	potent	ADJ
dti-3177	35	17	cd8	cd8	PROPN
dti-3177	35	18	+	+	PROPN
dti-3177	35	19	t	t	PROPN
dti-3177	35	20	-	-	PUNCT
dti-3177	35	21	cell	cell	NOUN
dti-3177	35	22	immunity	immunity	NOUN
dti-3177	35	23	(	(	PUNCT
dti-3177	35	24	11	11	NUM
dti-3177	35	25	)	)	PUNCT
dti-3177	35	26	.	.	PUNCT
dti-3177	36	1	in	in	ADP
dti-3177	36	2	the	the	DET
dti-3177	36	3	current	current	ADJ
dti-3177	36	4	study	study	NOUN
dti-3177	36	5	,	,	PUNCT
dti-3177	36	6	the	the	DET
dti-3177	36	7	effect	effect	NOUN
dti-3177	36	8	of	of	ADP
dti-3177	36	9	t.	t.	PROPN
dti-3177	36	10	gondii	gondii	NOUN
dti-3177	36	11	-	-	PUNCT
dti-3177	36	12	synthesized	synthesize	VERB
dti-3177	36	13	excretory	excretory	NOUN
dti-3177	36	14	-	-	PUNCT
dti-3177	36	15	secretory	secretory	ADJ
dti-3177	36	16	compound	compound	NOUN
dti-3177	36	17	in	in	ADP
dti-3177	36	18	cell	cell	NOUN
dti-3177	36	19	growth	growth	NOUN
dti-3177	36	20	factors	factor	NOUN
dti-3177	36	21	and	and	CCONJ
dti-3177	36	22	inducing	induce	VERB
dti-3177	36	23	apoptosis	apoptosis	NOUN
dti-3177	36	24	was	be	AUX
dti-3177	36	25	investigated	investigate	VERB
dti-3177	36	26	.	.	PUNCT
dti-3177	37	1	materials	material	NOUN
dti-3177	37	2	and	and	CCONJ
dti-3177	37	3	methods	method	NOUN
dti-3177	37	4	synthesis	synthesis	NOUN
dti-3177	37	5	of	of	ADP
dti-3177	37	6	peptide	peptide	NOUN
dti-3177	37	7	out	out	ADP
dti-3177	37	8	of	of	ADP
dti-3177	37	9	the	the	DET
dti-3177	37	10	acknowledged	acknowledge	VERB
dti-3177	37	11	proteomes	proteome	NOUN
dti-3177	37	12	of	of	ADP
dti-3177	37	13	t.	t.	PROPN
dti-3177	37	14	gondii	gondii	NOUN
dti-3177	37	15	excretory	excretory	NOUN
dti-3177	37	16	-	-	PUNCT
dti-3177	37	17	secretory	secretory	ADJ
dti-3177	37	18	antigens	antigen	NOUN
dti-3177	37	19	,	,	PUNCT
dti-3177	37	20	the	the	DET
dti-3177	37	21	qledavsavasvvqde	qledavsavasvvqde	NOUN
dti-3177	37	22	amino	amino	NOUN
dti-3177	37	23	acid	acid	NOUN
dti-3177	37	24	sequence	sequence	NOUN
dti-3177	37	25	belonging	belong	VERB
dti-3177	37	26	to	to	ADP
dti-3177	37	27	part	part	NOUN
dti-3177	37	28	gra1	gra1	PROPN
dti-3177	37	29	was	be	AUX
dti-3177	37	30	selected	select	VERB
dti-3177	37	31	.	.	PUNCT
dti-3177	38	1	it	it	PRON
dti-3177	38	2	is	be	AUX
dti-3177	38	3	noteworthy	noteworthy	ADJ
dti-3177	38	4	that	that	SCONJ
dti-3177	38	5	this	this	DET
dti-3177	38	6	sequence	sequence	NOUN
dti-3177	38	7	has	have	VERB
dti-3177	38	8	the	the	DET
dti-3177	38	9	most	most	ADJ
dti-3177	38	10	similarity	similarity	NOUN
dti-3177	38	11	to	to	ADP
dti-3177	38	12	the	the	DET
dti-3177	38	13	other	other	ADJ
dti-3177	38	14	anticancer	anticancer	NOUN
dti-3177	38	15	agents	agent	NOUN
dti-3177	38	16	(	(	PUNCT
dti-3177	38	17	≈91	≈91	NOUN
dti-3177	38	18	%	%	NOUN
dti-3177	38	19	)	)	PUNCT
dti-3177	38	20	by	by	ADP
dti-3177	38	21	the	the	DET
dti-3177	38	22	analysis	analysis	NOUN
dti-3177	38	23	done	do	VERB
dti-3177	38	24	in	in	ADP
dti-3177	38	25	association	association	NOUN
dti-3177	38	26	with	with	ADP
dti-3177	38	27	the	the	DET
dti-3177	38	28	anticancer	anticancer	NOUN
dti-3177	38	29	peptide	peptide	NOUN
dti-3177	38	30	database	database	NOUN
dti-3177	38	31	:	:	PUNCT
dti-3177	38	32	cancerppd	cancerppd	NOUN
dti-3177	38	33	site	site	NOUN
dti-3177	38	34	(	(	PUNCT
dti-3177	38	35	online	online	ADJ
dti-3177	38	36	)	)	PUNCT
dti-3177	38	37	.	.	PUNCT
dti-3177	39	1	following	follow	VERB
dti-3177	39	2	analysis	analysis	NOUN
dti-3177	39	3	of	of	ADP
dti-3177	39	4	the	the	DET
dti-3177	39	5	nominated	nominate	VERB
dti-3177	39	6	sequence	sequence	NOUN
dti-3177	39	7	and	and	CCONJ
dti-3177	39	8	confirmation	confirmation	NOUN
dti-3177	39	9	of	of	ADP
dti-3177	39	10	its	its	PRON
dti-3177	39	11	anticancer	anticancer	NOUN
dti-3177	39	12	potential	potential	NOUN
dti-3177	39	13	,	,	PUNCT
dti-3177	39	14	elabscience	elabscience	NOUN
dti-3177	39	15	was	be	AUX
dti-3177	39	16	proposed	propose	VERB
dti-3177	39	17	for	for	ADP
dti-3177	39	18	peptide	peptide	ADJ
dti-3177	39	19	synthesis	synthesis	NOUN
dti-3177	39	20	(	(	PUNCT
dti-3177	39	21	united	united	PROPN
dti-3177	39	22	states	states	PROPN
dti-3177	39	23	,	,	PUNCT
dti-3177	39	24	lot	lot	NOUN
dti-3177	39	25	no	no	PRON
dti-3177	39	26	:	:	PUNCT
dti-3177	39	27	yzigy9rhud	yzigy9rhud	PROPN
dti-3177	39	28	)	)	PUNCT
dti-3177	39	29	with	with	ADP
dti-3177	39	30	a	a	DET
dti-3177	39	31	purity	purity	NOUN
dti-3177	39	32	of	of	ADP
dti-3177	39	33	over	over	ADP
dti-3177	39	34	97.5	97.5	NUM
dti-3177	39	35	%	%	NOUN
dti-3177	39	36	and	and	CCONJ
dti-3177	39	37	a	a	DET
dti-3177	39	38	molecular	molecular	ADJ
dti-3177	39	39	weight	weight	NOUN
dti-3177	39	40	of	of	ADP
dti-3177	39	41	2,425.5	2,425.5	NUM
dti-3177	39	42	.	.	PUNCT
dti-3177	40	1	as	as	ADP
dti-3177	40	2	per	per	ADP
dti-3177	40	3	the	the	DET
dti-3177	40	4	guidelines	guideline	NOUN
dti-3177	40	5	provided	provide	VERB
dti-3177	40	6	by	by	ADP
dti-3177	40	7	the	the	DET
dti-3177	40	8	manufacturer	manufacturer	NOUN
dti-3177	40	9	,	,	PUNCT
dti-3177	40	10	by	by	ADP
dti-3177	40	11	applying	apply	VERB
dti-3177	40	12	ultra	ultra	ADJ
dti-3177	40	13	-	-	ADJ
dti-3177	40	14	pure	pure	ADJ
dti-3177	40	15	water	water	NOUN
dti-3177	40	16	,	,	PUNCT
dti-3177	40	17	the	the	DET
dti-3177	40	18	synthesized	synthesize	VERB
dti-3177	40	19	peptide	peptide	NOUN
dti-3177	40	20	underwent	underwent	NOUN
dti-3177	40	21	dilution	dilution	NOUN
dti-3177	40	22	and	and	CCONJ
dti-3177	40	23	was	be	AUX
dti-3177	40	24	subsequently	subsequently	ADV
dti-3177	40	25	prepared	prepare	VERB
dti-3177	40	26	in	in	ADP
dti-3177	40	27	various	various	ADJ
dti-3177	40	28	concentrations	concentration	NOUN
dti-3177	40	29	to	to	PART
dti-3177	40	30	evaluate	evaluate	VERB
dti-3177	40	31	cell	cell	NOUN
dti-3177	40	32	viability	viability	NOUN
dti-3177	40	33	and	and	CCONJ
dti-3177	40	34	perform	perform	VERB
dti-3177	40	35	molecular	molecular	ADJ
dti-3177	40	36	assays	assay	NOUN
dti-3177	40	37	.	.	PUNCT
dti-3177	41	1	anticancer	anticancer	NOUN
dti-3177	41	2	assays	assay	NOUN
dti-3177	41	3	in	in	ADP
dti-3177	41	4	vitro	vitro	X
dti-3177	41	5	cell	cell	NOUN
dti-3177	41	6	culture	culture	NOUN
dti-3177	41	7	and	and	CCONJ
dti-3177	41	8	treatments	treatment	VERB
dti-3177	41	9	the	the	DET
dti-3177	41	10	iranian	iranian	ADJ
dti-3177	41	11	biological	biological	ADJ
dti-3177	41	12	resource	resource	NOUN
dti-3177	41	13	center	center	PROPN
dti-3177	41	14	(	(	PUNCT
dti-3177	41	15	ibrc	ibrc	NOUN
dti-3177	41	16	)	)	PUNCT
dti-3177	41	17	provided	provide	VERB
dti-3177	41	18	the	the	DET
dti-3177	41	19	caco-2	caco-2	NOUN
dti-3177	41	20	,	,	PUNCT
dti-3177	41	21	hep	hep	NOUN
dti-3177	41	22	-	-	PUNCT
dti-3177	41	23	g2	g2	PROPN
dti-3177	41	24	,	,	PUNCT
dti-3177	41	25	and	and	CCONJ
dti-3177	41	26	ht29	ht29	PROPN
dti-3177	41	27	cell	cell	NOUN
dti-3177	41	28	lines	line	NOUN
dti-3177	41	29	,	,	PUNCT
dti-3177	41	30	which	which	PRON
dti-3177	41	31	are	be	AUX
dti-3177	41	32	human	human	ADJ
dti-3177	41	33	gastric	gastric	NOUN
dti-3177	41	34	,	,	PUNCT
dti-3177	41	35	colon	colon	NOUN
dti-3177	41	36	,	,	PUNCT
dti-3177	41	37	and	and	CCONJ
dti-3177	41	38	liver	liver	NOUN
dti-3177	41	39	cancer	cancer	NOUN
dti-3177	41	40	cell	cell	NOUN
dti-3177	41	41	lines	line	NOUN
dti-3177	41	42	,	,	PUNCT
dti-3177	41	43	respectively	respectively	ADV
dti-3177	41	44	.	.	PUNCT
dti-3177	42	1	these	these	DET
dti-3177	42	2	cell	cell	NOUN
dti-3177	42	3	lines	line	NOUN
dti-3177	42	4	were	be	AUX
dti-3177	42	5	cultured	cultured	ADJ
dti-3177	42	6	in	in	ADP
dti-3177	42	7	dulbecco	dulbecco	NOUN
dti-3177	42	8	’s	’s	PART
dti-3177	42	9	modified	modified	PROPN
dti-3177	42	10	eagle	eagle	PROPN
dti-3177	42	11	’s	’s	PART
dti-3177	42	12	medium	medium	NOUN
dti-3177	42	13	(	(	PUNCT
dti-3177	42	14	dmem)/f12	dmem)/f12	NOUN
dti-3177	42	15	,	,	PUNCT
dti-3177	42	16	supplemented	supplement	VERB
dti-3177	42	17	with	with	ADP
dti-3177	42	18	10	10	NUM
dti-3177	42	19	%	%	NOUN
dti-3177	42	20	fetal	fetal	ADJ
dti-3177	42	21	bovine	bovine	NOUN
dti-3177	42	22	serum	serum	NOUN
dti-3177	42	23	(	(	PUNCT
dti-3177	42	24	fbs	fbs	PROPN
dti-3177	42	25	;	;	PUNCT
dti-3177	42	26	gibco	gibco	NOUN
dti-3177	42	27	,	,	PUNCT
dti-3177	42	28	thermo	thermo	NOUN
dti-3177	42	29	fisher	fisher	PROPN
dti-3177	42	30	scientific	scientific	PROPN
dti-3177	42	31	)	)	PUNCT
dti-3177	42	32	and	and	CCONJ
dti-3177	42	33	2	2	NUM
dti-3177	42	34	mmol	mmol	NOUN
dti-3177	42	35	/	/	SYM
dti-3177	42	36	l	l	NOUN
dti-3177	42	37	l	l	NOUN
dti-3177	42	38	-	-	NOUN
dti-3177	42	39	glutamine	glutamine	NOUN
dti-3177	42	40	(	(	PUNCT
dti-3177	42	41	bio	bio	PROPN
dti-3177	42	42	idea	idea	PROPN
dti-3177	42	43	co	co	NOUN
dti-3177	42	44	,	,	PUNCT
dti-3177	42	45	iran	iran	PROPN
dti-3177	42	46	)	)	PUNCT
dti-3177	42	47	.	.	PUNCT
dti-3177	43	1	the	the	DET
dti-3177	43	2	growth	growth	NOUN
dti-3177	43	3	medium	medium	NOUN
dti-3177	43	4	for	for	ADP
dti-3177	43	5	all	all	DET
dti-3177	43	6	cell	cell	NOUN
dti-3177	43	7	lines	line	NOUN
dti-3177	43	8	consisted	consist	VERB
dti-3177	43	9	of	of	ADP
dti-3177	43	10	dmem	dmem	ADJ
dti-3177	43	11	/	/	SYM
dti-3177	43	12	f12	f12	NOUN
dti-3177	43	13	supplemented	supplement	VERB
dti-3177	43	14	with	with	ADP
dti-3177	43	15	glutamax	glutamax	ADJ
dti-3177	43	16	,	,	PUNCT
dti-3177	43	17	nahco3	nahco3	ADJ
dti-3177	43	18	,	,	PUNCT
dti-3177	43	19	and	and	CCONJ
dti-3177	43	20	15	15	NUM
dti-3177	43	21	mm	mm	NOUN
dti-3177	43	22	hepes	hepe	NOUN
dti-3177	43	23	.	.	PUNCT
dti-3177	44	1	to	to	PART
dti-3177	44	2	ensure	ensure	VERB
dti-3177	44	3	optimal	optimal	ADJ
dti-3177	44	4	conditions	condition	NOUN
dti-3177	44	5	for	for	ADP
dti-3177	44	6	cell	cell	NOUN
dti-3177	44	7	growth	growth	NOUN
dti-3177	44	8	,	,	PUNCT
dti-3177	44	9	the	the	DET
dti-3177	44	10	cells	cell	NOUN
dti-3177	44	11	were	be	AUX
dti-3177	44	12	incubated	incubate	VERB
dti-3177	44	13	at	at	ADP
dti-3177	44	14	a	a	DET
dti-3177	44	15	temperature	temperature	NOUN
dti-3177	44	16	of	of	ADP
dti-3177	44	17	37	37	NUM
dti-3177	44	18	°	°	NOUN
dti-3177	44	19	c	c	NOUN
dti-3177	44	20	in	in	ADP
dti-3177	44	21	a	a	DET
dti-3177	44	22	humidified	humidify	VERB
dti-3177	44	23	atmosphere	atmosphere	NOUN
dti-3177	44	24	consisting	consist	VERB
dti-3177	44	25	of	of	ADP
dti-3177	44	26	5	5	NUM
dti-3177	44	27	%	%	NOUN
dti-3177	44	28	carbon	carbon	NOUN
dti-3177	44	29	dioxide	dioxide	NOUN
dti-3177	44	30	(	(	PUNCT
dti-3177	44	31	12	12	NUM
dti-3177	44	32	)	)	PUNCT
dti-3177	44	33	.	.	PUNCT
dti-3177	45	1	mtt	mtt	PROPN
dti-3177	45	2	assay	assay	VERB
dti-3177	45	3	for	for	ADP
dti-3177	45	4	cell	cell	NOUN
dti-3177	45	5	viability	viability	NOUN
dti-3177	45	6	detection	detection	NOUN
dti-3177	45	7	after	after	ADP
dti-3177	45	8	achieving	achieve	VERB
dti-3177	45	9	a	a	DET
dti-3177	45	10	confluence	confluence	NOUN
dti-3177	45	11	of	of	ADP
dti-3177	45	12	90	90	NUM
dti-3177	45	13	%	%	NOUN
dti-3177	45	14	,	,	PUNCT
dti-3177	45	15	the	the	DET
dti-3177	45	16	cells	cell	NOUN
dti-3177	45	17	were	be	AUX
dti-3177	45	18	seeded	seed	VERB
dti-3177	45	19	into	into	ADP
dti-3177	45	20	the	the	DET
dti-3177	45	21	wells	well	NOUN
dti-3177	45	22	using	use	VERB
dti-3177	45	23	microscopic	microscopic	ADJ
dti-3177	45	24	counting	counting	NOUN
dti-3177	45	25	after	after	ADP
dti-3177	45	26	being	be	AUX
dti-3177	45	27	stained	stain	VERB
dti-3177	45	28	with	with	ADP
dti-3177	45	29	trypan	trypan	NOUN
dti-3177	45	30	blue	blue	NOUN
dti-3177	45	31	.	.	PUNCT
dti-3177	46	1	mtt	mtt	PROPN
dti-3177	46	2	assay	assay	PROPN
dti-3177	46	3	was	be	AUX
dti-3177	46	4	administered	administer	VERB
dti-3177	46	5	in	in	ADP
dti-3177	46	6	96	96	NUM
dti-3177	46	7	-	-	PUNCT
dti-3177	46	8	well	well	NOUN
dti-3177	46	9	culture	culture	NOUN
dti-3177	46	10	plates	plate	NOUN
dti-3177	46	11	for	for	ADP
dti-3177	46	12	cell	cell	NOUN
dti-3177	46	13	viability	viability	NOUN
dti-3177	46	14	.	.	PUNCT
dti-3177	47	1	each	each	DET
dti-3177	47	2	well	well	INTJ
dti-3177	47	3	was	be	AUX
dti-3177	47	4	seeded	seed	VERB
dti-3177	47	5	with	with	ADP
dti-3177	47	6	approximately	approximately	ADV
dti-3177	47	7	2	2	NUM
dti-3177	47	8	×	×	NOUN
dti-3177	47	9	104	104	NUM
dti-3177	47	10	cells	cell	NOUN
dti-3177	47	11	in	in	ADP
dti-3177	47	12	200	200	NUM
dti-3177	47	13	μl	μl	ADP
dti-3177	47	14	of	of	ADP
dti-3177	47	15	dmem	dmem	ADJ
dti-3177	47	16	medium	medium	NOUN
dti-3177	47	17	.	.	PUNCT
dti-3177	48	1	the	the	DET
dti-3177	48	2	plates	plate	NOUN
dti-3177	48	3	were	be	AUX
dti-3177	48	4	then	then	ADV
dti-3177	48	5	incubated	incubate	VERB
dti-3177	48	6	at	at	ADP
dti-3177	48	7	37	37	NUM
dti-3177	48	8	°	°	ADP
dti-3177	48	9	c	c	NOUN
dti-3177	48	10	and	and	CCONJ
dti-3177	48	11	5	5	NUM
dti-3177	48	12	%	%	NOUN
dti-3177	48	13	co2	co2	NOUN
dti-3177	48	14	for	for	ADP
dti-3177	48	15	24	24	NUM
dti-3177	48	16	hours	hour	NOUN
dti-3177	48	17	to	to	PART
dti-3177	48	18	ensure	ensure	VERB
dti-3177	48	19	proper	proper	ADJ
dti-3177	48	20	adherence	adherence	NOUN
dti-3177	48	21	of	of	ADP
dti-3177	48	22	the	the	DET
dti-3177	48	23	cells	cell	NOUN
dti-3177	48	24	to	to	ADP
dti-3177	48	25	the	the	DET
dti-3177	48	26	wells	well	NOUN
dti-3177	48	27	of	of	ADP
dti-3177	48	28	the	the	DET
dti-3177	48	29	plate	plate	NOUN
dti-3177	48	30	.	.	PUNCT
dti-3177	49	1	subsequently	subsequently	ADV
dti-3177	49	2	,	,	PUNCT
dti-3177	49	3	hep	hep	NOUN
dti-3177	49	4	-	-	PUNCT
dti-3177	49	5	g2	g2	PROPN
dti-3177	49	6	,	,	PUNCT
dti-3177	49	7	ht29	ht29	PROPN
dti-3177	49	8	,	,	PUNCT
dti-3177	49	9	and	and	CCONJ
dti-3177	49	10	caco-2	caco-2	NUM
dti-3177	49	11	cells	cell	NOUN
dti-3177	49	12	were	be	AUX
dti-3177	49	13	exposed	expose	VERB
dti-3177	49	14	to	to	ADP
dti-3177	49	15	elevating	elevate	VERB
dti-3177	49	16	concentrations	concentration	NOUN
dti-3177	49	17	of	of	ADP
dti-3177	49	18	t.	t.	NOUN
dti-3177	49	19	gondii	gondii	NOUN
dti-3177	49	20	peptide	peptide	NOUN
dti-3177	49	21	(	(	PUNCT
dti-3177	49	22	40	40	NUM
dti-3177	49	23	,	,	PUNCT
dti-3177	49	24	80	80	NUM
dti-3177	49	25	,	,	PUNCT
dti-3177	49	26	and	and	CCONJ
dti-3177	49	27	160	160	NUM
dti-3177	49	28	μg	μg	NOUN
dti-3177	49	29	/	/	SYM
dti-3177	49	30	ml	ml	NOUN
dti-3177	49	31	)	)	PUNCT
dti-3177	49	32	and	and	CCONJ
dti-3177	49	33	incubated	incubate	VERB
dti-3177	49	34	for	for	ADP
dti-3177	49	35	24	24	NUM
dti-3177	49	36	and	and	CCONJ
dti-3177	49	37	48	48	NUM
dti-3177	49	38	hours	hour	NOUN
dti-3177	49	39	in	in	ADP
dti-3177	49	40	the	the	DET
dti-3177	49	41	96	96	NUM
dti-3177	49	42	-	-	PUNCT
dti-3177	49	43	well	well	NOUN
dti-3177	49	44	culture	culture	NOUN
dti-3177	49	45	plates	plate	NOUN
dti-3177	49	46	.	.	PUNCT
dti-3177	50	1	the	the	DET
dti-3177	50	2	growth	growth	NOUN
dti-3177	50	3	of	of	ADP
dti-3177	50	4	the	the	DET
dti-3177	50	5	cells	cell	NOUN
dti-3177	50	6	was	be	AUX
dti-3177	50	7	assessed	assess	VERB
dti-3177	50	8	based	base	VERB
dti-3177	50	9	on	on	ADP
dti-3177	50	10	the	the	DET
dti-3177	50	11	activity	activity	NOUN
dti-3177	50	12	of	of	ADP
dti-3177	50	13	mitochondrial	mitochondrial	ADJ
dti-3177	50	14	enzymes	enzyme	NOUN
dti-3177	50	15	determined	determine	VERB
dti-3177	50	16	in	in	ADP
dti-3177	50	17	the	the	DET
dti-3177	50	18	mtt	mtt	NOUN
dti-3177	50	19	assay	assay	VERB
dti-3177	50	20	.	.	PUNCT
dti-3177	51	1	following	follow	VERB
dti-3177	51	2	24and	24and	NOUN
dti-3177	51	3	48	48	NUM
dti-3177	51	4	-	-	PUNCT
dti-3177	51	5	hour	hour	NOUN
dti-3177	51	6	exposure	exposure	NOUN
dti-3177	51	7	of	of	ADP
dti-3177	51	8	cell	cell	NOUN
dti-3177	51	9	lines	line	NOUN
dti-3177	51	10	to	to	ADP
dti-3177	51	11	the	the	DET
dti-3177	51	12	peptides	peptide	NOUN
dti-3177	51	13	,	,	PUNCT
dti-3177	51	14	20	20	NUM
dti-3177	51	15	μl	μl	ADP
dti-3177	51	16	volume	volume	NOUN
dti-3177	51	17	of	of	ADP
dti-3177	51	18	5	5	NUM
dti-3177	51	19	μg	μg	NOUN
dti-3177	51	20	/	/	SYM
dti-3177	51	21	ml	ml	NOUN
dti-3177	51	22	mtt	mtt	NOUN
dti-3177	51	23	solutions	solution	NOUN
dti-3177	51	24	were	be	AUX
dti-3177	51	25	added	add	VERB
dti-3177	51	26	to	to	ADP
dti-3177	51	27	the	the	DET
dti-3177	51	28	wells	well	NOUN
dti-3177	51	29	,	,	PUNCT
dti-3177	51	30	and	and	CCONJ
dti-3177	51	31	the	the	DET
dti-3177	51	32	plates	plate	NOUN
dti-3177	51	33	were	be	AUX
dti-3177	51	34	then	then	ADV
dti-3177	51	35	incubated	incubate	VERB
dti-3177	51	36	at	at	ADP
dti-3177	51	37	37	37	NUM
dti-3177	51	38	°	°	ADP
dti-3177	51	39	c	c	NOUN
dti-3177	51	40	for	for	ADP
dti-3177	51	41	an	an	DET
dti-3177	51	42	additional	additional	ADJ
dti-3177	51	43	4	4	NUM
dti-3177	51	44	hours	hour	NOUN
dti-3177	51	45	.	.	PUNCT
dti-3177	52	1	subsequently	subsequently	ADV
dti-3177	52	2	,	,	PUNCT
dti-3177	52	3	the	the	DET
dti-3177	52	4	wells	well	NOUN
dti-3177	52	5	were	be	AUX
dti-3177	52	6	emptied	empty	VERB
dti-3177	52	7	and	and	CCONJ
dti-3177	52	8	200	200	NUM
dti-3177	52	9	μl	μl	ADP
dti-3177	52	10	of	of	ADP
dti-3177	52	11	dimethyl	dimethyl	NOUN
dti-3177	52	12	sulfoxide	sulfoxide	NOUN
dti-3177	52	13	(	(	PUNCT
dti-3177	52	14	dmso	dmso	NOUN
dti-3177	52	15	)	)	PUNCT
dti-3177	52	16	was	be	AUX
dti-3177	52	17	added	add	VERB
dti-3177	52	18	to	to	ADP
dti-3177	52	19	all	all	DET
dti-3177	52	20	wells	well	NOUN
dti-3177	52	21	;	;	PUNCT
dti-3177	52	22	in	in	ADP
dti-3177	52	23	this	this	DET
dti-3177	52	24	specific	specific	ADJ
dti-3177	52	25	approach	approach	NOUN
dti-3177	52	26	,	,	PUNCT
dti-3177	52	27	living	living	NOUN
dti-3177	52	28	cells	cell	NOUN
dti-3177	52	29	contain	contain	VERB
dti-3177	52	30	nad(p)h	nad(p)h	NOUN
dti-3177	52	31	-	-	PUNCT
dti-3177	52	32	dependent	dependent	ADJ
dti-3177	52	33	oxidoreductase	oxidoreductase	NOUN
dti-3177	52	34	enzymes	enzyme	NOUN
dti-3177	52	35	that	that	PRON
dti-3177	52	36	facilitate	facilitate	VERB
dti-3177	52	37	the	the	DET
dti-3177	52	38	conversion	conversion	NOUN
dti-3177	52	39	of	of	ADP
dti-3177	52	40	the	the	DET
dti-3177	52	41	mtt	mtt	NOUN
dti-3177	52	42	reagent	reagent	NOUN
dti-3177	52	43	into	into	ADP
dti-3177	52	44	formazan	formazan	ADJ
dti-3177	52	45	crystalline	crystalline	NOUN
dti-3177	52	46	product	product	NOUN
dti-3177	52	47	,	,	PUNCT
dti-3177	52	48	leading	lead	VERB
dti-3177	52	49	to	to	ADP
dti-3177	52	50	purple	purple	ADJ
dti-3177	52	51	color	color	NOUN
dti-3177	52	52	.	.	PUNCT
dti-3177	53	1	the	the	DET
dti-3177	53	2	more	more	ADV
dti-3177	53	3	viable	viable	ADJ
dti-3177	53	4	cells	cell	NOUN
dti-3177	53	5	and	and	CCONJ
dti-3177	53	6	metabolic	metabolic	NOUN
dti-3177	53	7	activity	activity	NOUN
dti-3177	53	8	,	,	PUNCT
dti-3177	53	9	the	the	DET
dti-3177	53	10	more	more	ADJ
dti-3177	53	11	intensity	intensity	NOUN
dti-3177	53	12	of	of	ADP
dti-3177	53	13	purple	purple	ADJ
dti-3177	53	14	color	color	NOUN
dti-3177	53	15	(	(	PUNCT
dti-3177	53	16	13	13	NUM
dti-3177	53	17	)	)	PUNCT
dti-3177	53	18	.	.	PUNCT
dti-3177	54	1	to	to	PART
dti-3177	54	2	measure	measure	VERB
dti-3177	54	3	the	the	DET
dti-3177	54	4	optical	optical	ADJ
dti-3177	54	5	density	density	NOUN
dti-3177	54	6	(	(	PUNCT
dti-3177	54	7	od	od	NOUN
dti-3177	54	8	)	)	PUNCT
dti-3177	54	9	of	of	ADP
dti-3177	54	10	the	the	DET
dti-3177	54	11	wells	well	NOUN
dti-3177	54	12	,	,	PUNCT
dti-3177	54	13	a	a	DET
dti-3177	54	14	microplate	microplate	NOUN
dti-3177	54	15	spectrophotometer	spectrophotometer	NOUN
dti-3177	54	16	(	(	PUNCT
dti-3177	54	17	biotekelx800	biotekelx800	PROPN
dti-3177	54	18	,	,	PUNCT
dti-3177	54	19	united	united	ADJ
dti-3177	54	20	states	states	PROPN
dti-3177	54	21	)	)	PUNCT
dti-3177	54	22	was	be	AUX
dti-3177	54	23	employed	employ	VERB
dti-3177	54	24	at	at	ADP
dti-3177	54	25	570	570	NUM
dti-3177	54	26	nm	nm	NOUN
dti-3177	54	27	,	,	PUNCT
dti-3177	54	28	both	both	PRON
dti-3177	54	29	24	24	NUM
dti-3177	54	30	and	and	CCONJ
dti-3177	54	31	48	48	NUM
dti-3177	54	32	hours	hour	NOUN
dti-3177	54	33	after	after	ADP
dti-3177	54	34	exposure	exposure	NOUN
dti-3177	54	35	.	.	PUNCT
dti-3177	55	1	each	each	DET
dti-3177	55	2	concentration	concentration	NOUN
dti-3177	55	3	and	and	CCONJ
dti-3177	55	4	cell	cell	NOUN
dti-3177	55	5	lines	line	NOUN
dti-3177	55	6	were	be	AUX
dti-3177	55	7	subjected	subject	VERB
dti-3177	55	8	to	to	PART
dti-3177	55	9	triplicate	triplicate	VERB
dti-3177	55	10	experiments	experiment	NOUN
dti-3177	55	11	to	to	PART
dti-3177	55	12	ensure	ensure	VERB
dti-3177	55	13	the	the	DET
dti-3177	55	14	accuracy	accuracy	NOUN
dti-3177	55	15	and	and	CCONJ
dti-3177	55	16	reliability	reliability	NOUN
dti-3177	55	17	of	of	ADP
dti-3177	55	18	the	the	DET
dti-3177	55	19	results	result	NOUN
dti-3177	55	20	.	.	PUNCT
dti-3177	56	1	bcl2	bcl2	NOUN
dti-3177	56	2	,	,	PUNCT
dti-3177	56	3	apaf1	apaf1	NOUN
dti-3177	56	4	gene	gene	NOUN
dti-3177	56	5	expression	expression	NOUN
dti-3177	56	6	analysis	analysis	NOUN
dti-3177	56	7	the	the	DET
dti-3177	56	8	evaluation	evaluation	NOUN
dti-3177	56	9	of	of	ADP
dti-3177	56	10	gene	gene	NOUN
dti-3177	56	11	expression	expression	NOUN
dti-3177	56	12	was	be	AUX
dti-3177	56	13	conducted	conduct	VERB
dti-3177	56	14	using	use	VERB
dti-3177	56	15	the	the	DET
dti-3177	56	16	sybr	sybr	ADJ
dti-3177	56	17	green	green	ADV
dti-3177	56	18	-	-	PUNCT
dti-3177	56	19	based	base	VERB
dti-3177	56	20	quantitative	quantitative	ADJ
dti-3177	56	21	real	real	ADJ
dti-3177	56	22	-	-	PUNCT
dti-3177	56	23	time	time	NOUN
dti-3177	56	24	polymerase	polymerase	NOUN
dti-3177	56	25	chain	chain	NOUN
dti-3177	56	26	reaction	reaction	NOUN
dti-3177	56	27	(	(	PUNCT
dti-3177	56	28	pcr	pcr	ADJ
dti-3177	56	29	)	)	PUNCT
dti-3177	56	30	technique	technique	NOUN
dti-3177	56	31	.	.	PUNCT
dti-3177	57	1	in	in	ADP
dti-3177	57	2	order	order	NOUN
dti-3177	57	3	to	to	PART
dti-3177	57	4	measure	measure	VERB
dti-3177	57	5	the	the	DET
dti-3177	57	6	messenger	messenger	NOUN
dti-3177	57	7	ribonucleic	ribonucleic	ADJ
dti-3177	57	8	acid	acid	PROPN
dti-3177	57	9	(	(	PUNCT
dti-3177	57	10	mrna	mrna	PROPN
dti-3177	57	11	)	)	PUNCT
dti-3177	57	12	expression	expression	NOUN
dti-3177	57	13	of	of	ADP
dti-3177	57	14	the	the	DET
dti-3177	57	15	bcl2	bcl2	NOUN
dti-3177	57	16	and	and	CCONJ
dti-3177	57	17	apaf1	apaf1	NOUN
dti-3177	57	18	genes	gene	NOUN
dti-3177	57	19	,	,	PUNCT
dti-3177	57	20	the	the	DET
dti-3177	57	21	genomic	genomic	NOUN
dti-3177	57	22	content	content	NOUN
dti-3177	57	23	(	(	PUNCT
dti-3177	57	24	total	total	ADJ
dti-3177	57	25	rna	rna	NOUN
dti-3177	57	26	)	)	PUNCT
dti-3177	57	27	was	be	AUX
dti-3177	57	28	extracted	extract	VERB
dti-3177	57	29	from	from	ADP
dti-3177	57	30	all	all	DET
dti-3177	57	31	cultured	cultured	ADJ
dti-3177	57	32	cell	cell	NOUN
dti-3177	57	33	lines	line	NOUN
dti-3177	57	34	.	.	PUNCT
dti-3177	58	1	qiazol	qiazol	ADJ
dti-3177	58	2	rna	rna	NOUN
dti-3177	58	3	(	(	PUNCT
dti-3177	58	4	qiagen	qiagen	PROPN
dti-3177	58	5	,	,	PUNCT
dti-3177	58	6	united	united	PROPN
dti-3177	58	7	states	states	PROPN
dti-3177	58	8	)	)	PUNCT
dti-3177	58	9	was	be	AUX
dti-3177	58	10	utilized	utilize	VERB
dti-3177	58	11	for	for	ADP
dti-3177	58	12	this	this	DET
dti-3177	58	13	purpose	purpose	NOUN
dti-3177	58	14	,	,	PUNCT
dti-3177	58	15	following	follow	VERB
dti-3177	58	16	the	the	DET
dti-3177	58	17	manufacturer	manufacturer	NOUN
dti-3177	58	18	’s	’s	PART
dti-3177	58	19	protocol	protocol	NOUN
dti-3177	58	20	.	.	PUNCT
dti-3177	59	1	the	the	DET
dti-3177	59	2	nanodrop	nanodrop	PROPN
dti-3177	59	3	spectrophotometer	spectrophotometer	NOUN
dti-3177	59	4	(	(	PUNCT
dti-3177	59	5	thermo	thermo	NOUN
dti-3177	59	6	scientific	scientific	ADJ
dti-3177	59	7	™	™	ADJ
dti-3177	59	8	nanodrop	nanodrop	NOUN
dti-3177	59	9	2000c	2000c	NUM
dti-3177	59	10	spectrophotometer	spectrophotometer	NOUN
dti-3177	59	11	)	)	PUNCT
dti-3177	59	12	was	be	AUX
dti-3177	59	13	used	use	VERB
dti-3177	59	14	to	to	PART
dti-3177	59	15	evaluate	evaluate	VERB
dti-3177	59	16	the	the	DET
dti-3177	59	17	quantity	quantity	NOUN
dti-3177	59	18	,	,	PUNCT
dti-3177	59	19	quality	quality	NOUN
dti-3177	59	20	,	,	PUNCT
dti-3177	59	21	and	and	CCONJ
dti-3177	59	22	optimal	optimal	ADJ
dti-3177	59	23	concentration	concentration	NOUN
dti-3177	59	24	of	of	ADP
dti-3177	59	25	the	the	DET
dti-3177	59	26	collected	collect	VERB
dti-3177	59	27	rnas	rna	NOUN
dti-3177	59	28	at	at	ADP
dti-3177	59	29	a	a	DET
dti-3177	59	30	260/280	260/280	NUM
dti-3177	59	31	nm	nm	PRON
dti-3177	59	32	ratio	ratio	NOUN
dti-3177	59	33	.	.	PUNCT
dti-3177	60	1	following	follow	VERB
dti-3177	60	2	this	this	PRON
dti-3177	60	3	,	,	PUNCT
dti-3177	60	4	the	the	DET
dti-3177	60	5	rnas	rna	NOUN
dti-3177	60	6	were	be	AUX
dti-3177	60	7	transformed	transform	VERB
dti-3177	60	8	into	into	ADP
dti-3177	60	9	complementary	complementary	ADJ
dti-3177	60	10	deoxyribonucleic	deoxyribonucleic	ADJ
dti-3177	60	11	acid	acid	NOUN
dti-3177	60	12	(	(	PUNCT
dti-3177	60	13	cdna	cdna	PROPN
dti-3177	60	14	)	)	PUNCT
dti-3177	60	15	by	by	ADP
dti-3177	60	16	reverse	reverse	ADJ
dti-3177	60	17	transcription	transcription	NOUN
dti-3177	60	18	,	,	PUNCT
dti-3177	60	19	utilizing	utilize	VERB
dti-3177	60	20	rt	rt	NOUN
dti-3177	60	21	-	-	PUNCT
dti-3177	60	22	specific	specific	ADJ
dti-3177	60	23	primers	primer	NOUN
dti-3177	60	24	and	and	CCONJ
dti-3177	60	25	glyceraldehyde	glyceraldehyde	NOUN
dti-3177	60	26	3	3	NUM
dti-3177	60	27	-	-	PUNCT
dti-3177	60	28	phosphate	phosphate	NOUN
dti-3177	60	29	dehydrogenase	dehydrogenase	NOUN
dti-3177	60	30	(	(	PUNCT
dti-3177	60	31	gapdh	gapdh	NOUN
dti-3177	60	32	)	)	PUNCT
dti-3177	60	33	as	as	ADP
dti-3177	60	34	a	a	DET
dti-3177	60	35	reference	reference	NOUN
dti-3177	60	36	gene	gene	NOUN
dti-3177	60	37	for	for	ADP
dti-3177	60	38	data	data	NOUN
dti-3177	60	39	normalization	normalization	NOUN
dti-3177	60	40	(	(	PUNCT
dti-3177	60	41	tab	tab	NOUN
dti-3177	60	42	.	.	NOUN
dti-3177	60	43	1	1	NUM
dti-3177	60	44	)	)	PUNCT
dti-3177	60	45	.	.	PUNCT
dti-3177	61	1	a	a	DET
dti-3177	61	2	lightcycler	lightcycler	ADJ
dti-3177	61	3	®	®	NOUN
dti-3177	61	4	96	96	NUM
dti-3177	61	5	thermal	thermal	ADJ
dti-3177	61	6	cycler	cycler	NOUN
dti-3177	61	7	(	(	PUNCT
dti-3177	61	8	roche	roche	PROPN
dti-3177	61	9	,	,	PUNCT
dti-3177	61	10	germany	germany	PROPN
dti-3177	61	11	)	)	PUNCT
dti-3177	61	12	was	be	AUX
dti-3177	61	13	used	use	VERB
dti-3177	61	14	to	to	PART
dti-3177	61	15	conduct	conduct	VERB
dti-3177	61	16	real	real	ADJ
dti-3177	61	17	-	-	PUNCT
dti-3177	61	18	time	time	NOUN
dti-3177	61	19	reverse	reverse	NOUN
dti-3177	61	20	transcription	transcription	NOUN
dti-3177	61	21	(	(	PUNCT
dti-3177	61	22	rt)-pcr	rt)-pcr	PROPN
dti-3177	61	23	.	.	PUNCT
dti-3177	62	1	within	within	ADP
dti-3177	62	2	each	each	DET
dti-3177	62	3	reaction	reaction	NOUN
dti-3177	62	4	,	,	PUNCT
dti-3177	62	5	a	a	DET
dti-3177	62	6	20	20	NUM
dti-3177	62	7	μl	μl	PRON
dti-3177	62	8	mixture	mixture	NOUN
dti-3177	62	9	was	be	AUX
dti-3177	62	10	prepared	prepare	VERB
dti-3177	62	11	,	,	PUNCT
dti-3177	62	12	containing	contain	VERB
dti-3177	62	13	8	8	NUM
dti-3177	62	14	μl	μl	ADP
dti-3177	62	15	of	of	ADP
dti-3177	62	16	sybr	sybr	NOUN
dti-3177	62	17	green	green	NOUN
dti-3177	63	1	i	i	PRON
dti-3177	63	2	master	master	NOUN
dti-3177	63	3	mix	mix	PROPN
dti-3177	63	4	,	,	PUNCT
dti-3177	63	5	1	1	NUM
dti-3177	63	6	μl	μl	NUM
dti-3177	63	7	of	of	ADP
dti-3177	63	8	cdna	cdna	PROPN
dti-3177	63	9	serving	serve	VERB
dti-3177	63	10	as	as	ADP
dti-3177	63	11	the	the	DET
dti-3177	63	12	template	template	NOUN
dti-3177	63	13	,	,	PUNCT
dti-3177	63	14	8	8	NUM
dti-3177	63	15	μl	μl	NUM
dti-3177	63	16	of	of	ADP
dti-3177	63	17	nuclease	nuclease	NOUN
dti-3177	63	18	-	-	PUNCT
dti-3177	63	19	free	free	ADJ
dti-3177	63	20	distilled	distil	VERB
dti-3177	63	21	water	water	NOUN
dti-3177	63	22	,	,	PUNCT
dti-3177	63	23	and	and	CCONJ
dti-3177	63	24	10	10	NUM
dti-3177	63	25	pmol	pmol	NOUN
dti-3177	63	26	of	of	ADP
dti-3177	63	27	each	each	DET
dti-3177	63	28	primer	primer	NOUN
dti-3177	63	29	.	.	PUNCT
dti-3177	64	1	in	in	ADP
dti-3177	64	2	the	the	DET
dti-3177	64	3	amplification	amplification	NOUN
dti-3177	64	4	program	program	NOUN
dti-3177	64	5	,	,	PUNCT
dti-3177	64	6	the	the	DET
dti-3177	64	7	initial	initial	ADJ
dti-3177	64	8	denaturation	denaturation	NOUN
dti-3177	64	9	step	step	NOUN
dti-3177	64	10	was	be	AUX
dti-3177	64	11	performed	perform	VERB
dti-3177	64	12	at	at	ADP
dti-3177	64	13	a	a	DET
dti-3177	64	14	temperature	temperature	NOUN
dti-3177	64	15	of	of	ADP
dti-3177	64	16	95	95	NUM
dti-3177	64	17	°	°	ADP
dti-3177	64	18	c	c	NOUN
dti-3177	64	19	for	for	ADP
dti-3177	64	20	a	a	DET
dti-3177	64	21	duration	duration	NOUN
dti-3177	64	22	of	of	ADP
dti-3177	64	23	8	8	NUM
dti-3177	64	24	minutes	minute	NOUN
dti-3177	64	25	.	.	PUNCT
dti-3177	65	1	this	this	PRON
dti-3177	65	2	was	be	AUX
dti-3177	65	3	followed	follow	VERB
dti-3177	65	4	by	by	ADP
dti-3177	65	5	40	40	NUM
dti-3177	65	6	-	-	SYM
dti-3177	65	7	45	45	NUM
dti-3177	65	8	cycles	cycle	NOUN
dti-3177	65	9	of	of	ADP
dti-3177	65	10	denaturation	denaturation	NOUN
dti-3177	65	11	at	at	ADP
dti-3177	65	12	95	95	NUM
dti-3177	65	13	°	°	ADP
dti-3177	65	14	c	c	NOUN
dti-3177	65	15	for	for	ADP
dti-3177	65	16	10	10	NUM
dti-3177	65	17	seconds	second	NOUN
dti-3177	65	18	,	,	PUNCT
dti-3177	65	19	annealing	anneal	VERB
dti-3177	65	20	at	at	ADP
dti-3177	65	21	57	57	NUM
dti-3177	65	22	-	-	SYM
dti-3177	65	23	62	62	NUM
dti-3177	65	24	°	°	ADP
dti-3177	65	25	c	c	NOUN
dti-3177	65	26	for	for	ADP
dti-3177	65	27	5	5	NUM
dti-3177	65	28	seconds	second	NOUN
dti-3177	65	29	,	,	PUNCT
dti-3177	65	30	and	and	CCONJ
dti-3177	65	31	extension	extension	NOUN
dti-3177	65	32	at	at	ADP
dti-3177	65	33	72	72	NUM
dti-3177	65	34	°	°	ADP
dti-3177	65	35	c	c	NOUN
dti-3177	65	36	for	for	ADP
dti-3177	65	37	20	20	NUM
dti-3177	65	38	seconds	second	NOUN
dti-3177	65	39	(	(	PUNCT
dti-3177	65	40	14,15	14,15	NUM
dti-3177	65	41	)	)	PUNCT
dti-3177	65	42	.	.	PUNCT
dti-3177	66	1	http://crdd.osdd.net/raghava/cancerppd/index.php	http://crdd.osdd.net/raghava/cancerppd/index.php	PROPN
dti-3177	66	2	toxoplasma	toxoplasma	NOUN
dti-3177	66	3	gondii	gondii	NOUN
dti-3177	66	4	es	es	NOUN
dti-3177	66	5	ags	ag	NOUN
dti-3177	66	6	peptide	peptide	NOUN
dti-3177	66	7	induces	induce	VERB
dti-3177	66	8	apoptosis72	apoptosis72	NOUN
dti-3177	67	1	©	©	ADP
dti-3177	67	2	2024	2024	NUM
dti-3177	68	1	the	the	DET
dti-3177	68	2	authors	author	NOUN
dti-3177	68	3	.	.	PUNCT
dti-3177	69	1	drug	drug	NOUN
dti-3177	69	2	target	target	NOUN
dti-3177	69	3	insights	insight	NOUN
dti-3177	69	4	issn	issn	VERB
dti-3177	69	5	1177	1177	NUM
dti-3177	69	6	-	-	SYM
dti-3177	69	7	3928	3928	NUM
dti-3177	69	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-3177	69	9	apoptosis	apoptosis	NOUN
dti-3177	69	10	analysis	analysis	NOUN
dti-3177	69	11	apoptosis	apoptosis	NOUN
dti-3177	69	12	evaluation	evaluation	NOUN
dti-3177	69	13	was	be	AUX
dti-3177	69	14	conducted	conduct	VERB
dti-3177	69	15	using	use	VERB
dti-3177	69	16	the	the	DET
dti-3177	69	17	annexin	annexin	NOUN
dti-3177	69	18	v	v	ADP
dti-3177	69	19	/	/	SYM
dti-3177	69	20	pi	pi	NOUN
dti-3177	69	21	apoptosis	apoptosis	NOUN
dti-3177	69	22	detection	detection	NOUN
dti-3177	69	23	kit	kit	NOUN
dti-3177	69	24	(	(	PUNCT
dti-3177	69	25	cat	cat	NOUN
dti-3177	69	26	.	.	PUNCT
dti-3177	70	1	no	no	INTJ
dti-3177	70	2	.	.	PUNCT
dti-3177	71	1	anxf100pi	anxf100pi	PROPN
dti-3177	71	2	,	,	PUNCT
dti-3177	71	3	mabtag	mabtag	NOUN
dti-3177	71	4	gmbh	gmbh	NOUN
dti-3177	71	5	)	)	PUNCT
dti-3177	71	6	following	follow	VERB
dti-3177	71	7	peptide	peptide	ADJ
dti-3177	71	8	treatments	treatment	NOUN
dti-3177	71	9	.	.	PUNCT
dti-3177	72	1	a	a	DET
dti-3177	72	2	6	6	NUM
dti-3177	72	3	-	-	PUNCT
dti-3177	72	4	well	well	NOUN
dti-3177	72	5	plate	plate	NOUN
dti-3177	72	6	was	be	AUX
dti-3177	72	7	utilized	utilize	VERB
dti-3177	72	8	,	,	PUNCT
dti-3177	72	9	with	with	ADP
dti-3177	72	10	each	each	DET
dti-3177	72	11	well	well	NOUN
dti-3177	72	12	containing	contain	VERB
dti-3177	72	13	a	a	DET
dti-3177	72	14	volume	volume	NOUN
dti-3177	72	15	of	of	ADP
dti-3177	72	16	2.5	2.5	NUM
dti-3177	72	17	ml	ml	NOUN
dti-3177	72	18	cell	cell	NOUN
dti-3177	72	19	suspension	suspension	NOUN
dti-3177	72	20	at	at	ADP
dti-3177	72	21	a	a	DET
dti-3177	72	22	density	density	NOUN
dti-3177	72	23	of	of	ADP
dti-3177	72	24	3	3	NUM
dti-3177	72	25	×	×	NOUN
dti-3177	72	26	105	105	NUM
dti-3177	72	27	cells	cell	NOUN
dti-3177	72	28	/	/	SYM
dti-3177	72	29	ml	ml	NOUN
dti-3177	72	30	.	.	PUNCT
dti-3177	73	1	following	follow	VERB
dti-3177	73	2	24	24	NUM
dti-3177	73	3	-	-	PUNCT
dti-3177	73	4	hour	hour	NOUN
dti-3177	73	5	cultures	culture	NOUN
dti-3177	73	6	of	of	ADP
dti-3177	73	7	all	all	DET
dti-3177	73	8	three	three	NUM
dti-3177	73	9	kinds	kind	NOUN
dti-3177	73	10	of	of	ADP
dti-3177	73	11	cells	cell	NOUN
dti-3177	73	12	in	in	ADP
dti-3177	73	13	200	200	NUM
dti-3177	73	14	μm	μm	NOUN
dti-3177	73	15	of	of	ADP
dti-3177	73	16	the	the	DET
dti-3177	73	17	peptide	peptide	NOUN
dti-3177	73	18	,	,	PUNCT
dti-3177	73	19	in	in	ADP
dti-3177	73	20	accordance	accordance	NOUN
dti-3177	73	21	with	with	ADP
dti-3177	73	22	the	the	DET
dti-3177	73	23	procedures	procedure	NOUN
dti-3177	73	24	outlined	outline	VERB
dti-3177	73	25	in	in	ADP
dti-3177	73	26	the	the	DET
dti-3177	73	27	preceding	precede	VERB
dti-3177	73	28	section	section	NOUN
dti-3177	73	29	,	,	PUNCT
dti-3177	73	30	the	the	DET
dti-3177	73	31	cells	cell	NOUN
dti-3177	73	32	underwent	undergo	VERB
dti-3177	73	33	the	the	DET
dti-3177	73	34	specified	specified	ADJ
dti-3177	73	35	treatment	treatment	NOUN
dti-3177	73	36	.	.	PUNCT
dti-3177	74	1	the	the	DET
dti-3177	74	2	negative	negative	ADJ
dti-3177	74	3	control	control	PROPN
dti-3177	74	4	group	group	NOUN
dti-3177	74	5	received	receive	VERB
dti-3177	74	6	an	an	DET
dti-3177	74	7	equivalent	equivalent	ADJ
dti-3177	74	8	amount	amount	NOUN
dti-3177	74	9	of	of	ADP
dti-3177	74	10	phosphate	phosphate	NOUN
dti-3177	74	11	-	-	PUNCT
dti-3177	74	12	buffered	buffer	VERB
dti-3177	74	13	saline	saline	NOUN
dti-3177	74	14	(	(	PUNCT
dti-3177	74	15	pbs	pbs	PROPN
dti-3177	74	16	)	)	PUNCT
dti-3177	74	17	.	.	PUNCT
dti-3177	75	1	after	after	ADP
dti-3177	75	2	the	the	DET
dti-3177	75	3	incubation	incubation	NOUN
dti-3177	75	4	period	period	NOUN
dti-3177	75	5	,	,	PUNCT
dti-3177	75	6	the	the	DET
dti-3177	75	7	cells	cell	NOUN
dti-3177	75	8	were	be	AUX
dti-3177	75	9	collected	collect	VERB
dti-3177	75	10	and	and	CCONJ
dti-3177	75	11	underwent	undergo	VERB
dti-3177	75	12	two	two	NUM
dti-3177	75	13	rounds	round	NOUN
dti-3177	75	14	of	of	ADP
dti-3177	75	15	washing	washing	NOUN
dti-3177	75	16	with	with	ADP
dti-3177	75	17	cold	cold	ADJ
dti-3177	75	18	pbs	pbs	PROPN
dti-3177	75	19	at	at	ADP
dti-3177	75	20	a	a	DET
dti-3177	75	21	ph	ph	NOUN
dti-3177	75	22	of	of	ADP
dti-3177	75	23	7.4	7.4	NUM
dti-3177	75	24	.	.	PUNCT
dti-3177	76	1	subsequently	subsequently	ADV
dti-3177	76	2	,	,	PUNCT
dti-3177	76	3	the	the	DET
dti-3177	76	4	cells	cell	NOUN
dti-3177	76	5	were	be	AUX
dti-3177	76	6	suspended	suspend	VERB
dti-3177	76	7	in	in	ADP
dti-3177	76	8	annexin	annexin	NOUN
dti-3177	76	9	-	-	PUNCT
dti-3177	76	10	binding	bind	VERB
dti-3177	76	11	buffer	buffer	NOUN
dti-3177	76	12	and	and	CCONJ
dti-3177	76	13	exposed	expose	VERB
dti-3177	76	14	to	to	ADP
dti-3177	76	15	5	5	NUM
dti-3177	76	16	μl	μl	ADP
dti-3177	76	17	of	of	ADP
dti-3177	76	18	fluorescein	fluorescein	ADJ
dti-3177	76	19	isothiocyanate	isothiocyanate	NOUN
dti-3177	76	20	(	(	PUNCT
dti-3177	76	21	fitc)-annexin	fitc)-annexin	PROPN
dti-3177	76	22	v	v	PROPN
dti-3177	76	23	and	and	CCONJ
dti-3177	76	24	5	5	NUM
dti-3177	76	25	μl	μl	ADP
dti-3177	76	26	of	of	ADP
dti-3177	76	27	propidium	propidium	NOUN
dti-3177	76	28	iodide	iodide	NOUN
dti-3177	76	29	(	(	PUNCT
dti-3177	76	30	pi	pi	NOUN
dti-3177	76	31	)	)	PUNCT
dti-3177	76	32	.	.	PUNCT
dti-3177	77	1	the	the	DET
dti-3177	77	2	samples	sample	NOUN
dti-3177	77	3	were	be	AUX
dti-3177	77	4	thoroughly	thoroughly	ADV
dti-3177	77	5	mixed	mixed	ADJ
dti-3177	77	6	and	and	CCONJ
dti-3177	77	7	incubated	incubate	VERB
dti-3177	77	8	in	in	ADP
dti-3177	77	9	darkness	darkness	NOUN
dti-3177	77	10	at	at	ADP
dti-3177	77	11	a	a	DET
dti-3177	77	12	temperature	temperature	NOUN
dti-3177	77	13	of	of	ADP
dti-3177	77	14	25	25	NUM
dti-3177	77	15	°	°	NOUN
dti-3177	77	16	c	c	NOUN
dti-3177	77	17	for	for	ADP
dti-3177	77	18	a	a	DET
dti-3177	77	19	duration	duration	NOUN
dti-3177	77	20	of	of	ADP
dti-3177	77	21	15	15	NUM
dti-3177	77	22	minutes	minute	NOUN
dti-3177	77	23	.	.	PUNCT
dti-3177	78	1	the	the	DET
dti-3177	78	2	stained	stain	VERB
dti-3177	78	3	cells	cell	NOUN
dti-3177	78	4	were	be	AUX
dti-3177	78	5	then	then	ADV
dti-3177	78	6	analyzed	analyze	VERB
dti-3177	78	7	using	use	VERB
dti-3177	78	8	a	a	DET
dti-3177	78	9	sysmex	sysmex	NOUN
dti-3177	78	10	cyflow	cyflow	NOUN
dti-3177	78	11	space	space	NOUN
dti-3177	78	12	flow	flow	NOUN
dti-3177	78	13	cytometer	cytometer	NOUN
dti-3177	78	14	.	.	PUNCT
dti-3177	79	1	the	the	DET
dti-3177	79	2	fluorescence	fluorescence	NOUN
dti-3177	79	3	emitted	emit	VERB
dti-3177	79	4	by	by	ADP
dti-3177	79	5	the	the	DET
dti-3177	79	6	cells	cell	NOUN
dti-3177	79	7	was	be	AUX
dti-3177	79	8	measured	measure	VERB
dti-3177	79	9	at	at	ADP
dti-3177	79	10	wavelengths	wavelength	NOUN
dti-3177	79	11	of	of	ADP
dti-3177	79	12	495	495	NUM
dti-3177	79	13	and	and	CCONJ
dti-3177	79	14	519	519	NUM
dti-3177	79	15	nm	nm	ADJ
dti-3177	79	16	following	follow	VERB
dti-3177	79	17	excitation	excitation	NOUN
dti-3177	79	18	at	at	ADP
dti-3177	79	19	488	488	NUM
dti-3177	79	20	nm	nm	NOUN
dti-3177	79	21	(	(	PUNCT
dti-3177	79	22	16	16	NUM
dti-3177	79	23	)	)	PUNCT
dti-3177	79	24	.	.	PUNCT
dti-3177	80	1	statistical	statistical	ADJ
dti-3177	80	2	analysis	analysis	NOUN
dti-3177	80	3	in	in	ADP
dti-3177	80	4	the	the	DET
dti-3177	80	5	current	current	ADJ
dti-3177	80	6	investigation	investigation	NOUN
dti-3177	80	7	,	,	PUNCT
dti-3177	80	8	all	all	DET
dti-3177	80	9	experiments	experiment	NOUN
dti-3177	80	10	were	be	AUX
dti-3177	80	11	repeated	repeat	VERB
dti-3177	80	12	in	in	ADP
dti-3177	80	13	triplicate	triplicate	NOUN
dti-3177	80	14	.	.	PUNCT
dti-3177	81	1	statistical	statistical	ADJ
dti-3177	81	2	analysis	analysis	NOUN
dti-3177	81	3	was	be	AUX
dti-3177	81	4	conducted	conduct	VERB
dti-3177	81	5	to	to	PART
dti-3177	81	6	compare	compare	VERB
dti-3177	81	7	and	and	CCONJ
dti-3177	81	8	evaluate	evaluate	VERB
dti-3177	81	9	the	the	DET
dti-3177	81	10	treated	treat	VERB
dti-3177	81	11	groups	group	NOUN
dti-3177	81	12	in	in	ADP
dti-3177	81	13	relation	relation	NOUN
dti-3177	81	14	to	to	ADP
dti-3177	81	15	both	both	DET
dti-3177	81	16	each	each	DET
dti-3177	81	17	other	other	ADJ
dti-3177	81	18	and	and	CCONJ
dti-3177	81	19	the	the	DET
dti-3177	81	20	control	control	NOUN
dti-3177	81	21	group	group	NOUN
dti-3177	81	22	.	.	PUNCT
dti-3177	82	1	the	the	DET
dti-3177	82	2	comparative	comparative	ADJ
dti-3177	82	3	ct	ct	PROPN
dti-3177	82	4	(	(	PUNCT
dti-3177	82	5	δδct	δδct	NOUN
dti-3177	82	6	)	)	PUNCT
dti-3177	82	7	method	method	NOUN
dti-3177	82	8	was	be	AUX
dti-3177	82	9	employed	employ	VERB
dti-3177	82	10	to	to	PART
dti-3177	82	11	statistically	statistically	ADV
dti-3177	82	12	analyze	analyze	VERB
dti-3177	82	13	the	the	DET
dti-3177	82	14	data	datum	NOUN
dti-3177	82	15	.	.	PUNCT
dti-3177	83	1	prior	prior	ADV
dti-3177	83	2	to	to	ADP
dti-3177	83	3	analysis	analysis	NOUN
dti-3177	83	4	,	,	PUNCT
dti-3177	83	5	the	the	DET
dti-3177	83	6	real	real	ADJ
dti-3177	83	7	-	-	PUNCT
dti-3177	83	8	time	time	NOUN
dti-3177	83	9	pcr	pcr	PROPN
dti-3177	83	10	findings	finding	NOUN
dti-3177	83	11	underwent	underwent	NOUN
dti-3177	83	12	preprocessing	preprocessing	NOUN
dti-3177	83	13	.	.	PUNCT
dti-3177	84	1	subsequently	subsequently	ADV
dti-3177	84	2	,	,	PUNCT
dti-3177	84	3	the	the	DET
dti-3177	84	4	expression	expression	NOUN
dti-3177	84	5	levels	level	NOUN
dti-3177	84	6	of	of	ADP
dti-3177	84	7	selected	select	VERB
dti-3177	84	8	genes	gene	NOUN
dti-3177	84	9	(	(	PUNCT
dti-3177	84	10	bcl2	bcl2	NOUN
dti-3177	84	11	,	,	PUNCT
dti-3177	84	12	apaf1	apaf1	PROPN
dti-3177	84	13	)	)	PUNCT
dti-3177	84	14	among	among	ADP
dti-3177	84	15	the	the	DET
dti-3177	84	16	study	study	NOUN
dti-3177	84	17	groups	group	NOUN
dti-3177	84	18	were	be	AUX
dti-3177	84	19	evaluated	evaluate	VERB
dti-3177	84	20	using	use	VERB
dti-3177	84	21	kruskal	kruskal	PROPN
dti-3177	84	22	-	-	PUNCT
dti-3177	84	23	wallis	wallis	PROPN
dti-3177	84	24	and	and	CCONJ
dti-3177	84	25	mann	mann	PROPN
dti-3177	84	26	-	-	PUNCT
dti-3177	84	27	whitney	whitney	PROPN
dti-3177	84	28	u	u	NOUN
dti-3177	84	29	-	-	NOUN
dti-3177	84	30	tests	test	NOUN
dti-3177	84	31	.	.	PUNCT
dti-3177	85	1	a	a	DET
dti-3177	85	2	p	p	NOUN
dti-3177	85	3	-	-	PUNCT
dti-3177	85	4	value	value	NOUN
dti-3177	85	5	<	<	NOUN
dti-3177	85	6	0.05	0.05	NUM
dti-3177	85	7	was	be	AUX
dti-3177	85	8	deemed	deem	VERB
dti-3177	85	9	to	to	PART
dti-3177	85	10	be	be	AUX
dti-3177	85	11	statistically	statistically	ADV
dti-3177	85	12	significant	significant	ADJ
dti-3177	85	13	.	.	PUNCT
dti-3177	86	1	all	all	DET
dti-3177	86	2	statistical	statistical	ADJ
dti-3177	86	3	analyses	analysis	NOUN
dti-3177	86	4	were	be	AUX
dti-3177	86	5	assessed	assess	VERB
dti-3177	86	6	using	use	VERB
dti-3177	86	7	graphpad	graphpad	NOUN
dti-3177	86	8	prism	prism	NOUN
dti-3177	86	9	v	v	ADP
dti-3177	86	10	6.1	6.1	NUM
dti-3177	86	11	software	software	NOUN
dti-3177	86	12	.	.	PUNCT
dti-3177	87	1	results	result	VERB
dti-3177	87	2	mortality	mortality	NOUN
dti-3177	87	3	and	and	CCONJ
dti-3177	87	4	proliferation	proliferation	NOUN
dti-3177	87	5	alter	alter	NOUN
dti-3177	87	6	under	under	ADP
dti-3177	87	7	t.	t.	NOUN
dti-3177	87	8	gondii	gondii	NOUN
dti-3177	87	9	peptide	peptide	NOUN
dti-3177	87	10	impact	impact	NOUN
dti-3177	87	11	in	in	ADP
dti-3177	87	12	all	all	DET
dti-3177	87	13	cell	cell	NOUN
dti-3177	87	14	lines	line	NOUN
dti-3177	87	15	in	in	ADP
dti-3177	87	16	each	each	DET
dti-3177	87	17	cell	cell	NOUN
dti-3177	87	18	line	line	NOUN
dti-3177	87	19	,	,	PUNCT
dti-3177	87	20	the	the	DET
dti-3177	87	21	effect	effect	NOUN
dti-3177	87	22	of	of	ADP
dti-3177	87	23	peptides	peptide	NOUN
dti-3177	87	24	on	on	ADP
dti-3177	87	25	cell	cell	NOUN
dti-3177	87	26	viability	viability	NOUN
dti-3177	87	27	,	,	PUNCT
dti-3177	87	28	mortality	mortality	NOUN
dti-3177	87	29	,	,	PUNCT
dti-3177	87	30	and	and	CCONJ
dti-3177	87	31	proliferation	proliferation	NOUN
dti-3177	87	32	was	be	AUX
dti-3177	87	33	examined	examine	VERB
dti-3177	87	34	at	at	ADP
dti-3177	87	35	24	24	NUM
dti-3177	87	36	and	and	CCONJ
dti-3177	87	37	48	48	NUM
dti-3177	87	38	hours	hour	NOUN
dti-3177	87	39	at	at	ADP
dti-3177	87	40	escalating	escalate	VERB
dti-3177	87	41	concentrations	concentration	NOUN
dti-3177	87	42	(	(	PUNCT
dti-3177	87	43	fig	fig	NOUN
dti-3177	87	44	.	.	PUNCT
dti-3177	88	1	1	1	NUM
dti-3177	88	2	)	)	PUNCT
dti-3177	88	3	.	.	PUNCT
dti-3177	89	1	a	a	DET
dti-3177	89	2	direct	direct	ADJ
dti-3177	89	3	correlation	correlation	NOUN
dti-3177	89	4	table	table	NOUN
dti-3177	89	5	1	1	NUM
dti-3177	89	6	the	the	DET
dti-3177	89	7	sequence	sequence	NOUN
dti-3177	89	8	of	of	ADP
dti-3177	89	9	primer	primer	NOUN
dti-3177	89	10	runs	run	NOUN
dti-3177	89	11	in	in	ADP
dti-3177	89	12	real	real	ADJ
dti-3177	89	13	-	-	PUNCT
dti-3177	89	14	time	time	NOUN
dti-3177	89	15	pcr	pcr	PROPN
dti-3177	89	16	gene	gene	NOUN
dti-3177	89	17	seq	seq	NOUN
dti-3177	89	18	(	(	PUNCT
dti-3177	89	19	5′-3′	5′-3′	NUM
dti-3177	89	20	)	)	PUNCT
dti-3177	89	21	annealing	anneal	VERB
dti-3177	89	22	ref	ref	NOUN
dti-3177	89	23	bcl2	bcl2	PROPN
dti-3177	90	1	f	f	NOUN
dti-3177	90	2	:	:	PUNCT
dti-3177	90	3	tcgccctgtggatgactga	tcgccctgtggatgactga	ADJ
dti-3177	90	4	60	60	NUM
dti-3177	90	5	(	(	PUNCT
dti-3177	90	6	14	14	NUM
dti-3177	90	7	)	)	PUNCT
dti-3177	90	8	r	r	NOUN
dti-3177	90	9	:	:	PUNCT
dti-3177	90	10	cagagacagccaggagaaatca	cagagacagccaggagaaatca	ADJ
dti-3177	90	11	apaf1	apaf1	NOUN
dti-3177	91	1	f	f	X
dti-3177	91	2	:	:	PUNCT
dti-3177	91	3	ttaggagccaggtgcggt	ttaggagccaggtgcggt	NOUN
dti-3177	91	4	58	58	NUM
dti-3177	91	5	(	(	PUNCT
dti-3177	91	6	29	29	NUM
dti-3177	91	7	)	)	PUNCT
dti-3177	91	8	r	r	NOUN
dti-3177	91	9	:	:	PUNCT
dti-3177	91	10	gcttgtctttcttcccatttttc	gcttgtctttcttcccatttttc	NOUN
dti-3177	91	11	gapdh	gapdh	NOUN
dti-3177	91	12	f	f	NOUN
dti-3177	91	13	:	:	PUNCT
dti-3177	91	14	acggatttggtcgtattggg	acggatttggtcgtattggg	NOUN
dti-3177	91	15	57	57	NUM
dti-3177	91	16	(	(	PUNCT
dti-3177	91	17	30	30	NUM
dti-3177	91	18	)	)	PUNCT
dti-3177	91	19	r	r	NOUN
dti-3177	91	20	:	:	PUNCT
dti-3177	91	21	tgattttggagggatctcgc	tgattttggagggatctcgc	PROPN
dti-3177	91	22	was	be	AUX
dti-3177	91	23	discovered	discover	VERB
dti-3177	91	24	between	between	ADP
dti-3177	91	25	the	the	DET
dti-3177	91	26	rise	rise	NOUN
dti-3177	91	27	in	in	ADP
dti-3177	91	28	concentration	concentration	NOUN
dti-3177	91	29	and	and	CCONJ
dti-3177	91	30	the	the	DET
dti-3177	91	31	rise	rise	NOUN
dti-3177	91	32	in	in	ADP
dti-3177	91	33	mortality	mortality	NOUN
dti-3177	91	34	and	and	CCONJ
dti-3177	91	35	interpreted	interpret	VERB
dti-3177	91	36	as	as	ADP
dti-3177	91	37	dose	dose	NOUN
dti-3177	91	38	-	-	PUNCT
dti-3177	91	39	dependent	dependent	ADJ
dti-3177	91	40	manner	manner	NOUN
dti-3177	91	41	but	but	CCONJ
dti-3177	91	42	was	be	AUX
dti-3177	91	43	n’t	n’t	ADJ
dti-3177	91	44	time	time	NOUN
dti-3177	91	45	dependent	dependent	ADJ
dti-3177	91	46	.	.	PUNCT
dti-3177	92	1	at	at	ADP
dti-3177	92	2	concentrations	concentration	NOUN
dti-3177	92	3	of	of	ADP
dti-3177	92	4	40	40	NUM
dti-3177	92	5	,	,	PUNCT
dti-3177	92	6	80	80	NUM
dti-3177	92	7	,	,	PUNCT
dti-3177	92	8	and	and	CCONJ
dti-3177	92	9	160	160	NUM
dti-3177	92	10	μg	μg	NOUN
dti-3177	92	11	,	,	PUNCT
dti-3177	92	12	the	the	DET
dti-3177	92	13	cell	cell	NOUN
dti-3177	92	14	viability	viability	NOUN
dti-3177	92	15	rate	rate	NOUN
dti-3177	92	16	exhibited	exhibit	VERB
dti-3177	92	17	a	a	DET
dti-3177	92	18	significant	significant	ADJ
dti-3177	92	19	decrease	decrease	NOUN
dti-3177	92	20	across	across	ADP
dti-3177	92	21	all	all	DET
dti-3177	92	22	cell	cell	NOUN
dti-3177	92	23	lines	line	NOUN
dti-3177	92	24	.	.	PUNCT
dti-3177	93	1	after	after	ADP
dti-3177	93	2	24	24	NUM
dti-3177	93	3	hours	hour	NOUN
dti-3177	93	4	,	,	PUNCT
dti-3177	93	5	the	the	DET
dti-3177	93	6	cell	cell	NOUN
dti-3177	93	7	lines	line	NOUN
dti-3177	93	8	demonstrated	demonstrate	VERB
dti-3177	93	9	the	the	DET
dti-3177	93	10	most	most	ADV
dti-3177	93	11	significant	significant	ADJ
dti-3177	93	12	impact	impact	NOUN
dti-3177	93	13	when	when	SCONJ
dti-3177	93	14	exposed	expose	VERB
dti-3177	93	15	to	to	ADP
dti-3177	93	16	concentrations	concentration	NOUN
dti-3177	93	17	of	of	ADP
dti-3177	93	18	160	160	NUM
dti-3177	93	19	μg	μg	NOUN
dti-3177	93	20	(	(	PUNCT
dti-3177	93	21	p	p	X
dti-3177	93	22	<	<	X
dti-3177	93	23	0.001	0.001	NUM
dti-3177	93	24	)	)	PUNCT
dti-3177	93	25	.	.	PUNCT
dti-3177	94	1	like	like	ADP
dti-3177	94	2	the	the	DET
dti-3177	94	3	earlier	early	ADJ
dti-3177	94	4	pattern	pattern	NOUN
dti-3177	94	5	,	,	PUNCT
dti-3177	94	6	after	after	ADP
dti-3177	94	7	48	48	NUM
dti-3177	94	8	hours	hour	NOUN
dti-3177	94	9	of	of	ADP
dti-3177	94	10	peptide	peptide	ADJ
dti-3177	94	11	exposure	exposure	NOUN
dti-3177	94	12	,	,	PUNCT
dti-3177	94	13	cell	cell	NOUN
dti-3177	94	14	viability	viability	NOUN
dti-3177	94	15	declined	decline	VERB
dti-3177	94	16	at	at	ADP
dti-3177	94	17	40	40	NUM
dti-3177	94	18	,	,	PUNCT
dti-3177	94	19	80	80	NUM
dti-3177	94	20	,	,	PUNCT
dti-3177	94	21	and	and	CCONJ
dti-3177	94	22	160	160	NUM
dti-3177	94	23	μg	μg	NOUN
dti-3177	94	24	concentrations	concentration	NOUN
dti-3177	94	25	in	in	ADP
dti-3177	94	26	contrast	contrast	NOUN
dti-3177	94	27	to	to	ADP
dti-3177	94	28	accumulative	accumulative	ADJ
dti-3177	94	29	doses	dose	NOUN
dti-3177	94	30	.	.	PUNCT
dti-3177	95	1	in	in	ADP
dti-3177	95	2	caco-2	caco-2	NUM
dti-3177	95	3	cells	cell	NOUN
dti-3177	95	4	,	,	PUNCT
dti-3177	95	5	in	in	ADP
dti-3177	95	6	comparison	comparison	NOUN
dti-3177	95	7	with	with	ADP
dti-3177	95	8	the	the	DET
dti-3177	95	9	control	control	NOUN
dti-3177	95	10	group	group	NOUN
dti-3177	95	11	,	,	PUNCT
dti-3177	95	12	a	a	DET
dti-3177	95	13	significant	significant	ADJ
dti-3177	95	14	mortality	mortality	NOUN
dti-3177	95	15	induction	induction	NOUN
dti-3177	95	16	was	be	AUX
dti-3177	95	17	experienced	experience	VERB
dti-3177	95	18	in	in	ADP
dti-3177	95	19	the	the	DET
dti-3177	95	20	concentration	concentration	NOUN
dti-3177	95	21	of	of	ADP
dti-3177	95	22	160	160	NUM
dti-3177	95	23	μg	μg	NOUN
dti-3177	95	24	(	(	PUNCT
dti-3177	95	25	p	p	X
dti-3177	95	26	<	<	X
dti-3177	95	27	0.001	0.001	NUM
dti-3177	95	28	)	)	PUNCT
dti-3177	95	29	.	.	PUNCT
dti-3177	96	1	the	the	DET
dti-3177	96	2	same	same	ADJ
dti-3177	96	3	significant	significant	ADJ
dti-3177	96	4	mortality	mortality	NOUN
dti-3177	96	5	induction	induction	NOUN
dti-3177	96	6	was	be	AUX
dti-3177	96	7	found	find	VERB
dti-3177	96	8	in	in	ADP
dti-3177	96	9	hep	hep	NOUN
dti-3177	96	10	-	-	ADJ
dti-3177	96	11	g2	g2	PROPN
dti-3177	96	12	cell	cell	NOUN
dti-3177	96	13	line	line	NOUN
dti-3177	96	14	at	at	ADP
dti-3177	96	15	the	the	DET
dti-3177	96	16	concentration	concentration	NOUN
dti-3177	96	17	of	of	ADP
dti-3177	96	18	160	160	NUM
dti-3177	96	19	μg	μg	NOUN
dti-3177	96	20	at	at	ADP
dti-3177	96	21	48	48	NUM
dti-3177	96	22	hours	hour	NOUN
dti-3177	96	23	exposure	exposure	NOUN
dti-3177	96	24	.	.	PUNCT
dti-3177	97	1	but	but	CCONJ
dti-3177	97	2	in	in	ADP
dti-3177	97	3	ht29	ht29	PROPN
dti-3177	97	4	cell	cell	NOUN
dti-3177	97	5	line	line	NOUN
dti-3177	97	6	this	this	DET
dti-3177	97	7	significant	significant	ADJ
dti-3177	97	8	mortality	mortality	NOUN
dti-3177	97	9	induction	induction	NOUN
dti-3177	97	10	started	start	VERB
dti-3177	97	11	at	at	ADP
dti-3177	97	12	40	40	NUM
dti-3177	97	13	μg	μg	NOUN
dti-3177	97	14	concentration	concentration	NOUN
dti-3177	97	15	.	.	PUNCT
dti-3177	98	1	cell	cell	NOUN
dti-3177	98	2	viability	viability	NOUN
dti-3177	98	3	rates	rate	NOUN
dti-3177	98	4	were	be	AUX
dti-3177	98	5	assessed	assess	VERB
dti-3177	98	6	at	at	ADP
dti-3177	98	7	figure	figure	NOUN
dti-3177	98	8	1	1	NUM
dti-3177	98	9	the	the	DET
dti-3177	98	10	cell	cell	NOUN
dti-3177	98	11	viability	viability	NOUN
dti-3177	98	12	of	of	ADP
dti-3177	98	13	cancer	cancer	NOUN
dti-3177	98	14	cells	cell	NOUN
dti-3177	98	15	.	.	PUNCT
dti-3177	99	1	a	a	DET
dti-3177	99	2	)	)	PUNCT
dti-3177	99	3	caco-2	caco-2	PROPN
dti-3177	99	4	,	,	PUNCT
dti-3177	99	5	b	b	NOUN
dti-3177	99	6	)	)	PUNCT
dti-3177	99	7	hepg2	hepg2	NOUN
dti-3177	99	8	,	,	PUNCT
dti-3177	99	9	and	and	CCONJ
dti-3177	99	10	c	c	X
dti-3177	99	11	)	)	PUNCT
dti-3177	100	1	ht29	ht29	PROPN
dti-3177	100	2	were	be	AUX
dti-3177	100	3	assessed	assess	VERB
dti-3177	100	4	after	after	ADP
dti-3177	100	5	24	24	NUM
dti-3177	100	6	(	(	PUNCT
dti-3177	100	7	left	leave	VERB
dti-3177	100	8	)	)	PUNCT
dti-3177	100	9	and	and	CCONJ
dti-3177	100	10	48	48	NUM
dti-3177	100	11	hours	hour	NOUN
dti-3177	100	12	(	(	PUNCT
dti-3177	100	13	right	right	ADJ
dti-3177	100	14	)	)	PUNCT
dti-3177	100	15	exposure	exposure	NOUN
dti-3177	100	16	to	to	ADP
dti-3177	100	17	specific	specific	ADJ
dti-3177	100	18	concentrations	concentration	NOUN
dti-3177	100	19	of	of	ADP
dti-3177	100	20	toxoplasma	toxoplasma	NOUN
dti-3177	100	21	gondii	gondii	NOUN
dti-3177	100	22	-	-	PUNCT
dti-3177	100	23	derived	derive	VERB
dti-3177	100	24	peptide	peptide	NOUN
dti-3177	100	25	(	(	PUNCT
dti-3177	100	26	*	*	PUNCT
dti-3177	100	27	p	p	X
dti-3177	100	28	<	<	NOUN
dti-3177	100	29	0.05	0.05	NUM
dti-3177	100	30	;	;	PUNCT
dti-3177	100	31	*	*	PUNCT
dti-3177	100	32	*	*	PUNCT
dti-3177	100	33	p	p	X
dti-3177	100	34	<	<	X
dti-3177	100	35	0.01	0.01	NUM
dti-3177	100	36	;	;	PUNCT
dti-3177	100	37	*	*	PUNCT
dti-3177	100	38	*	*	PUNCT
dti-3177	100	39	*	*	PUNCT
dti-3177	100	40	p	p	X
dti-3177	100	41	<	<	NOUN
dti-3177	100	42	0.001	0.001	NUM
dti-3177	100	43	)	)	PUNCT
dti-3177	100	44	.	.	PUNCT
dti-3177	101	1	sd	sd	NOUN
dti-3177	101	2	=	=	SYM
dti-3177	101	3	standard	standard	ADJ
dti-3177	101	4	deviation	deviation	NOUN
dti-3177	101	5	.	.	PUNCT
dti-3177	102	1	shahrivar	shahrivar	PROPN
dti-3177	102	2	et	et	PROPN
dti-3177	102	3	al	al	PROPN
dti-3177	102	4	drug	drug	PROPN
dti-3177	102	5	target	target	NOUN
dti-3177	102	6	insights	insight	NOUN
dti-3177	102	7	2024	2024	NUM
dti-3177	102	8	;	;	PUNCT
dti-3177	102	9	18	18	NUM
dti-3177	102	10	:	:	SYM
dti-3177	102	11	73	73	NUM
dti-3177	102	12	©	©	PROPN
dti-3177	102	13	2024	2024	NUM
dti-3177	102	14	the	the	DET
dti-3177	102	15	authors	author	NOUN
dti-3177	102	16	.	.	PUNCT
dti-3177	103	1	published	publish	VERB
dti-3177	103	2	by	by	ADP
dti-3177	103	3	aboutscience	aboutscience	NOUN
dti-3177	103	4	www.aboutscience.eu	www.aboutscience.eu	VERB
dti-3177	103	5	various	various	ADJ
dti-3177	103	6	concentrations	concentration	NOUN
dti-3177	103	7	based	base	VERB
dti-3177	103	8	on	on	ADP
dti-3177	103	9	the	the	DET
dti-3177	103	10	duration	duration	NOUN
dti-3177	103	11	of	of	ADP
dti-3177	103	12	each	each	DET
dti-3177	103	13	cell	cell	NOUN
dti-3177	103	14	line	line	NOUN
dti-3177	103	15	.	.	PUNCT
dti-3177	104	1	as	as	SCONJ
dti-3177	104	2	depicted	depict	VERB
dti-3177	104	3	in	in	ADP
dti-3177	104	4	figure	figure	NOUN
dti-3177	104	5	1	1	NUM
dti-3177	104	6	,	,	PUNCT
dti-3177	104	7	it	it	PRON
dti-3177	104	8	was	be	AUX
dti-3177	104	9	observed	observe	VERB
dti-3177	104	10	that	that	SCONJ
dti-3177	104	11	the	the	DET
dti-3177	104	12	impact	impact	NOUN
dti-3177	104	13	of	of	ADP
dti-3177	104	14	the	the	DET
dti-3177	104	15	peptide	peptide	NOUN
dti-3177	104	16	on	on	ADP
dti-3177	104	17	cancer	cancer	NOUN
dti-3177	104	18	cells	cell	NOUN
dti-3177	104	19	differed	differ	VERB
dti-3177	104	20	depending	depend	VERB
dti-3177	104	21	on	on	ADP
dti-3177	104	22	the	the	DET
dti-3177	104	23	dosage	dosage	NOUN
dti-3177	104	24	administered	administer	VERB
dti-3177	104	25	.	.	PUNCT
dti-3177	105	1	the	the	DET
dti-3177	105	2	cell	cell	NOUN
dti-3177	105	3	viability	viability	NOUN
dti-3177	105	4	rate	rate	NOUN
dti-3177	105	5	in	in	ADP
dti-3177	105	6	each	each	DET
dti-3177	105	7	cell	cell	NOUN
dti-3177	105	8	line	line	NOUN
dti-3177	105	9	was	be	AUX
dti-3177	105	10	compared	compare	VERB
dti-3177	105	11	at	at	ADP
dti-3177	105	12	the	the	DET
dti-3177	105	13	aforementioned	aforementioned	ADJ
dti-3177	105	14	concentrations	concentration	NOUN
dti-3177	105	15	,	,	PUNCT
dti-3177	105	16	which	which	PRON
dti-3177	105	17	have	have	AUX
dti-3177	105	18	been	be	AUX
dti-3177	105	19	provided	provide	VERB
dti-3177	105	20	in	in	ADP
dti-3177	105	21	figure	figure	NOUN
dti-3177	105	22	1	1	NUM
dti-3177	105	23	.	.	PUNCT
dti-3177	106	1	briefly	briefly	NOUN
dti-3177	106	2	,	,	PUNCT
dti-3177	106	3	a	a	DET
dti-3177	106	4	significant	significant	ADJ
dti-3177	106	5	mortality	mortality	NOUN
dti-3177	106	6	induction	induction	NOUN
dti-3177	106	7	in	in	ADP
dti-3177	106	8	caco-2	caco-2	NUM
dti-3177	106	9	was	be	AUX
dti-3177	106	10	started	start	VERB
dti-3177	106	11	in	in	ADP
dti-3177	106	12	160	160	NUM
dti-3177	106	13	and	and	CCONJ
dti-3177	106	14	80	80	NUM
dti-3177	106	15	μg	μg	NOUN
dti-3177	106	16	at	at	ADP
dti-3177	106	17	24	24	NUM
dti-3177	106	18	and	and	CCONJ
dti-3177	106	19	48	48	NUM
dti-3177	106	20	hours	hour	NOUN
dti-3177	106	21	,	,	PUNCT
dti-3177	106	22	respectively	respectively	ADV
dti-3177	106	23	.	.	PUNCT
dti-3177	107	1	for	for	ADP
dti-3177	107	2	hep	hep	NOUN
dti-3177	107	3	-	-	PUNCT
dti-3177	107	4	g2	g2	PROPN
dti-3177	107	5	,	,	PUNCT
dti-3177	107	6	the	the	DET
dti-3177	107	7	significant	significant	ADJ
dti-3177	107	8	mortality	mortality	NOUN
dti-3177	107	9	induction	induction	NOUN
dti-3177	107	10	was	be	AUX
dti-3177	107	11	in	in	ADP
dti-3177	107	12	160	160	NUM
dti-3177	107	13	μg	μg	NOUN
dti-3177	107	14	at	at	ADP
dti-3177	107	15	24	24	NUM
dti-3177	107	16	and	and	CCONJ
dti-3177	107	17	48	48	NUM
dti-3177	107	18	hours	hour	NOUN
dti-3177	107	19	.	.	PUNCT
dti-3177	108	1	this	this	DET
dti-3177	108	2	situation	situation	NOUN
dti-3177	108	3	was	be	AUX
dti-3177	108	4	observed	observe	VERB
dti-3177	108	5	in	in	ADP
dti-3177	108	6	160	160	NUM
dti-3177	108	7	and	and	CCONJ
dti-3177	108	8	40	40	NUM
dti-3177	108	9	μg	μg	NOUN
dti-3177	108	10	at	at	ADP
dti-3177	108	11	24	24	NUM
dti-3177	108	12	and	and	CCONJ
dti-3177	108	13	48	48	NUM
dti-3177	108	14	hours	hour	NOUN
dti-3177	108	15	,	,	PUNCT
dti-3177	108	16	respectively	respectively	ADV
dti-3177	108	17	.	.	PUNCT
dti-3177	109	1	the	the	DET
dti-3177	109	2	ic50	ic50	PROPN
dti-3177	109	3	of	of	ADP
dti-3177	109	4	the	the	DET
dti-3177	109	5	excretory	excretory	NOUN
dti-3177	109	6	-	-	PUNCT
dti-3177	109	7	secretory	secretory	ADJ
dti-3177	109	8	peptide	peptide	NOUN
dti-3177	109	9	of	of	ADP
dti-3177	109	10	t.	t.	NOUN
dti-3177	109	11	gondii	gondii	NOUN
dti-3177	109	12	based	base	VERB
dti-3177	109	13	on	on	ADP
dti-3177	109	14	the	the	DET
dti-3177	109	15	results	result	NOUN
dti-3177	109	16	obtained	obtain	VERB
dti-3177	109	17	from	from	ADP
dti-3177	109	18	the	the	DET
dti-3177	109	19	mtt	mtt	NOUN
dti-3177	109	20	assay	assay	VERB
dti-3177	109	21	,	,	PUNCT
dti-3177	109	22	the	the	DET
dti-3177	109	23	ic50	ic50	PROPN
dti-3177	109	24	values	value	NOUN
dti-3177	109	25	for	for	ADP
dti-3177	109	26	each	each	DET
dti-3177	109	27	cell	cell	NOUN
dti-3177	109	28	line	line	NOUN
dti-3177	109	29	were	be	AUX
dti-3177	109	30	determined	determine	VERB
dti-3177	109	31	after	after	ADP
dti-3177	109	32	exposure	exposure	NOUN
dti-3177	109	33	to	to	ADP
dti-3177	109	34	the	the	DET
dti-3177	109	35	peptide	peptide	NOUN
dti-3177	109	36	at	at	ADP
dti-3177	109	37	both	both	DET
dti-3177	109	38	24	24	NUM
dti-3177	109	39	and	and	CCONJ
dti-3177	109	40	48	48	NUM
dti-3177	109	41	hours	hour	NOUN
dti-3177	109	42	.	.	PUNCT
dti-3177	110	1	at	at	ADP
dti-3177	110	2	the	the	DET
dti-3177	110	3	conclusion	conclusion	NOUN
dti-3177	110	4	of	of	ADP
dti-3177	110	5	the	the	DET
dti-3177	110	6	24	24	NUM
dti-3177	110	7	-	-	PUNCT
dti-3177	110	8	hour	hour	NOUN
dti-3177	110	9	period	period	NOUN
dti-3177	110	10	,	,	PUNCT
dti-3177	110	11	the	the	DET
dti-3177	110	12	caco-2	caco-2	NUM
dti-3177	110	13	cell	cell	NOUN
dti-3177	110	14	line	line	NOUN
dti-3177	110	15	exhibited	exhibit	VERB
dti-3177	110	16	the	the	DET
dti-3177	110	17	highest	high	ADJ
dti-3177	110	18	ic50	ic50	PROPN
dti-3177	110	19	concentration	concentration	NOUN
dti-3177	110	20	(	(	PUNCT
dti-3177	110	21	149.6	149.6	NUM
dti-3177	110	22	μg	μg	NOUN
dti-3177	110	23	/	/	SYM
dti-3177	110	24	ml	ml	PROPN
dti-3177	110	25	)	)	PUNCT
dti-3177	110	26	,	,	PUNCT
dti-3177	110	27	while	while	SCONJ
dti-3177	110	28	the	the	DET
dti-3177	110	29	hep	hep	NOUN
dti-3177	110	30	-	-	ADJ
dti-3177	110	31	g2	g2	PROPN
dti-3177	110	32	cell	cell	NOUN
dti-3177	110	33	line	line	NOUN
dti-3177	110	34	displayed	display	VERB
dti-3177	110	35	the	the	DET
dti-3177	110	36	lowest	low	ADJ
dti-3177	110	37	ic50	ic50	PROPN
dti-3177	110	38	concentration	concentration	NOUN
dti-3177	110	39	(	(	PUNCT
dti-3177	110	40	126.8	126.8	NUM
dti-3177	110	41	μg	μg	NOUN
dti-3177	110	42	/	/	SYM
dti-3177	110	43	ml	ml	NOUN
dti-3177	110	44	)	)	PUNCT
dti-3177	110	45	.	.	PUNCT
dti-3177	111	1	furthermore	furthermore	ADV
dti-3177	111	2	,	,	PUNCT
dti-3177	111	3	during	during	ADP
dti-3177	111	4	the	the	DET
dti-3177	111	5	48	48	NUM
dti-3177	111	6	-	-	PUNCT
dti-3177	111	7	hour	hour	NOUN
dti-3177	111	8	timeframe	timeframe	NOUN
dti-3177	111	9	,	,	PUNCT
dti-3177	111	10	the	the	DET
dti-3177	111	11	ht29	ht29	PROPN
dti-3177	111	12	cell	cell	NOUN
dti-3177	111	13	line	line	NOUN
dti-3177	111	14	demonstrated	demonstrate	VERB
dti-3177	111	15	the	the	DET
dti-3177	111	16	lowest	low	ADJ
dti-3177	111	17	ic50	ic50	PROPN
dti-3177	111	18	concentration	concentration	NOUN
dti-3177	111	19	(	(	PUNCT
dti-3177	111	20	107.2	107.2	NUM
dti-3177	111	21	μg	μg	NOUN
dti-3177	111	22	/	/	SYM
dti-3177	111	23	ml	ml	NOUN
dti-3177	111	24	)	)	PUNCT
dti-3177	111	25	,	,	PUNCT
dti-3177	111	26	whereas	whereas	SCONJ
dti-3177	111	27	the	the	DET
dti-3177	111	28	hep	hep	NOUN
dti-3177	111	29	-	-	PUNCT
dti-3177	111	30	g2	g2	PROPN
dti-3177	111	31	cell	cell	NOUN
dti-3177	111	32	line	line	NOUN
dti-3177	111	33	exhibited	exhibit	VERB
dti-3177	111	34	the	the	DET
dti-3177	111	35	highest	high	ADJ
dti-3177	111	36	ic50	ic50	PROPN
dti-3177	111	37	concentration	concentration	NOUN
dti-3177	111	38	(	(	PUNCT
dti-3177	111	39	140.6	140.6	NUM
dti-3177	111	40	μg	μg	NOUN
dti-3177	111	41	/	/	SYM
dti-3177	111	42	ml	ml	NOUN
dti-3177	111	43	)	)	PUNCT
dti-3177	111	44	(	(	PUNCT
dti-3177	111	45	fig	fig	NOUN
dti-3177	111	46	.	.	PUNCT
dti-3177	111	47	2	2	NUM
dti-3177	111	48	)	)	PUNCT
dti-3177	111	49	.	.	PUNCT
dti-3177	112	1	apoptosis	apoptosis	NOUN
dti-3177	112	2	-	-	PUNCT
dti-3177	112	3	related	relate	VERB
dti-3177	112	4	gene	gene	NOUN
dti-3177	112	5	expression	expression	NOUN
dti-3177	112	6	levels	level	NOUN
dti-3177	112	7	the	the	DET
dti-3177	112	8	mrna	mrna	PROPN
dti-3177	112	9	levels	level	NOUN
dti-3177	112	10	of	of	ADP
dti-3177	112	11	bcl2	bcl2	PROPN
dti-3177	112	12	and	and	CCONJ
dti-3177	112	13	apaf1	apaf1	NOUN
dti-3177	112	14	were	be	AUX
dti-3177	112	15	evaluated	evaluate	VERB
dti-3177	112	16	in	in	ADP
dti-3177	112	17	three	three	NUM
dti-3177	112	18	types	type	NOUN
dti-3177	112	19	of	of	ADP
dti-3177	112	20	cancer	cancer	NOUN
dti-3177	112	21	cells	cell	NOUN
dti-3177	112	22	at	at	ADP
dti-3177	112	23	exposed	expose	VERB
dti-3177	112	24	concentrations	concentration	NOUN
dti-3177	112	25	close	close	ADJ
dti-3177	112	26	to	to	ADP
dti-3177	112	27	ic50	ic50	PROPN
dti-3177	112	28	by	by	ADP
dti-3177	112	29	using	use	VERB
dti-3177	112	30	real	real	ADJ
dti-3177	112	31	-	-	PUNCT
dti-3177	112	32	time	time	NOUN
dti-3177	112	33	pcr	pcr	NOUN
dti-3177	112	34	and	and	CCONJ
dti-3177	112	35	results	result	NOUN
dti-3177	112	36	were	be	AUX
dti-3177	112	37	reported	report	VERB
dti-3177	112	38	as	as	ADP
dti-3177	112	39	a	a	DET
dti-3177	112	40	fold	fold	ADJ
dti-3177	112	41	change	change	NOUN
dti-3177	112	42	.	.	PUNCT
dti-3177	113	1	evaluated	evaluate	VERB
dti-3177	113	2	expression	expression	NOUN
dti-3177	113	3	levels	level	NOUN
dti-3177	113	4	of	of	ADP
dti-3177	113	5	bcl2	bcl2	PROPN
dti-3177	113	6	and	and	CCONJ
dti-3177	113	7	apaf1	apaf1	NOUN
dti-3177	113	8	genes	gene	NOUN
dti-3177	113	9	are	be	AUX
dti-3177	113	10	shown	show	VERB
dti-3177	113	11	in	in	ADP
dti-3177	113	12	figure	figure	NOUN
dti-3177	113	13	3	3	NUM
dti-3177	113	14	.	.	PUNCT
dti-3177	114	1	in	in	ADP
dti-3177	114	2	fact	fact	NOUN
dti-3177	114	3	,	,	PUNCT
dti-3177	114	4	the	the	DET
dti-3177	114	5	caco-2	caco-2	NUM
dti-3177	114	6	cell	cell	NOUN
dti-3177	114	7	line	line	NOUN
dti-3177	114	8	showed	show	VERB
dti-3177	114	9	an	an	DET
dti-3177	114	10	increase	increase	NOUN
dti-3177	114	11	in	in	ADP
dti-3177	114	12	gene	gene	NOUN
dti-3177	114	13	expression	expression	NOUN
dti-3177	114	14	level	level	NOUN
dti-3177	114	15	of	of	ADP
dti-3177	114	16	bcl2	bcl2	NOUN
dti-3177	114	17	and	and	CCONJ
dti-3177	114	18	nonelevated	nonelevate	VERB
dti-3177	114	19	expression	expression	NOUN
dti-3177	114	20	level	level	NOUN
dti-3177	114	21	in	in	ADP
dti-3177	114	22	apaf1	apaf1	NOUN
dti-3177	114	23	gene	gene	NOUN
dti-3177	114	24	.	.	PUNCT
dti-3177	115	1	a	a	DET
dti-3177	115	2	notable	notable	ADJ
dti-3177	115	3	decline	decline	NOUN
dti-3177	115	4	in	in	ADP
dti-3177	115	5	the	the	DET
dti-3177	115	6	expression	expression	NOUN
dti-3177	115	7	levels	level	NOUN
dti-3177	115	8	of	of	ADP
dti-3177	115	9	bcl2	bcl2	PROPN
dti-3177	115	10	and	and	CCONJ
dti-3177	115	11	apaf1	apaf1	NOUN
dti-3177	115	12	genes	gene	NOUN
dti-3177	115	13	was	be	AUX
dti-3177	115	14	detected	detect	VERB
dti-3177	115	15	in	in	ADP
dti-3177	115	16	hep	hep	NOUN
dti-3177	115	17	-	-	ADJ
dti-3177	115	18	g2	g2	PROPN
dti-3177	115	19	and	and	CCONJ
dti-3177	115	20	ht29	ht29	PROPN
dti-3177	115	21	cell	cell	NOUN
dti-3177	115	22	lines	line	NOUN
dti-3177	115	23	(	(	PUNCT
dti-3177	115	24	fig	fig	NOUN
dti-3177	115	25	.	.	PUNCT
dti-3177	116	1	3	3	NUM
dti-3177	116	2	)	)	PUNCT
dti-3177	116	3	.	.	PUNCT
dti-3177	117	1	figure	figure	NOUN
dti-3177	117	2	2	2	NUM
dti-3177	117	3	ic50	ic50	PROPN
dti-3177	117	4	values	value	NOUN
dti-3177	117	5	of	of	ADP
dti-3177	117	6	toxoplasma	toxoplasma	NOUN
dti-3177	117	7	gondii	gondii	NOUN
dti-3177	117	8	peptide	peptide	ADV
dti-3177	117	9	in	in	ADP
dti-3177	117	10	cell	cell	NOUN
dti-3177	117	11	lines	line	NOUN
dti-3177	117	12	after	after	ADP
dti-3177	117	13	24	24	NUM
dti-3177	117	14	(	(	PUNCT
dti-3177	117	15	left	leave	VERB
dti-3177	117	16	)	)	PUNCT
dti-3177	117	17	and	and	CCONJ
dti-3177	117	18	48	48	NUM
dti-3177	117	19	hours	hour	NOUN
dti-3177	117	20	(	(	PUNCT
dti-3177	117	21	right	right	INTJ
dti-3177	117	22	):	):	PUNCT
dti-3177	117	23	a	a	X
dti-3177	117	24	)	)	PUNCT
dti-3177	117	25	caco-2	caco-2	PROPN
dti-3177	117	26	,	,	PUNCT
dti-3177	117	27	b	b	NOUN
dti-3177	117	28	)	)	PUNCT
dti-3177	117	29	hep	hep	NOUN
dti-3177	117	30	-	-	PUNCT
dti-3177	117	31	g2	g2	PROPN
dti-3177	117	32	,	,	PUNCT
dti-3177	117	33	and	and	CCONJ
dti-3177	117	34	c	c	X
dti-3177	117	35	)	)	PUNCT
dti-3177	117	36	ht29	ht29	PROPN
dti-3177	117	37	.	.	PUNCT
dti-3177	118	1	the	the	DET
dti-3177	118	2	highest	high	ADJ
dti-3177	118	3	and	and	CCONJ
dti-3177	118	4	lowest	low	ADJ
dti-3177	118	5	values	value	NOUN
dti-3177	118	6	after	after	ADP
dti-3177	118	7	24	24	NUM
dti-3177	118	8	hours	hour	NOUN
dti-3177	118	9	were	be	AUX
dti-3177	118	10	found	find	VERB
dti-3177	118	11	in	in	ADP
dti-3177	118	12	caco-2	caco-2	NUM
dti-3177	118	13	and	and	CCONJ
dti-3177	118	14	hepg2	hepg2	NOUN
dti-3177	118	15	cell	cell	NOUN
dti-3177	118	16	lines	line	NOUN
dti-3177	118	17	(	(	PUNCT
dti-3177	118	18	149.6	149.6	NUM
dti-3177	118	19	and	and	CCONJ
dti-3177	118	20	126.8	126.8	NUM
dti-3177	118	21	µg	µg	NOUN
dti-3177	118	22	/	/	SYM
dti-3177	118	23	ml	ml	NOUN
dti-3177	118	24	,	,	PUNCT
dti-3177	118	25	respectively	respectively	ADV
dti-3177	118	26	)	)	PUNCT
dti-3177	118	27	and	and	CCONJ
dti-3177	118	28	the	the	DET
dti-3177	118	29	highest	high	ADJ
dti-3177	118	30	and	and	CCONJ
dti-3177	118	31	lowest	low	ADJ
dti-3177	118	32	values	value	NOUN
dti-3177	118	33	after	after	ADP
dti-3177	118	34	48	48	NUM
dti-3177	118	35	hours	hour	NOUN
dti-3177	118	36	were	be	AUX
dti-3177	118	37	150.3	150.3	NUM
dti-3177	118	38	and	and	CCONJ
dti-3177	118	39	107	107	NUM
dti-3177	118	40	µg	µg	ADV
dti-3177	118	41	/	/	SYM
dti-3177	118	42	ml	ml	X
dti-3177	118	43	for	for	ADP
dti-3177	118	44	caco-2	caco-2	NUM
dti-3177	118	45	and	and	CCONJ
dti-3177	118	46	ht29	ht29	PROPN
dti-3177	118	47	cell	cell	NOUN
dti-3177	118	48	lines	line	NOUN
dti-3177	118	49	.	.	PUNCT
dti-3177	119	1	toxoplasma	toxoplasma	NOUN
dti-3177	119	2	gondii	gondii	NOUN
dti-3177	119	3	es	es	NOUN
dti-3177	119	4	ags	ag	NOUN
dti-3177	119	5	peptide	peptide	NOUN
dti-3177	119	6	induces	induce	VERB
dti-3177	119	7	apoptosis74	apoptosis74	NOUN
dti-3177	120	1	©	©	ADP
dti-3177	120	2	2024	2024	NUM
dti-3177	121	1	the	the	DET
dti-3177	121	2	authors	author	NOUN
dti-3177	121	3	.	.	PUNCT
dti-3177	122	1	drug	drug	NOUN
dti-3177	122	2	target	target	NOUN
dti-3177	122	3	insights	insight	NOUN
dti-3177	122	4	issn	issn	VERB
dti-3177	122	5	1177	1177	NUM
dti-3177	122	6	-	-	SYM
dti-3177	122	7	3928	3928	NUM
dti-3177	122	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-3177	122	9	flow	flow	NOUN
dti-3177	122	10	cytometry	cytometry	NOUN
dti-3177	122	11	the	the	DET
dti-3177	122	12	apoptotic	apoptotic	ADJ
dti-3177	122	13	effect	effect	NOUN
dti-3177	122	14	was	be	AUX
dti-3177	122	15	examined	examine	VERB
dti-3177	122	16	on	on	ADP
dti-3177	122	17	caco-2	caco-2	NUM
dti-3177	122	18	,	,	PUNCT
dti-3177	122	19	hep	hep	NOUN
dti-3177	122	20	-	-	PUNCT
dti-3177	122	21	g2	g2	PROPN
dti-3177	122	22	,	,	PUNCT
dti-3177	122	23	and	and	CCONJ
dti-3177	122	24	ht29	ht29	PROPN
dti-3177	122	25	cell	cell	NOUN
dti-3177	122	26	lines	line	NOUN
dti-3177	122	27	following	follow	VERB
dti-3177	122	28	treatment	treatment	NOUN
dti-3177	122	29	with	with	ADP
dti-3177	122	30	the	the	DET
dti-3177	122	31	peptide	peptide	NOUN
dti-3177	122	32	and	and	CCONJ
dti-3177	122	33	subsequent	subsequent	ADJ
dti-3177	122	34	staining	stain	VERB
dti-3177	122	35	with	with	ADP
dti-3177	122	36	annexin	annexin	NOUN
dti-3177	122	37	v	v	PROPN
dti-3177	122	38	and	and	CCONJ
dti-3177	122	39	pi	pi	PROPN
dti-3177	122	40	(	(	PUNCT
dti-3177	122	41	fig	fig	NOUN
dti-3177	122	42	.	.	PUNCT
dti-3177	122	43	4	4	NUM
dti-3177	122	44	)	)	PUNCT
dti-3177	122	45	.	.	PUNCT
dti-3177	123	1	after	after	ADP
dti-3177	123	2	a	a	DET
dti-3177	123	3	24	24	NUM
dti-3177	123	4	-	-	PUNCT
dti-3177	123	5	hour	hour	NOUN
dti-3177	123	6	exposure	exposure	NOUN
dti-3177	123	7	to	to	ADP
dti-3177	123	8	the	the	DET
dti-3177	123	9	peptide	peptide	NOUN
dti-3177	123	10	,	,	PUNCT
dti-3177	123	11	a	a	DET
dti-3177	123	12	noteworthy	noteworthy	ADJ
dti-3177	123	13	rise	rise	NOUN
dti-3177	123	14	in	in	ADP
dti-3177	123	15	apoptosis	apoptosis	NOUN
dti-3177	123	16	was	be	AUX
dti-3177	123	17	detected	detect	VERB
dti-3177	123	18	across	across	ADP
dti-3177	123	19	all	all	DET
dti-3177	123	20	cell	cell	NOUN
dti-3177	123	21	lines	line	NOUN
dti-3177	123	22	(	(	PUNCT
dti-3177	123	23	p	p	X
dti-3177	123	24	=	=	NOUN
dti-3177	123	25	0.005	0.005	NUM
dti-3177	123	26	)	)	PUNCT
dti-3177	123	27	.	.	PUNCT
dti-3177	124	1	notably	notably	ADV
dti-3177	124	2	,	,	PUNCT
dti-3177	124	3	the	the	DET
dti-3177	124	4	highest	high	ADJ
dti-3177	124	5	level	level	NOUN
dti-3177	124	6	of	of	ADP
dti-3177	124	7	apoptosis	apoptosis	NOUN
dti-3177	124	8	was	be	AUX
dti-3177	124	9	observed	observe	VERB
dti-3177	124	10	in	in	ADP
dti-3177	124	11	ht29	ht29	PROPN
dti-3177	124	12	cells	cell	NOUN
dti-3177	124	13	,	,	PUNCT
dti-3177	124	14	reaching	reach	VERB
dti-3177	124	15	a	a	DET
dti-3177	124	16	rate	rate	NOUN
dti-3177	124	17	of	of	ADP
dti-3177	124	18	32	32	NUM
dti-3177	124	19	%	%	NOUN
dti-3177	124	20	(	(	PUNCT
dti-3177	124	21	fig	fig	NOUN
dti-3177	124	22	.	.	PUNCT
dti-3177	125	1	5	5	NUM
dti-3177	125	2	)	)	PUNCT
dti-3177	125	3	.	.	PUNCT
dti-3177	126	1	discussion	discussion	NOUN
dti-3177	126	2	in	in	ADP
dti-3177	126	3	the	the	DET
dti-3177	126	4	current	current	ADJ
dti-3177	126	5	investigation	investigation	NOUN
dti-3177	126	6	,	,	PUNCT
dti-3177	126	7	we	we	PRON
dti-3177	126	8	demonstrated	demonstrate	VERB
dti-3177	126	9	the	the	DET
dti-3177	126	10	anticancer	anticancer	NOUN
dti-3177	126	11	effect	effect	NOUN
dti-3177	126	12	of	of	ADP
dti-3177	126	13	candidate	candidate	NOUN
dti-3177	126	14	toxoplasma	toxoplasma	NOUN
dti-3177	126	15	excretory	excretory	NOUN
dti-3177	126	16	-	-	PUNCT
dti-3177	126	17	secretory	secretory	ADJ
dti-3177	126	18	antigen	antigen	NOUN
dti-3177	126	19	on	on	ADP
dti-3177	126	20	three	three	NUM
dti-3177	126	21	cancerous	cancerous	ADJ
dti-3177	126	22	cell	cell	NOUN
dti-3177	126	23	lines	line	NOUN
dti-3177	126	24	:	:	PUNCT
dti-3177	126	25	caco-2	caco-2	NUM
dti-3177	126	26	,	,	PUNCT
dti-3177	126	27	hep	hep	NOUN
dti-3177	126	28	-	-	PUNCT
dti-3177	126	29	g2	g2	PROPN
dti-3177	126	30	,	,	PUNCT
dti-3177	126	31	and	and	CCONJ
dti-3177	126	32	ht29	ht29	PROPN
dti-3177	126	33	.	.	PUNCT
dti-3177	127	1	currently	currently	ADV
dti-3177	127	2	,	,	PUNCT
dti-3177	127	3	researchers	researcher	NOUN
dti-3177	127	4	are	be	AUX
dti-3177	127	5	still	still	ADV
dti-3177	127	6	exploring	explore	VERB
dti-3177	127	7	different	different	ADJ
dti-3177	127	8	ways	way	NOUN
dti-3177	127	9	to	to	PART
dti-3177	127	10	treat	treat	VERB
dti-3177	127	11	cancer	cancer	NOUN
dti-3177	127	12	using	use	VERB
dti-3177	127	13	natural	natural	ADJ
dti-3177	127	14	substances	substance	NOUN
dti-3177	127	15	instead	instead	ADV
dti-3177	127	16	of	of	ADP
dti-3177	127	17	chemicals	chemical	NOUN
dti-3177	127	18	.	.	PUNCT
dti-3177	128	1	besides	besides	SCONJ
dti-3177	128	2	studying	study	VERB
dti-3177	128	3	plant	plant	NOUN
dti-3177	128	4	compounds	compound	NOUN
dti-3177	128	5	,	,	PUNCT
dti-3177	128	6	researchers	researcher	NOUN
dti-3177	128	7	are	be	AUX
dti-3177	128	8	also	also	ADV
dti-3177	128	9	assessing	assess	VERB
dti-3177	128	10	the	the	DET
dti-3177	128	11	effectiveness	effectiveness	NOUN
dti-3177	128	12	of	of	ADP
dti-3177	128	13	different	different	ADJ
dti-3177	128	14	other	other	ADJ
dti-3177	128	15	sources	source	NOUN
dti-3177	128	16	in	in	ADP
dti-3177	128	17	inhibiting	inhibit	VERB
dti-3177	128	18	the	the	DET
dti-3177	128	19	growth	growth	NOUN
dti-3177	128	20	of	of	ADP
dti-3177	128	21	cancer	cancer	NOUN
dti-3177	128	22	cells	cell	NOUN
dti-3177	128	23	.	.	PUNCT
dti-3177	129	1	sometimes	sometimes	ADV
dti-3177	129	2	,	,	PUNCT
dti-3177	129	3	it	it	PRON
dti-3177	129	4	is	be	AUX
dti-3177	129	5	troublesome	troublesome	ADJ
dti-3177	129	6	to	to	PART
dti-3177	129	7	anticipate	anticipate	VERB
dti-3177	129	8	events	event	NOUN
dti-3177	129	9	of	of	ADP
dti-3177	129	10	antagonistic	antagonistic	ADJ
dti-3177	129	11	impacts	impact	NOUN
dti-3177	129	12	from	from	ADP
dti-3177	129	13	chemotherapeutic	chemotherapeutic	ADJ
dti-3177	129	14	drugs	drug	NOUN
dti-3177	129	15	amid	amid	ADP
dti-3177	129	16	treatment	treatment	NOUN
dti-3177	129	17	(	(	PUNCT
dti-3177	129	18	17	17	NUM
dti-3177	129	19	)	)	PUNCT
dti-3177	129	20	.	.	PUNCT
dti-3177	130	1	cancer	cancer	NOUN
dti-3177	130	2	cells	cell	NOUN
dti-3177	130	3	can	can	AUX
dti-3177	130	4	become	become	VERB
dti-3177	130	5	resistant	resistant	ADJ
dti-3177	130	6	to	to	ADP
dti-3177	130	7	drugs	drug	NOUN
dti-3177	130	8	while	while	SCONJ
dti-3177	130	9	receiving	receive	VERB
dti-3177	130	10	chemotherapy	chemotherapy	NOUN
dti-3177	130	11	.	.	PUNCT
dti-3177	131	1	so	so	ADV
dti-3177	131	2	,	,	PUNCT
dti-3177	131	3	to	to	PART
dti-3177	131	4	get	get	VERB
dti-3177	131	5	the	the	DET
dti-3177	131	6	same	same	ADJ
dti-3177	131	7	effect	effect	NOUN
dti-3177	131	8	in	in	ADP
dti-3177	131	9	killing	kill	VERB
dti-3177	131	10	tumors	tumor	NOUN
dti-3177	131	11	,	,	PUNCT
dti-3177	131	12	more	more	ADJ
dti-3177	131	13	medicine	medicine	NOUN
dti-3177	131	14	is	be	AUX
dti-3177	131	15	needed	need	VERB
dti-3177	131	16	than	than	ADP
dti-3177	131	17	what	what	PRON
dti-3177	131	18	was	be	AUX
dti-3177	131	19	given	give	VERB
dti-3177	131	20	initially	initially	ADV
dti-3177	131	21	.	.	PUNCT
dti-3177	132	1	frequently	frequently	ADV
dti-3177	132	2	,	,	PUNCT
dti-3177	132	3	higher	high	ADJ
dti-3177	132	4	dosage	dosage	NOUN
dti-3177	132	5	administration	administration	NOUN
dti-3177	132	6	creates	create	VERB
dti-3177	132	7	a	a	DET
dti-3177	132	8	higher	high	ADJ
dti-3177	132	9	possibility	possibility	NOUN
dti-3177	132	10	of	of	ADP
dti-3177	132	11	side	side	NOUN
dti-3177	132	12	effects	effect	NOUN
dti-3177	132	13	in	in	ADP
dti-3177	132	14	patients	patient	NOUN
dti-3177	132	15	(	(	PUNCT
dti-3177	132	16	18	18	NUM
dti-3177	132	17	)	)	PUNCT
dti-3177	132	18	.	.	PUNCT
dti-3177	133	1	therefore	therefore	ADV
dti-3177	133	2	,	,	PUNCT
dti-3177	133	3	taking	take	VERB
dti-3177	133	4	a	a	DET
dti-3177	133	5	blend	blend	NOUN
dti-3177	133	6	of	of	ADP
dti-3177	133	7	drugs	drug	NOUN
dti-3177	133	8	with	with	ADP
dti-3177	133	9	various	various	ADJ
dti-3177	133	10	mechanisms	mechanism	NOUN
dti-3177	133	11	could	could	AUX
dti-3177	133	12	synergistically	synergistically	ADV
dti-3177	133	13	facilitate	facilitate	VERB
dti-3177	133	14	therapeutic	therapeutic	ADJ
dti-3177	133	15	efficiency	efficiency	NOUN
dti-3177	133	16	(	(	PUNCT
dti-3177	133	17	19	19	NUM
dti-3177	133	18	)	)	PUNCT
dti-3177	133	19	.	.	PUNCT
dti-3177	134	1	one	one	NUM
dti-3177	134	2	of	of	ADP
dti-3177	134	3	these	these	DET
dti-3177	134	4	mechanisms	mechanism	NOUN
dti-3177	134	5	could	could	AUX
dti-3177	134	6	be	be	AUX
dti-3177	134	7	addressing	address	VERB
dti-3177	134	8	live	live	ADJ
dti-3177	134	9	organism	organism	NOUN
dti-3177	134	10	compounds	compound	NOUN
dti-3177	134	11	that	that	PRON
dti-3177	134	12	have	have	VERB
dti-3177	134	13	a	a	DET
dti-3177	134	14	long	long	ADJ
dti-3177	134	15	relationship	relationship	NOUN
dti-3177	134	16	with	with	ADP
dti-3177	134	17	humans	human	NOUN
dti-3177	134	18	and	and	CCONJ
dti-3177	134	19	successfully	successfully	ADV
dti-3177	134	20	adapted	adapt	VERB
dti-3177	134	21	to	to	ADP
dti-3177	134	22	the	the	DET
dti-3177	134	23	human	human	ADJ
dti-3177	134	24	body	body	NOUN
dti-3177	134	25	:	:	PUNCT
dti-3177	134	26	parasites	parasite	NOUN
dti-3177	134	27	.	.	PUNCT
dti-3177	135	1	some	some	DET
dti-3177	135	2	studies	study	NOUN
dti-3177	135	3	were	be	AUX
dti-3177	135	4	conducted	conduct	VERB
dti-3177	135	5	by	by	ADP
dti-3177	135	6	applying	apply	VERB
dti-3177	135	7	protozoa	protozoan	NOUN
dti-3177	135	8	figure	figure	NOUN
dti-3177	135	9	3	3	NUM
dti-3177	135	10	expression	expression	NOUN
dti-3177	135	11	levels	level	NOUN
dti-3177	135	12	of	of	ADP
dti-3177	135	13	bcl2	bcl2	NOUN
dti-3177	135	14	and	and	CCONJ
dti-3177	135	15	apaf1	apaf1	NOUN
dti-3177	135	16	in	in	ADP
dti-3177	135	17	three	three	NUM
dti-3177	135	18	cancer	cancer	NOUN
dti-3177	135	19	cell	cell	NOUN
dti-3177	135	20	lines	line	NOUN
dti-3177	135	21	exposed	expose	VERB
dti-3177	135	22	to	to	ADP
dti-3177	135	23	toxoplasma	toxoplasma	NOUN
dti-3177	135	24	gondii	gondii	NOUN
dti-3177	135	25	peptide	peptide	ADV
dti-3177	135	26	in	in	ADP
dti-3177	135	27	terms	term	NOUN
dti-3177	135	28	of	of	ADP
dti-3177	135	29	fold	fold	ADJ
dti-3177	135	30	change	change	NOUN
dti-3177	135	31	:	:	PUNCT
dti-3177	135	32	a	a	X
dti-3177	135	33	)	)	PUNCT
dti-3177	135	34	caco-2	caco-2	PROPN
dti-3177	135	35	,	,	PUNCT
dti-3177	135	36	b	b	NOUN
dti-3177	135	37	)	)	PUNCT
dti-3177	135	38	hep	hep	NOUN
dti-3177	135	39	-	-	PUNCT
dti-3177	135	40	g2	g2	PROPN
dti-3177	135	41	,	,	PUNCT
dti-3177	135	42	c	c	X
dti-3177	135	43	)	)	PUNCT
dti-3177	136	1	ht29	ht29	PROPN
dti-3177	136	2	(	(	PUNCT
dti-3177	136	3	ns	ns	ADJ
dti-3177	136	4	,	,	PUNCT
dti-3177	136	5	not	not	PART
dti-3177	136	6	significant	significant	ADJ
dti-3177	136	7	;	;	PUNCT
dti-3177	136	8	*	*	PUNCT
dti-3177	136	9	p	p	X
dti-3177	136	10	<	<	NOUN
dti-3177	136	11	0.05	0.05	NUM
dti-3177	136	12	;	;	PUNCT
dti-3177	136	13	*	*	PUNCT
dti-3177	136	14	*	*	PUNCT
dti-3177	136	15	p	p	X
dti-3177	136	16	<	<	X
dti-3177	136	17	0.01	0.01	NUM
dti-3177	136	18	;	;	PUNCT
dti-3177	136	19	*	*	PUNCT
dti-3177	136	20	*	*	PUNCT
dti-3177	136	21	*	*	PUNCT
dti-3177	136	22	p	p	X
dti-3177	136	23	<	<	X
dti-3177	136	24	0.001	0.001	NUM
dti-3177	136	25	;	;	PUNCT
dti-3177	136	26	*	*	PUNCT
dti-3177	136	27	*	*	PUNCT
dti-3177	136	28	*	*	PUNCT
dti-3177	136	29	*	*	PUNCT
dti-3177	136	30	p	p	X
dti-3177	136	31	<	<	X
dti-3177	136	32	0.0001	0.0001	NUM
dti-3177	136	33	)	)	PUNCT
dti-3177	136	34	.	.	PUNCT
dti-3177	137	1	sd	sd	NOUN
dti-3177	137	2	=	=	SYM
dti-3177	137	3	standard	standard	ADJ
dti-3177	137	4	deviation	deviation	NOUN
dti-3177	137	5	.	.	PUNCT
dti-3177	138	1	figure	figure	VERB
dti-3177	138	2	4	4	NUM
dti-3177	138	3	the	the	DET
dti-3177	138	4	distribution	distribution	NOUN
dti-3177	138	5	of	of	ADP
dti-3177	138	6	apoptotic	apoptotic	ADJ
dti-3177	138	7	cells	cell	NOUN
dti-3177	138	8	stained	stain	VERB
dti-3177	138	9	with	with	ADP
dti-3177	138	10	annexin	annexin	NOUN
dti-3177	138	11	v	v	NOUN
dti-3177	138	12	-	-	PUNCT
dti-3177	138	13	fitc	fitc	NOUN
dti-3177	138	14	/	/	SYM
dti-3177	138	15	pi	pi	NOUN
dti-3177	138	16	in	in	ADP
dti-3177	138	17	dual	dual	ADJ
dti-3177	138	18	parametric	parametric	ADJ
dti-3177	138	19	dot	dot	NOUN
dti-3177	138	20	plots	plot	NOUN
dti-3177	138	21	of	of	ADP
dti-3177	138	22	pi	pi	NOUN
dti-3177	138	23	fluorescence	fluorescence	NOUN
dti-3177	138	24	(	(	PUNCT
dti-3177	138	25	y	y	NOUN
dti-3177	138	26	-	-	PUNCT
dti-3177	138	27	axis	axis	NOUN
dti-3177	138	28	)	)	PUNCT
dti-3177	138	29	vs.	vs.	ADP
dti-3177	138	30	annexin	annexin	NOUN
dti-3177	138	31	v	v	NOUN
dti-3177	138	32	-	-	PUNCT
dti-3177	138	33	fitc	fitc	NOUN
dti-3177	138	34	fluorescence	fluorescence	NOUN
dti-3177	138	35	(	(	PUNCT
dti-3177	138	36	x	x	NOUN
dti-3177	138	37	-	-	NOUN
dti-3177	138	38	axis	axis	ADJ
dti-3177	138	39	)	)	PUNCT
dti-3177	138	40	.	.	PUNCT
dti-3177	139	1	dot	dot	NOUN
dti-3177	139	2	plots	plot	NOUN
dti-3177	139	3	represent	represent	VERB
dti-3177	139	4	cancerous	cancerous	ADJ
dti-3177	139	5	cell	cell	NOUN
dti-3177	139	6	lines	line	NOUN
dti-3177	139	7	(	(	PUNCT
dti-3177	139	8	a	a	X
dti-3177	139	9	)	)	PUNCT
dti-3177	139	10	caco-2	caco-2	NOUN
dti-3177	139	11	,	,	PUNCT
dti-3177	139	12	b	b	NOUN
dti-3177	139	13	)	)	PUNCT
dti-3177	139	14	hep	hep	NOUN
dti-3177	139	15	-	-	PUNCT
dti-3177	139	16	g2	g2	PROPN
dti-3177	139	17	,	,	PUNCT
dti-3177	139	18	and	and	CCONJ
dti-3177	139	19	c	c	X
dti-3177	139	20	)	)	PUNCT
dti-3177	139	21	ht29	ht29	PROPN
dti-3177	139	22	)	)	PUNCT
dti-3177	139	23	.	.	PUNCT
dti-3177	140	1	the	the	DET
dti-3177	140	2	highest	high	ADJ
dti-3177	140	3	rate	rate	NOUN
dti-3177	140	4	of	of	ADP
dti-3177	140	5	apoptosis	apoptosis	NOUN
dti-3177	140	6	belongs	belong	VERB
dti-3177	140	7	to	to	ADP
dti-3177	140	8	ht29	ht29	PROPN
dti-3177	140	9	with	with	ADP
dti-3177	140	10	32	32	NUM
dti-3177	140	11	%	%	NOUN
dti-3177	140	12	.	.	PUNCT
dti-3177	141	1	fitc	fitc	NOUN
dti-3177	141	2	=	=	PUNCT
dti-3177	141	3	fluorescein	fluorescein	NOUN
dti-3177	141	4	isothiocyanate	isothiocyanate	NOUN
dti-3177	141	5	;	;	PUNCT
dti-3177	141	6	pi	pi	NOUN
dti-3177	141	7	=	=	SYM
dti-3177	141	8	propidium	propidium	NOUN
dti-3177	141	9	iodide	iodide	NOUN
dti-3177	141	10	.	.	PUNCT
dti-3177	142	1	shahrivar	shahrivar	NOUN
dti-3177	142	2	et	et	PROPN
dti-3177	142	3	al	al	PROPN
dti-3177	142	4	drug	drug	PROPN
dti-3177	142	5	target	target	NOUN
dti-3177	142	6	insights	insight	NOUN
dti-3177	142	7	2024	2024	NUM
dti-3177	142	8	;	;	PUNCT
dti-3177	142	9	18	18	NUM
dti-3177	142	10	:	:	SYM
dti-3177	142	11	75	75	NUM
dti-3177	142	12	©	©	PROPN
dti-3177	142	13	2024	2024	NUM
dti-3177	142	14	the	the	DET
dti-3177	142	15	authors	author	NOUN
dti-3177	142	16	.	.	PUNCT
dti-3177	143	1	published	publish	VERB
dti-3177	143	2	by	by	ADP
dti-3177	143	3	aboutscience	aboutscience	NOUN
dti-3177	143	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-3177	143	5	and	and	CCONJ
dti-3177	143	6	helminths	helminth	NOUN
dti-3177	143	7	to	to	PART
dti-3177	143	8	improve	improve	VERB
dti-3177	143	9	immunotherapies	immunotherapy	NOUN
dti-3177	143	10	concentrating	concentrate	VERB
dti-3177	143	11	against	against	ADP
dti-3177	143	12	tumors	tumor	NOUN
dti-3177	143	13	aiming	aim	VERB
dti-3177	143	14	to	to	PART
dti-3177	143	15	empower	empower	VERB
dti-3177	143	16	the	the	DET
dti-3177	143	17	antitumor	antitumor	PROPN
dti-3177	143	18	immune	immune	ADJ
dti-3177	143	19	response	response	NOUN
dti-3177	143	20	and	and	CCONJ
dti-3177	143	21	therefore	therefore	ADV
dti-3177	143	22	eliminate	eliminate	VERB
dti-3177	143	23	the	the	DET
dti-3177	143	24	progressing	progressing	ADJ
dti-3177	143	25	neoplasm	neoplasm	NOUN
dti-3177	143	26	(	(	PUNCT
dti-3177	143	27	7	7	NUM
dti-3177	143	28	)	)	PUNCT
dti-3177	143	29	.	.	PUNCT
dti-3177	144	1	the	the	DET
dti-3177	144	2	pioneer	pioneer	NOUN
dti-3177	144	3	protozoan	protozoan	NOUN
dti-3177	144	4	in	in	ADP
dti-3177	144	5	uncovering	uncover	VERB
dti-3177	144	6	antitumor	antitumor	PROPN
dti-3177	144	7	effects	effect	NOUN
dti-3177	144	8	was	be	AUX
dti-3177	144	9	trypanosoma	trypanosoma	PROPN
dti-3177	144	10	cruzi	cruzi	PROPN
dti-3177	144	11	,	,	PUNCT
dti-3177	144	12	as	as	SCONJ
dti-3177	144	13	affected	affect	VERB
dti-3177	144	14	patients	patient	NOUN
dti-3177	144	15	showed	show	VERB
dti-3177	144	16	no	no	DET
dti-3177	144	17	symptoms	symptom	NOUN
dti-3177	144	18	of	of	ADP
dti-3177	144	19	colon	colon	NOUN
dti-3177	144	20	cancer	cancer	NOUN
dti-3177	144	21	despite	despite	SCONJ
dti-3177	144	22	having	have	VERB
dti-3177	144	23	a	a	DET
dti-3177	144	24	tumorigenic	tumorigenic	ADJ
dti-3177	144	25	process	process	NOUN
dti-3177	144	26	(	(	PUNCT
dti-3177	144	27	20	20	NUM
dti-3177	144	28	)	)	PUNCT
dti-3177	144	29	.	.	PUNCT
dti-3177	145	1	investigations	investigation	NOUN
dti-3177	145	2	have	have	AUX
dti-3177	145	3	revealed	reveal	VERB
dti-3177	145	4	that	that	SCONJ
dti-3177	145	5	some	some	DET
dti-3177	145	6	molecules	molecule	NOUN
dti-3177	145	7	on	on	ADP
dti-3177	145	8	the	the	DET
dti-3177	145	9	surface	surface	NOUN
dti-3177	145	10	of	of	ADP
dti-3177	145	11	the	the	DET
dti-3177	145	12	parasite	parasite	NOUN
dti-3177	145	13	can	can	AUX
dti-3177	145	14	induce	induce	VERB
dti-3177	145	15	the	the	DET
dti-3177	145	16	production	production	NOUN
dti-3177	145	17	of	of	ADP
dti-3177	145	18	antibodies	antibody	NOUN
dti-3177	145	19	that	that	PRON
dti-3177	145	20	diagnose	diagnose	VERB
dti-3177	145	21	neoplastic	neoplastic	ADJ
dti-3177	145	22	cells	cell	NOUN
dti-3177	145	23	due	due	ADP
dti-3177	145	24	to	to	ADP
dti-3177	145	25	the	the	DET
dti-3177	145	26	antigenic	antigenic	ADJ
dti-3177	145	27	similarity	similarity	NOUN
dti-3177	145	28	between	between	ADP
dti-3177	145	29	them	they	PRON
dti-3177	145	30	,	,	PUNCT
dti-3177	145	31	or	or	CCONJ
dti-3177	145	32	they	they	PRON
dti-3177	145	33	could	could	AUX
dti-3177	145	34	be	be	AUX
dti-3177	145	35	activators	activator	NOUN
dti-3177	145	36	of	of	ADP
dti-3177	145	37	cells	cell	NOUN
dti-3177	145	38	involved	involve	VERB
dti-3177	145	39	in	in	ADP
dti-3177	145	40	the	the	DET
dti-3177	145	41	process	process	NOUN
dti-3177	145	42	of	of	ADP
dti-3177	145	43	cancer	cancer	NOUN
dti-3177	145	44	cell	cell	NOUN
dti-3177	145	45	recognition	recognition	NOUN
dti-3177	145	46	.	.	PUNCT
dti-3177	146	1	t.	t.	PROPN
dti-3177	146	2	gondii	gondii	PROPN
dti-3177	146	3	itself	itself	PRON
dti-3177	146	4	can	can	AUX
dti-3177	146	5	trigger	trigger	VERB
dti-3177	146	6	a	a	DET
dti-3177	146	7	cascade	cascade	NOUN
dti-3177	146	8	that	that	PRON
dti-3177	146	9	starts	start	VERB
dti-3177	146	10	with	with	ADP
dti-3177	146	11	the	the	DET
dti-3177	146	12	induction	induction	NOUN
dti-3177	146	13	of	of	ADP
dti-3177	146	14	interleukin	interleukin	NOUN
dti-3177	146	15	(	(	PUNCT
dti-3177	146	16	il)-12	il)-12	NOUN
dti-3177	146	17	production	production	NOUN
dti-3177	146	18	and	and	CCONJ
dti-3177	146	19	continues	continue	VERB
dti-3177	146	20	with	with	ADP
dti-3177	146	21	stimulating	stimulate	VERB
dti-3177	146	22	natural	natural	ADJ
dti-3177	146	23	killer	killer	NOUN
dti-3177	146	24	(	(	PUNCT
dti-3177	146	25	nk	nk	PROPN
dti-3177	146	26	)	)	PUNCT
dti-3177	146	27	cells	cell	NOUN
dti-3177	146	28	and	and	CCONJ
dti-3177	146	29	t	t	NOUN
dti-3177	146	30	cells	cell	NOUN
dti-3177	146	31	for	for	ADP
dti-3177	146	32	producing	produce	VERB
dti-3177	146	33	interferon	interferon	ADJ
dti-3177	146	34	gamma	gamma	NOUN
dti-3177	146	35	(	(	PUNCT
dti-3177	146	36	ifn	ifn	PROPN
dti-3177	146	37	-	-	PUNCT
dti-3177	146	38	γ	γ	NOUN
dti-3177	146	39	)	)	PUNCT
dti-3177	146	40	and	and	CCONJ
dti-3177	146	41	modifying	modify	VERB
dti-3177	146	42	the	the	DET
dti-3177	146	43	spread	spread	NOUN
dti-3177	146	44	of	of	ADP
dti-3177	146	45	cd8	cd8	PROPN
dti-3177	146	46	t	t	PROPN
dti-3177	146	47	lymphocytes	lymphocyte	NOUN
dti-3177	146	48	and	and	CCONJ
dti-3177	146	49	their	their	PRON
dti-3177	146	50	cytotoxic	cytotoxic	ADJ
dti-3177	146	51	capability	capability	NOUN
dti-3177	146	52	and	and	CCONJ
dti-3177	146	53	finally	finally	ADV
dti-3177	146	54	elevating	elevate	VERB
dti-3177	146	55	antitumor	antitumor	PROPN
dti-3177	146	56	immune	immune	ADJ
dti-3177	146	57	response	response	NOUN
dti-3177	146	58	(	(	PUNCT
dti-3177	146	59	21	21	NUM
dti-3177	146	60	)	)	PUNCT
dti-3177	146	61	.	.	PUNCT
dti-3177	147	1	the	the	DET
dti-3177	147	2	ability	ability	NOUN
dti-3177	147	3	of	of	ADP
dti-3177	147	4	toxoplasma	toxoplasma	NOUN
dti-3177	147	5	to	to	PART
dti-3177	147	6	modify	modify	VERB
dti-3177	147	7	its	its	PRON
dti-3177	147	8	host	host	NOUN
dti-3177	147	9	immune	immune	ADJ
dti-3177	147	10	response	response	NOUN
dti-3177	147	11	in	in	ADP
dti-3177	147	12	several	several	ADJ
dti-3177	147	13	studies	study	NOUN
dti-3177	147	14	makes	make	VERB
dti-3177	147	15	addressing	address	VERB
dti-3177	147	16	this	this	DET
dti-3177	147	17	parasite	parasite	NOUN
dti-3177	147	18	as	as	ADP
dti-3177	147	19	a	a	DET
dti-3177	147	20	potent	potent	ADJ
dti-3177	147	21	inducer	inducer	NOUN
dti-3177	147	22	of	of	ADP
dti-3177	147	23	antitumor	antitumor	PROPN
dti-3177	147	24	responses	response	NOUN
dti-3177	147	25	(	(	PUNCT
dti-3177	147	26	11	11	NUM
dti-3177	147	27	)	)	PUNCT
dti-3177	147	28	.	.	PUNCT
dti-3177	148	1	our	our	PRON
dti-3177	148	2	investigation	investigation	NOUN
dti-3177	148	3	shows	show	VERB
dti-3177	148	4	that	that	SCONJ
dti-3177	148	5	parasite	parasite	NOUN
dti-3177	148	6	-	-	PUNCT
dti-3177	148	7	derived	derive	VERB
dti-3177	148	8	peptide	peptide	NOUN
dti-3177	148	9	could	could	AUX
dti-3177	148	10	induce	induce	VERB
dti-3177	148	11	apoptosis	apoptosis	NOUN
dti-3177	148	12	in	in	ADP
dti-3177	148	13	cancer	cancer	NOUN
dti-3177	148	14	cell	cell	NOUN
dti-3177	148	15	lines	line	NOUN
dti-3177	148	16	,	,	PUNCT
dti-3177	148	17	which	which	PRON
dti-3177	148	18	was	be	AUX
dti-3177	148	19	in	in	ADP
dti-3177	148	20	line	line	NOUN
dti-3177	148	21	with	with	ADP
dti-3177	148	22	the	the	DET
dti-3177	148	23	lately	lately	ADV
dti-3177	148	24	done	do	VERB
dti-3177	148	25	study	study	NOUN
dti-3177	148	26	by	by	ADP
dti-3177	148	27	bahadory	bahadory	NOUN
dti-3177	148	28	et	et	PROPN
dti-3177	148	29	al	al	PROPN
dti-3177	148	30	(	(	PUNCT
dti-3177	148	31	10	10	NUM
dti-3177	148	32	)	)	PUNCT
dti-3177	148	33	.	.	PUNCT
dti-3177	149	1	according	accord	VERB
dti-3177	149	2	to	to	ADP
dti-3177	149	3	this	this	DET
dti-3177	149	4	study	study	NOUN
dti-3177	149	5	,	,	PUNCT
dti-3177	149	6	toxocara	toxocara	ADP
dti-3177	149	7	canis	canis	NOUN
dti-3177	149	8	excretory	excretory	NOUN
dti-3177	149	9	-	-	PUNCT
dti-3177	149	10	secretory	secretory	ADJ
dti-3177	149	11	troponin	troponin	ADJ
dti-3177	149	12	protein	protein	NOUN
dti-3177	149	13	peptide	peptide	NOUN
dti-3177	149	14	(	(	PUNCT
dti-3177	149	15	es	es	ADP
dti-3177	149	16	tpp	tpp	PROPN
dti-3177	149	17	)	)	PUNCT
dti-3177	149	18	could	could	AUX
dti-3177	149	19	successfully	successfully	ADV
dti-3177	149	20	alter	alter	VERB
dti-3177	149	21	the	the	DET
dti-3177	149	22	expression	expression	NOUN
dti-3177	149	23	of	of	ADP
dti-3177	149	24	apoptotic	apoptotic	ADJ
dti-3177	149	25	involved	involve	VERB
dti-3177	149	26	factors	factor	NOUN
dti-3177	149	27	.	.	PUNCT
dti-3177	150	1	peptides	peptide	NOUN
dti-3177	150	2	have	have	AUX
dti-3177	150	3	characteristically	characteristically	ADV
dti-3177	150	4	gained	gain	VERB
dti-3177	150	5	more	more	ADJ
dti-3177	150	6	attention	attention	NOUN
dti-3177	150	7	in	in	ADP
dti-3177	150	8	researches	research	NOUN
dti-3177	150	9	due	due	ADP
dti-3177	150	10	to	to	ADP
dti-3177	150	11	their	their	PRON
dti-3177	150	12	advantages	advantage	NOUN
dti-3177	150	13	;	;	PUNCT
dti-3177	150	14	first	first	ADV
dti-3177	150	15	of	of	ADP
dti-3177	150	16	all	all	PRON
dti-3177	150	17	,	,	PUNCT
dti-3177	150	18	peptides	peptide	NOUN
dti-3177	150	19	are	be	AUX
dti-3177	150	20	the	the	DET
dti-3177	150	21	functional	functional	ADJ
dti-3177	150	22	piece	piece	NOUN
dti-3177	150	23	of	of	ADP
dti-3177	150	24	natural	natural	ADJ
dti-3177	150	25	proteins	protein	NOUN
dti-3177	150	26	that	that	PRON
dti-3177	150	27	can	can	AUX
dti-3177	150	28	exhibit	exhibit	VERB
dti-3177	150	29	innumerable	innumerable	ADJ
dti-3177	150	30	biological	biological	ADJ
dti-3177	150	31	functions	function	NOUN
dti-3177	150	32	and	and	CCONJ
dti-3177	150	33	offer	offer	VERB
dti-3177	150	34	higher	high	ADJ
dti-3177	150	35	selectivity	selectivity	NOUN
dti-3177	150	36	and	and	CCONJ
dti-3177	150	37	potency	potency	NOUN
dti-3177	150	38	in	in	ADP
dti-3177	150	39	comparison	comparison	NOUN
dti-3177	150	40	to	to	ADP
dti-3177	150	41	ordinary	ordinary	ADJ
dti-3177	150	42	small	small	ADJ
dti-3177	150	43	molecule	molecule	NOUN
dti-3177	150	44	drugs	drug	NOUN
dti-3177	150	45	.	.	PUNCT
dti-3177	151	1	secondly	secondly	ADV
dti-3177	151	2	,	,	PUNCT
dti-3177	151	3	they	they	PRON
dti-3177	151	4	could	could	AUX
dti-3177	151	5	be	be	AUX
dti-3177	151	6	simply	simply	ADV
dti-3177	151	7	manufactured	manufacture	VERB
dti-3177	151	8	by	by	ADP
dti-3177	151	9	chemically	chemically	ADV
dti-3177	151	10	solid	solid	ADJ
dti-3177	151	11	-	-	PUNCT
dti-3177	151	12	phase	phase	NOUN
dti-3177	151	13	synthesis	synthesis	NOUN
dti-3177	151	14	.	.	PUNCT
dti-3177	152	1	lastly	lastly	ADV
dti-3177	152	2	,	,	PUNCT
dti-3177	152	3	possessing	possess	VERB
dti-3177	152	4	amide	amide	NOUN
dti-3177	152	5	backbone	backbone	NOUN
dti-3177	152	6	makes	make	VERB
dti-3177	152	7	the	the	DET
dti-3177	152	8	peptides	peptide	NOUN
dti-3177	152	9	to	to	PART
dti-3177	152	10	be	be	AUX
dti-3177	152	11	fundamentally	fundamentally	ADV
dti-3177	152	12	biodegradable	biodegradable	ADJ
dti-3177	152	13	,	,	PUNCT
dti-3177	152	14	which	which	PRON
dti-3177	152	15	may	may	AUX
dti-3177	152	16	minimize	minimize	VERB
dti-3177	152	17	the	the	DET
dti-3177	152	18	side	side	NOUN
dti-3177	152	19	effects	effect	NOUN
dti-3177	152	20	(	(	PUNCT
dti-3177	152	21	22	22	NUM
dti-3177	152	22	)	)	PUNCT
dti-3177	152	23	.	.	PUNCT
dti-3177	153	1	given	give	VERB
dti-3177	153	2	that	that	SCONJ
dti-3177	153	3	the	the	DET
dti-3177	153	4	peptide	peptide	NOUN
dti-3177	153	5	was	be	AUX
dti-3177	153	6	synthesized	synthesize	VERB
dti-3177	153	7	applying	apply	VERB
dti-3177	153	8	computer	computer	NOUN
dti-3177	153	9	database	database	NOUN
dti-3177	153	10	,	,	PUNCT
dti-3177	153	11	high	high	ADJ
dti-3177	153	12	concentration	concentration	NOUN
dti-3177	153	13	of	of	ADP
dti-3177	153	14	peptides	peptide	NOUN
dti-3177	153	15	,	,	PUNCT
dti-3177	153	16	regardless	regardless	ADV
dti-3177	153	17	of	of	ADP
dti-3177	153	18	online	online	ADJ
dti-3177	153	19	prediction	prediction	NOUN
dti-3177	153	20	,	,	PUNCT
dti-3177	153	21	is	be	AUX
dti-3177	153	22	needed	need	VERB
dti-3177	153	23	to	to	PART
dti-3177	153	24	kill	kill	VERB
dti-3177	153	25	the	the	DET
dti-3177	153	26	cells	cell	NOUN
dti-3177	153	27	or	or	CCONJ
dti-3177	153	28	induce	induce	VERB
dti-3177	153	29	cell	cell	NOUN
dti-3177	153	30	death	death	NOUN
dti-3177	153	31	.	.	PUNCT
dti-3177	154	1	scientists	scientist	NOUN
dti-3177	154	2	suggest	suggest	VERB
dti-3177	154	3	that	that	SCONJ
dti-3177	154	4	use	use	NOUN
dti-3177	154	5	of	of	ADP
dti-3177	154	6	nanoparticles	nanoparticle	NOUN
dti-3177	154	7	,	,	PUNCT
dti-3177	154	8	adjuvants	adjuvant	NOUN
dti-3177	154	9	,	,	PUNCT
dti-3177	154	10	and	and	CCONJ
dti-3177	154	11	improving	improve	VERB
dti-3177	154	12	target	target	NOUN
dti-3177	154	13	cell	cell	NOUN
dti-3177	154	14	delivery	delivery	NOUN
dti-3177	154	15	system	system	NOUN
dti-3177	154	16	are	be	AUX
dti-3177	154	17	means	mean	NOUN
dti-3177	154	18	for	for	ADP
dti-3177	154	19	optimizing	optimize	VERB
dti-3177	154	20	compounds	compound	NOUN
dti-3177	154	21	with	with	ADP
dti-3177	154	22	anticancer	anticancer	NOUN
dti-3177	154	23	potential	potential	NOUN
dti-3177	154	24	(	(	PUNCT
dti-3177	154	25	23	23	NUM
dti-3177	154	26	)	)	PUNCT
dti-3177	154	27	.	.	PUNCT
dti-3177	155	1	on	on	ADP
dti-3177	155	2	the	the	DET
dti-3177	155	3	basis	basis	NOUN
dti-3177	155	4	of	of	ADP
dti-3177	155	5	attained	attain	VERB
dti-3177	155	6	results	result	NOUN
dti-3177	155	7	,	,	PUNCT
dti-3177	155	8	the	the	DET
dti-3177	155	9	applied	apply	VERB
dti-3177	155	10	peptide	peptide	NOUN
dti-3177	155	11	causes	cause	VERB
dti-3177	155	12	a	a	DET
dti-3177	155	13	significant	significant	ADJ
dti-3177	155	14	reduction	reduction	NOUN
dti-3177	155	15	in	in	ADP
dti-3177	155	16	mortality	mortality	NOUN
dti-3177	155	17	rate	rate	NOUN
dti-3177	155	18	in	in	ADP
dti-3177	155	19	cell	cell	NOUN
dti-3177	155	20	lines	line	NOUN
dti-3177	155	21	,	,	PUNCT
dti-3177	155	22	which	which	PRON
dti-3177	155	23	are	be	AUX
dti-3177	155	24	referred	refer	VERB
dti-3177	155	25	as	as	ADP
dti-3177	155	26	dose	dose	NOUN
dti-3177	155	27	dependent	dependent	ADJ
dti-3177	155	28	.	.	PUNCT
dti-3177	156	1	hence	hence	ADV
dti-3177	156	2	,	,	PUNCT
dti-3177	156	3	in	in	ADP
dti-3177	156	4	comparison	comparison	NOUN
dti-3177	156	5	to	to	ADP
dti-3177	156	6	caco-2	caco-2	NUM
dti-3177	156	7	and	and	CCONJ
dti-3177	156	8	hep	hep	NOUN
dti-3177	156	9	-	-	PUNCT
dti-3177	156	10	g2	g2	PROPN
dti-3177	156	11	,	,	PUNCT
dti-3177	156	12	the	the	DET
dti-3177	156	13	least	least	ADJ
dti-3177	156	14	concentration	concentration	NOUN
dti-3177	156	15	to	to	PART
dti-3177	156	16	alert	alert	VERB
dti-3177	156	17	the	the	DET
dti-3177	156	18	mortality	mortality	NOUN
dti-3177	156	19	and	and	CCONJ
dti-3177	156	20	viability	viability	NOUN
dti-3177	156	21	rate	rate	NOUN
dti-3177	156	22	was	be	AUX
dti-3177	156	23	for	for	ADP
dti-3177	156	24	ht29	ht29	PROPN
dti-3177	156	25	,	,	PUNCT
dti-3177	156	26	40	40	NUM
dti-3177	156	27	µg	µg	NOUN
dti-3177	156	28	/	/	SYM
dti-3177	156	29	ml	ml	NOUN
dti-3177	156	30	.	.	PUNCT
dti-3177	157	1	it	it	PRON
dti-3177	157	2	is	be	AUX
dti-3177	157	3	noteworthy	noteworthy	ADJ
dti-3177	157	4	that	that	SCONJ
dti-3177	157	5	the	the	DET
dti-3177	157	6	cytotoxic	cytotoxic	ADJ
dti-3177	157	7	effect	effect	NOUN
dti-3177	157	8	was	be	AUX
dti-3177	157	9	remarkably	remarkably	ADV
dti-3177	157	10	higher	high	ADJ
dti-3177	157	11	on	on	ADP
dti-3177	157	12	ht29	ht29	PROPN
dti-3177	157	13	than	than	ADP
dti-3177	157	14	caco-2	caco-2	NUM
dti-3177	157	15	and	and	CCONJ
dti-3177	157	16	hep	hep	NOUN
dti-3177	157	17	-	-	NOUN
dti-3177	157	18	g2	g2	PROPN
dti-3177	157	19	with	with	ADP
dti-3177	157	20	lower	low	ADJ
dti-3177	157	21	ic50	ic50	PROPN
dti-3177	157	22	(	(	PUNCT
dti-3177	157	23	107	107	NUM
dti-3177	157	24	µg	µg	NOUN
dti-3177	157	25	/	/	SYM
dti-3177	157	26	ml	ml	NOUN
dti-3177	157	27	)	)	PUNCT
dti-3177	157	28	.	.	PUNCT
dti-3177	158	1	apoptosis	apoptosis	NOUN
dti-3177	158	2	,	,	PUNCT
dti-3177	158	3	a	a	DET
dti-3177	158	4	physiological	physiological	ADJ
dti-3177	158	5	mechanism	mechanism	NOUN
dti-3177	158	6	of	of	ADP
dti-3177	158	7	cellular	cellular	ADJ
dti-3177	158	8	demise	demise	NOUN
dti-3177	158	9	,	,	PUNCT
dti-3177	158	10	is	be	AUX
dti-3177	158	11	prompted	prompt	VERB
dti-3177	158	12	by	by	ADP
dti-3177	158	13	intraand	intraand	NOUN
dti-3177	158	14	extracellular	extracellular	ADJ
dti-3177	158	15	signals	signal	NOUN
dti-3177	158	16	.	.	PUNCT
dti-3177	159	1	this	this	DET
dti-3177	159	2	process	process	NOUN
dti-3177	159	3	serves	serve	VERB
dti-3177	159	4	a	a	DET
dti-3177	159	5	crucial	crucial	ADJ
dti-3177	159	6	role	role	NOUN
dti-3177	159	7	in	in	ADP
dti-3177	159	8	maintaining	maintain	VERB
dti-3177	159	9	the	the	DET
dti-3177	159	10	balance	balance	NOUN
dti-3177	159	11	and	and	CCONJ
dti-3177	159	12	proper	proper	ADJ
dti-3177	159	13	functioning	functioning	NOUN
dti-3177	159	14	of	of	ADP
dti-3177	159	15	normal	normal	ADJ
dti-3177	159	16	tissues	tissue	NOUN
dti-3177	159	17	during	during	ADP
dti-3177	159	18	development	development	NOUN
dti-3177	159	19	and	and	CCONJ
dti-3177	159	20	homeostasis	homeostasis	NOUN
dti-3177	159	21	.	.	PUNCT
dti-3177	160	1	in	in	ADP
dti-3177	160	2	the	the	DET
dti-3177	160	3	context	context	NOUN
dti-3177	160	4	of	of	ADP
dti-3177	160	5	cancer	cancer	NOUN
dti-3177	160	6	progression	progression	NOUN
dti-3177	160	7	,	,	PUNCT
dti-3177	160	8	apoptosis	apoptosis	NOUN
dti-3177	160	9	acts	act	VERB
dti-3177	160	10	as	as	ADP
dti-3177	160	11	a	a	DET
dti-3177	160	12	barricade	barricade	NOUN
dti-3177	160	13	against	against	ADP
dti-3177	160	14	the	the	DET
dti-3177	160	15	uncontrolled	uncontrolled	ADJ
dti-3177	160	16	growth	growth	NOUN
dti-3177	160	17	of	of	ADP
dti-3177	160	18	transformed	transform	VERB
dti-3177	160	19	cells	cell	NOUN
dti-3177	160	20	.	.	PUNCT
dti-3177	161	1	nevertheless	nevertheless	ADV
dti-3177	161	2	,	,	PUNCT
dti-3177	161	3	in	in	ADP
dti-3177	161	4	tumors	tumor	NOUN
dti-3177	161	5	that	that	PRON
dti-3177	161	6	have	have	AUX
dti-3177	161	7	undergone	undergo	VERB
dti-3177	161	8	significant	significant	ADJ
dti-3177	161	9	transformation	transformation	NOUN
dti-3177	161	10	and	and	CCONJ
dti-3177	161	11	exhibit	exhibit	VERB
dti-3177	161	12	resistance	resistance	NOUN
dti-3177	161	13	to	to	ADP
dti-3177	161	14	therapeutic	therapeutic	ADJ
dti-3177	161	15	interventions	intervention	NOUN
dti-3177	161	16	,	,	PUNCT
dti-3177	161	17	the	the	DET
dti-3177	161	18	occurrence	occurrence	NOUN
dti-3177	161	19	of	of	ADP
dti-3177	161	20	apoptosis	apoptosis	NOUN
dti-3177	161	21	may	may	AUX
dti-3177	161	22	be	be	AUX
dti-3177	161	23	reduced	reduce	VERB
dti-3177	161	24	(	(	PUNCT
dti-3177	161	25	6	6	NUM
dti-3177	161	26	)	)	PUNCT
dti-3177	161	27	.	.	PUNCT
dti-3177	162	1	bcl2	bcl2	PROPN
dti-3177	162	2	and	and	CCONJ
dti-3177	162	3	apaf1	apaf1	NOUN
dti-3177	162	4	are	be	AUX
dti-3177	162	5	key	key	ADJ
dti-3177	162	6	factors	factor	NOUN
dti-3177	162	7	in	in	ADP
dti-3177	162	8	the	the	DET
dti-3177	162	9	process	process	NOUN
dti-3177	162	10	of	of	ADP
dti-3177	162	11	cell	cell	NOUN
dti-3177	162	12	death	death	NOUN
dti-3177	162	13	,	,	PUNCT
dti-3177	162	14	which	which	PRON
dti-3177	162	15	were	be	AUX
dti-3177	162	16	evaluated	evaluate	VERB
dti-3177	162	17	by	by	ADP
dti-3177	162	18	both	both	PRON
dti-3177	162	19	mtt	mtt	NOUN
dti-3177	162	20	assay	assay	VERB
dti-3177	162	21	and	and	CCONJ
dti-3177	162	22	real	real	ADJ
dti-3177	162	23	-	-	PUNCT
dti-3177	162	24	time	time	NOUN
dti-3177	162	25	pcr	pcr	NOUN
dti-3177	162	26	;	;	PUNCT
dti-3177	162	27	the	the	DET
dti-3177	162	28	latter	latter	NOUN
dti-3177	162	29	is	be	AUX
dti-3177	162	30	more	more	ADV
dti-3177	162	31	sensitive	sensitive	ADJ
dti-3177	162	32	and	and	CCONJ
dti-3177	162	33	specific	specific	ADJ
dti-3177	162	34	.	.	PUNCT
dti-3177	163	1	in	in	ADP
dti-3177	163	2	fact	fact	NOUN
dti-3177	163	3	,	,	PUNCT
dti-3177	163	4	releasing	release	VERB
dti-3177	163	5	cytochrome	cytochrome	NOUN
dti-3177	163	6	c	c	NOUN
dti-3177	163	7	from	from	ADP
dti-3177	163	8	mitochondria	mitochondria	PROPN
dti-3177	163	9	is	be	AUX
dti-3177	163	10	the	the	DET
dti-3177	163	11	pivotal	pivotal	ADJ
dti-3177	163	12	triggering	trigger	VERB
dti-3177	163	13	episode	episode	NOUN
dti-3177	163	14	associating	associate	VERB
dti-3177	163	15	a	a	DET
dti-3177	163	16	cell	cell	NOUN
dti-3177	163	17	to	to	ADP
dti-3177	163	18	apoptosis	apoptosis	NOUN
dti-3177	163	19	,	,	PUNCT
dti-3177	163	20	resulting	result	VERB
dti-3177	163	21	in	in	ADP
dti-3177	163	22	the	the	DET
dti-3177	163	23	formation	formation	NOUN
dti-3177	163	24	of	of	ADP
dti-3177	163	25	apoptosome	apoptosome	NOUN
dti-3177	163	26	-	-	PUNCT
dti-3177	163	27	containing	contain	VERB
dti-3177	163	28	caspases	caspase	NOUN
dti-3177	163	29	.	.	PUNCT
dti-3177	164	1	bcl2	bcl2	PROPN
dti-3177	164	2	as	as	ADP
dti-3177	164	3	an	an	DET
dti-3177	164	4	antiapoptotic	antiapoptotic	ADJ
dti-3177	164	5	protein	protein	NOUN
dti-3177	164	6	interferes	interfere	VERB
dti-3177	164	7	in	in	ADP
dti-3177	164	8	the	the	DET
dti-3177	164	9	permeabilization	permeabilization	NOUN
dti-3177	164	10	of	of	ADP
dti-3177	164	11	the	the	DET
dti-3177	164	12	mitochondrial	mitochondrial	ADJ
dti-3177	164	13	outer	outer	ADJ
dti-3177	164	14	membrane	membrane	NOUN
dti-3177	164	15	,	,	PUNCT
dti-3177	164	16	thus	thus	ADV
dti-3177	164	17	barricading	barricade	VERB
dti-3177	164	18	apoptosis	apoptosis	NOUN
dti-3177	164	19	(	(	PUNCT
dti-3177	164	20	24,25	24,25	NUM
dti-3177	164	21	)	)	PUNCT
dti-3177	164	22	.	.	PUNCT
dti-3177	165	1	controversy	controversy	NOUN
dti-3177	165	2	,	,	PUNCT
dti-3177	165	3	oligomerization	oligomerization	NOUN
dti-3177	165	4	of	of	ADP
dti-3177	165	5	apaf1	apaf1	NOUN
dti-3177	165	6	in	in	ADP
dti-3177	165	7	response	response	NOUN
dti-3177	165	8	to	to	PART
dti-3177	165	9	discharge	discharge	VERB
dti-3177	165	10	of	of	ADP
dti-3177	165	11	cytochrome	cytochrome	NOUN
dti-3177	165	12	c	c	PROPN
dti-3177	165	13	facilitates	facilitate	VERB
dti-3177	165	14	the	the	DET
dti-3177	165	15	formation	formation	NOUN
dti-3177	165	16	of	of	ADP
dti-3177	165	17	apoptosome	apoptosome	NOUN
dti-3177	165	18	,	,	PUNCT
dti-3177	165	19	leading	lead	VERB
dti-3177	165	20	to	to	ADP
dti-3177	165	21	downregulation	downregulation	NOUN
dti-3177	165	22	of	of	ADP
dti-3177	165	23	caspases	caspase	NOUN
dti-3177	165	24	and	and	CCONJ
dti-3177	165	25	triggering	trigger	VERB
dti-3177	165	26	apoptosis	apoptosis	NOUN
dti-3177	165	27	(	(	PUNCT
dti-3177	165	28	26	26	NUM
dti-3177	165	29	)	)	PUNCT
dti-3177	165	30	.	.	PUNCT
dti-3177	166	1	in	in	ADP
dti-3177	166	2	our	our	PRON
dti-3177	166	3	study	study	NOUN
dti-3177	166	4	,	,	PUNCT
dti-3177	166	5	there	there	PRON
dti-3177	166	6	is	be	VERB
dti-3177	166	7	an	an	DET
dti-3177	166	8	increase	increase	NOUN
dti-3177	166	9	in	in	ADP
dti-3177	166	10	gene	gene	NOUN
dti-3177	166	11	expression	expression	NOUN
dti-3177	166	12	level	level	NOUN
dti-3177	166	13	of	of	ADP
dti-3177	166	14	bcl2	bcl2	NOUN
dti-3177	166	15	gene	gene	NOUN
dti-3177	166	16	but	but	CCONJ
dti-3177	166	17	it	it	PRON
dti-3177	166	18	was	be	AUX
dti-3177	166	19	n’t	not	PART
dti-3177	166	20	significant	significant	ADJ
dti-3177	166	21	in	in	ADP
dti-3177	166	22	caco-2	caco-2	NUM
dti-3177	166	23	cell	cell	NOUN
dti-3177	166	24	line	line	NOUN
dti-3177	166	25	.	.	PUNCT
dti-3177	167	1	a	a	DET
dti-3177	167	2	significant	significant	ADJ
dti-3177	167	3	decrease	decrease	NOUN
dti-3177	167	4	in	in	ADP
dti-3177	167	5	expression	expression	NOUN
dti-3177	167	6	levels	level	NOUN
dti-3177	167	7	of	of	ADP
dti-3177	167	8	bcl2	bcl2	PROPN
dti-3177	167	9	and	and	CCONJ
dti-3177	167	10	apaf1	apaf1	NOUN
dti-3177	167	11	genes	gene	NOUN
dti-3177	167	12	was	be	AUX
dti-3177	167	13	seen	see	VERB
dti-3177	167	14	in	in	ADP
dti-3177	167	15	both	both	CCONJ
dti-3177	167	16	hep	hep	NOUN
dti-3177	167	17	-	-	ADJ
dti-3177	167	18	g2	g2	NOUN
dti-3177	167	19	and	and	CCONJ
dti-3177	167	20	figure	figure	VERB
dti-3177	167	21	5	5	NUM
dti-3177	167	22	the	the	DET
dti-3177	167	23	effects	effect	NOUN
dti-3177	167	24	of	of	ADP
dti-3177	167	25	toxoplasma	toxoplasma	NOUN
dti-3177	167	26	gondii	gondii	NOUN
dti-3177	167	27	peptide	peptide	ADV
dti-3177	167	28	on	on	ADP
dti-3177	167	29	the	the	DET
dti-3177	167	30	viability	viability	NOUN
dti-3177	167	31	of	of	ADP
dti-3177	167	32	three	three	NUM
dti-3177	167	33	cancer	cancer	NOUN
dti-3177	167	34	cell	cell	NOUN
dti-3177	167	35	lines	line	NOUN
dti-3177	167	36	(	(	PUNCT
dti-3177	167	37	a	a	X
dti-3177	167	38	)	)	PUNCT
dti-3177	167	39	caco-2	caco-2	NOUN
dti-3177	167	40	,	,	PUNCT
dti-3177	167	41	b	b	NOUN
dti-3177	167	42	)	)	PUNCT
dti-3177	167	43	hep	hep	NOUN
dti-3177	167	44	-	-	PUNCT
dti-3177	167	45	g2	g2	PROPN
dti-3177	167	46	,	,	PUNCT
dti-3177	167	47	and	and	CCONJ
dti-3177	167	48	c	c	X
dti-3177	167	49	)	)	PUNCT
dti-3177	167	50	ht29	ht29	PROPN
dti-3177	167	51	)	)	PUNCT
dti-3177	167	52	show	show	VERB
dti-3177	167	53	a	a	DET
dti-3177	167	54	significant	significant	ADJ
dti-3177	167	55	increase	increase	NOUN
dti-3177	167	56	in	in	ADP
dti-3177	167	57	induction	induction	NOUN
dti-3177	167	58	in	in	ADP
dti-3177	167	59	comparison	comparison	NOUN
dti-3177	167	60	to	to	ADP
dti-3177	167	61	the	the	DET
dti-3177	167	62	control	control	NOUN
dti-3177	167	63	.	.	PUNCT
dti-3177	168	1	the	the	DET
dti-3177	168	2	error	error	NOUN
dti-3177	168	3	bars	bar	NOUN
dti-3177	168	4	represent	represent	VERB
dti-3177	168	5	mean	mean	NOUN
dti-3177	168	6	±	±	NUM
dti-3177	168	7	sd	sd	NOUN
dti-3177	168	8	of	of	ADP
dti-3177	168	9	the	the	DET
dti-3177	168	10	triplicate	triplicate	NOUN
dti-3177	168	11	measurements	measurement	NOUN
dti-3177	168	12	(	(	PUNCT
dti-3177	168	13	*	*	PUNCT
dti-3177	168	14	p	p	X
dti-3177	168	15	<	<	NOUN
dti-3177	168	16	0.05	0.05	NUM
dti-3177	168	17	;	;	PUNCT
dti-3177	168	18	*	*	PUNCT
dti-3177	168	19	*	*	PUNCT
dti-3177	168	20	p	p	X
dti-3177	168	21	<	<	X
dti-3177	168	22	0.01	0.01	NUM
dti-3177	168	23	;	;	PUNCT
dti-3177	168	24	*	*	PUNCT
dti-3177	168	25	*	*	PUNCT
dti-3177	168	26	*	*	PUNCT
dti-3177	168	27	p	p	X
dti-3177	168	28	<	<	X
dti-3177	168	29	0.001	0.001	NUM
dti-3177	168	30	;	;	PUNCT
dti-3177	168	31	*	*	PUNCT
dti-3177	168	32	*	*	PUNCT
dti-3177	168	33	*	*	PUNCT
dti-3177	168	34	*	*	PUNCT
dti-3177	168	35	p	p	X
dti-3177	168	36	<	<	X
dti-3177	168	37	0.0001	0.0001	NUM
dti-3177	168	38	)	)	PUNCT
dti-3177	168	39	.	.	PUNCT
dti-3177	169	1	sd	sd	NOUN
dti-3177	169	2	=	=	SYM
dti-3177	169	3	standard	standard	ADJ
dti-3177	169	4	deviation	deviation	NOUN
dti-3177	169	5	.	.	PUNCT
dti-3177	170	1	toxoplasma	toxoplasma	NOUN
dti-3177	170	2	gondii	gondii	NOUN
dti-3177	170	3	es	es	NOUN
dti-3177	170	4	ags	ag	NOUN
dti-3177	170	5	peptide	peptide	NOUN
dti-3177	170	6	induces	induce	VERB
dti-3177	170	7	apoptosis76	apoptosis76	NOUN
dti-3177	171	1	©	©	ADP
dti-3177	171	2	2024	2024	NUM
dti-3177	172	1	the	the	DET
dti-3177	172	2	authors	author	NOUN
dti-3177	172	3	.	.	PUNCT
dti-3177	173	1	drug	drug	NOUN
dti-3177	173	2	target	target	NOUN
dti-3177	173	3	insights	insight	NOUN
dti-3177	173	4	issn	issn	VERB
dti-3177	173	5	1177	1177	NUM
dti-3177	173	6	-	-	SYM
dti-3177	173	7	3928	3928	NUM
dti-3177	173	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-3177	173	9	ht29	ht29	PROPN
dti-3177	173	10	cell	cell	NOUN
dti-3177	173	11	lines	line	NOUN
dti-3177	173	12	.	.	PUNCT
dti-3177	174	1	on	on	ADP
dti-3177	174	2	the	the	DET
dti-3177	174	3	basis	basis	NOUN
dti-3177	174	4	of	of	ADP
dti-3177	174	5	update	update	NOUN
dti-3177	174	6	by	by	ADP
dti-3177	174	7	the	the	DET
dti-3177	174	8	nomenclature	nomenclature	NOUN
dti-3177	174	9	committee	committee	NOUN
dti-3177	174	10	on	on	ADP
dti-3177	174	11	cell	cell	NOUN
dti-3177	174	12	death	death	NOUN
dti-3177	174	13	(	(	PUNCT
dti-3177	174	14	nccd	nccd	PROPN
dti-3177	174	15	)	)	PUNCT
dti-3177	174	16	,	,	PUNCT
dti-3177	174	17	regulated	regulated	ADJ
dti-3177	174	18	cell	cell	NOUN
dti-3177	174	19	death	death	NOUN
dti-3177	174	20	could	could	AUX
dti-3177	174	21	be	be	AUX
dti-3177	174	22	classified	classify	VERB
dti-3177	174	23	,	,	PUNCT
dti-3177	174	24	based	base	VERB
dti-3177	174	25	on	on	ADP
dti-3177	174	26	its	its	PRON
dti-3177	174	27	molecular	molecular	ADJ
dti-3177	174	28	characteristics	characteristic	NOUN
dti-3177	174	29	,	,	PUNCT
dti-3177	174	30	into	into	ADP
dti-3177	174	31	multiple	multiple	ADJ
dti-3177	174	32	categories	category	NOUN
dti-3177	174	33	in	in	ADP
dti-3177	174	34	which	which	PRON
dti-3177	174	35	some	some	PRON
dti-3177	174	36	of	of	ADP
dti-3177	174	37	them	they	PRON
dti-3177	174	38	were	be	AUX
dti-3177	174	39	well	well	ADV
dti-3177	174	40	studied	study	VERB
dti-3177	174	41	like	like	ADP
dti-3177	174	42	:	:	PUNCT
dti-3177	174	43	apoptosis	apoptosis	NOUN
dti-3177	174	44	,	,	PUNCT
dti-3177	174	45	necrosis	necrosis	NOUN
dti-3177	174	46	,	,	PUNCT
dti-3177	174	47	necroptosis	necroptosis	NOUN
dti-3177	174	48	,	,	PUNCT
dti-3177	174	49	and	and	CCONJ
dti-3177	174	50	pyroptosis	pyroptosis	NOUN
dti-3177	174	51	,	,	PUNCT
dti-3177	174	52	while	while	SCONJ
dti-3177	174	53	others	other	NOUN
dti-3177	174	54	like	like	ADP
dti-3177	174	55	ferroptosis	ferroptosis	NOUN
dti-3177	174	56	,	,	PUNCT
dti-3177	174	57	entotic	entotic	ADJ
dti-3177	174	58	,	,	PUNCT
dti-3177	174	59	autophagy	autophagy	NOUN
dti-3177	174	60	,	,	PUNCT
dti-3177	174	61	etc	etc	X
dti-3177	174	62	.	.	X
dti-3177	174	63	,	,	PUNCT
dti-3177	174	64	are	be	AUX
dti-3177	174	65	underestimated	underestimate	VERB
dti-3177	174	66	and	and	CCONJ
dti-3177	174	67	less	less	ADV
dti-3177	174	68	well	well	ADV
dti-3177	174	69	-	-	PUNCT
dti-3177	174	70	studied	study	VERB
dti-3177	174	71	(	(	PUNCT
dti-3177	174	72	27	27	NUM
dti-3177	174	73	)	)	PUNCT
dti-3177	174	74	.	.	PUNCT
dti-3177	175	1	for	for	ADP
dti-3177	175	2	this	this	DET
dti-3177	175	3	case	case	NOUN
dti-3177	175	4	,	,	PUNCT
dti-3177	175	5	we	we	PRON
dti-3177	175	6	could	could	AUX
dti-3177	175	7	conclude	conclude	VERB
dti-3177	175	8	that	that	DET
dti-3177	175	9	downregulation	downregulation	NOUN
dti-3177	175	10	in	in	ADP
dti-3177	175	11	any	any	PRON
dti-3177	175	12	of	of	ADP
dti-3177	175	13	the	the	DET
dti-3177	175	14	aforementioned	aforementioned	ADJ
dti-3177	175	15	gene	gene	NOUN
dti-3177	175	16	expression	expression	NOUN
dti-3177	175	17	levels	level	NOUN
dti-3177	175	18	may	may	AUX
dti-3177	175	19	result	result	VERB
dti-3177	175	20	in	in	ADP
dti-3177	175	21	consequences	consequence	NOUN
dti-3177	175	22	of	of	ADP
dti-3177	175	23	any	any	PRON
dti-3177	175	24	of	of	ADP
dti-3177	175	25	the	the	DET
dti-3177	175	26	aforesaid	aforesaid	NOUN
dti-3177	175	27	cell	cell	NOUN
dti-3177	175	28	death	death	NOUN
dti-3177	175	29	types	type	NOUN
dti-3177	175	30	.	.	PUNCT
dti-3177	176	1	d’arcy	d’arcy	NOUN
dti-3177	176	2	states	state	VERB
dti-3177	176	3	that	that	SCONJ
dti-3177	176	4	the	the	DET
dti-3177	176	5	cell	cell	NOUN
dti-3177	176	6	in	in	ADP
dti-3177	176	7	media	medium	NOUN
dti-3177	176	8	could	could	AUX
dti-3177	176	9	react	react	VERB
dti-3177	176	10	in	in	ADP
dti-3177	176	11	different	different	ADJ
dti-3177	176	12	ways	way	NOUN
dti-3177	176	13	when	when	SCONJ
dti-3177	176	14	it	it	PRON
dti-3177	176	15	fails	fail	VERB
dti-3177	176	16	to	to	PART
dti-3177	176	17	maintain	maintain	VERB
dti-3177	176	18	homeostasis	homeostasis	NOUN
dti-3177	176	19	with	with	ADP
dti-3177	176	20	its	its	PRON
dti-3177	176	21	environment	environment	NOUN
dti-3177	176	22	.	.	PUNCT
dti-3177	177	1	hence	hence	ADV
dti-3177	177	2	,	,	PUNCT
dti-3177	177	3	the	the	DET
dti-3177	177	4	remains	remain	NOUN
dti-3177	177	5	of	of	ADP
dti-3177	177	6	late	late	ADJ
dti-3177	177	7	apoptotic	apoptotic	ADJ
dti-3177	177	8	cells	cell	NOUN
dti-3177	177	9	that	that	PRON
dti-3177	177	10	have	have	AUX
dti-3177	177	11	lost	lose	VERB
dti-3177	177	12	their	their	PRON
dti-3177	177	13	integrity	integrity	NOUN
dti-3177	177	14	are	be	AUX
dti-3177	177	15	simply	simply	ADV
dti-3177	177	16	described	describe	VERB
dti-3177	177	17	as	as	ADP
dti-3177	177	18	necrosis	necrosis	NOUN
dti-3177	177	19	(	(	PUNCT
dti-3177	177	20	28	28	NUM
dti-3177	177	21	)	)	PUNCT
dti-3177	177	22	.	.	PUNCT
dti-3177	178	1	for	for	ADP
dti-3177	178	2	future	future	ADJ
dti-3177	178	3	prospect	prospect	NOUN
dti-3177	178	4	,	,	PUNCT
dti-3177	178	5	conducting	conduct	VERB
dti-3177	178	6	experiments	experiment	NOUN
dti-3177	178	7	on	on	ADP
dti-3177	178	8	animal	animal	NOUN
dti-3177	178	9	models	model	NOUN
dti-3177	178	10	and	and	CCONJ
dti-3177	178	11	assessing	assess	VERB
dti-3177	178	12	cell	cell	NOUN
dti-3177	178	13	death	death	NOUN
dti-3177	178	14	molecular	molecular	ADJ
dti-3177	178	15	hallmarks	hallmark	NOUN
dti-3177	178	16	using	use	VERB
dti-3177	178	17	blotting	blot	VERB
dti-3177	178	18	techniques	technique	NOUN
dti-3177	178	19	would	would	AUX
dti-3177	178	20	give	give	VERB
dti-3177	178	21	a	a	DET
dti-3177	178	22	better	well	ADJ
dti-3177	178	23	point	point	NOUN
dti-3177	178	24	of	of	ADP
dti-3177	178	25	view	view	NOUN
dti-3177	178	26	for	for	ADP
dti-3177	178	27	conducting	conduct	VERB
dti-3177	178	28	upcoming	upcoming	ADJ
dti-3177	178	29	researches	research	NOUN
dti-3177	178	30	.	.	PUNCT
dti-3177	179	1	challenges	challenge	NOUN
dti-3177	179	2	include	include	VERB
dti-3177	179	3	being	be	AUX
dti-3177	179	4	unable	unable	ADJ
dti-3177	179	5	to	to	PART
dti-3177	179	6	synthesize	synthesize	VERB
dti-3177	179	7	the	the	DET
dti-3177	179	8	peptide	peptide	NOUN
dti-3177	179	9	in	in	ADP
dti-3177	179	10	our	our	PRON
dti-3177	179	11	country	country	NOUN
dti-3177	179	12	and	and	CCONJ
dti-3177	179	13	the	the	DET
dti-3177	179	14	need	need	NOUN
dti-3177	179	15	for	for	ADP
dti-3177	179	16	implementing	implement	VERB
dti-3177	179	17	more	more	ADV
dti-3177	179	18	accurate	accurate	ADJ
dti-3177	179	19	and	and	CCONJ
dti-3177	179	20	specific	specific	ADJ
dti-3177	179	21	tests	test	NOUN
dti-3177	179	22	for	for	ADP
dti-3177	179	23	applying	apply	VERB
dti-3177	179	24	blotting	blot	VERB
dti-3177	179	25	tests	test	NOUN
dti-3177	179	26	and	and	CCONJ
dti-3177	179	27	to	to	PART
dti-3177	179	28	evaluate	evaluate	VERB
dti-3177	179	29	whether	whether	SCONJ
dti-3177	179	30	the	the	DET
dti-3177	179	31	peptide	peptide	NOUN
dti-3177	179	32	could	could	AUX
dti-3177	179	33	enter	enter	VERB
dti-3177	179	34	the	the	DET
dti-3177	179	35	cells	cell	NOUN
dti-3177	179	36	.	.	PUNCT
dti-3177	180	1	conclusion	conclusion	NOUN
dti-3177	180	2	the	the	DET
dti-3177	180	3	results	result	NOUN
dti-3177	180	4	demonstrated	demonstrate	VERB
dti-3177	180	5	that	that	SCONJ
dti-3177	180	6	t.	t.	PROPN
dti-3177	180	7	gondii	gondii	NOUN
dti-3177	180	8	peptide	peptide	NOUN
dti-3177	180	9	exerted	exert	VERB
dti-3177	180	10	an	an	DET
dti-3177	180	11	influence	influence	NOUN
dti-3177	180	12	on	on	ADP
dti-3177	180	13	the	the	DET
dti-3177	180	14	mortality	mortality	NOUN
dti-3177	180	15	of	of	ADP
dti-3177	180	16	cancer	cancer	NOUN
dti-3177	180	17	cells	cell	NOUN
dti-3177	180	18	and	and	CCONJ
dti-3177	180	19	altered	alter	VERB
dti-3177	180	20	the	the	DET
dti-3177	180	21	expression	expression	NOUN
dti-3177	180	22	of	of	ADP
dti-3177	180	23	apoptosis	apoptosis	NOUN
dti-3177	180	24	-	-	PUNCT
dti-3177	180	25	related	relate	VERB
dti-3177	180	26	genes	gene	NOUN
dti-3177	180	27	.	.	PUNCT
dti-3177	181	1	however	however	ADV
dti-3177	181	2	,	,	PUNCT
dti-3177	181	3	further	further	ADJ
dti-3177	181	4	optimization	optimization	NOUN
dti-3177	181	5	and	and	CCONJ
dti-3177	181	6	redesign	redesign	NOUN
dti-3177	181	7	of	of	ADP
dti-3177	181	8	the	the	DET
dti-3177	181	9	peptide	peptide	NOUN
dti-3177	181	10	could	could	AUX
dti-3177	181	11	enhance	enhance	VERB
dti-3177	181	12	its	its	PRON
dti-3177	181	13	potential	potential	NOUN
dti-3177	181	14	as	as	ADP
dti-3177	181	15	a	a	DET
dti-3177	181	16	cancer	cancer	NOUN
dti-3177	181	17	therapy	therapy	NOUN
dti-3177	181	18	.	.	PUNCT
dti-3177	182	1	given	give	VERB
dti-3177	182	2	the	the	DET
dti-3177	182	3	potential	potential	NOUN
dti-3177	182	4	of	of	ADP
dti-3177	182	5	peptides	peptide	NOUN
dti-3177	182	6	as	as	ADP
dti-3177	182	7	selective	selective	ADJ
dti-3177	182	8	and	and	CCONJ
dti-3177	182	9	potent	potent	ADJ
dti-3177	182	10	therapeutic	therapeutic	ADJ
dti-3177	182	11	agents	agent	NOUN
dti-3177	182	12	,	,	PUNCT
dti-3177	182	13	enhancing	enhance	VERB
dti-3177	182	14	them	they	PRON
dti-3177	182	15	with	with	ADP
dti-3177	182	16	nanoparticles	nanoparticle	NOUN
dti-3177	182	17	and	and	CCONJ
dti-3177	182	18	improving	improve	VERB
dti-3177	182	19	delivery	delivery	NOUN
dti-3177	182	20	systems	system	NOUN
dti-3177	182	21	could	could	AUX
dti-3177	182	22	optimize	optimize	VERB
dti-3177	182	23	their	their	PRON
dti-3177	182	24	anticancer	anticancer	NOUN
dti-3177	182	25	efficacy	efficacy	NOUN
dti-3177	182	26	.	.	PUNCT
dti-3177	183	1	future	future	ADJ
dti-3177	183	2	research	research	NOUN
dti-3177	183	3	could	could	AUX
dti-3177	183	4	focus	focus	VERB
dti-3177	183	5	on	on	ADP
dti-3177	183	6	animal	animal	NOUN
dti-3177	183	7	models	model	NOUN
dti-3177	183	8	and	and	CCONJ
dti-3177	183	9	molecular	molecular	ADJ
dti-3177	183	10	analyses	analysis	NOUN
dti-3177	183	11	with	with	ADP
dti-3177	183	12	blotting	blot	VERB
dti-3177	183	13	techniques	technique	NOUN
dti-3177	183	14	to	to	PART
dti-3177	183	15	further	far	ADV
dti-3177	183	16	evaluate	evaluate	VERB
dti-3177	183	17	and	and	CCONJ
dti-3177	183	18	improve	improve	VERB
dti-3177	183	19	this	this	DET
dti-3177	183	20	promising	promise	VERB
dti-3177	183	21	therapeutic	therapeutic	ADJ
dti-3177	183	22	approach	approach	NOUN
dti-3177	183	23	.	.	PUNCT
dti-3177	184	1	disclosures	disclosure	VERB
dti-3177	184	2	authors	author	NOUN
dti-3177	184	3	’	'	PUNCT
dti-3177	184	4	contributions	contribution	NOUN
dti-3177	184	5	:	:	PUNCT
dti-3177	184	6	all	all	DET
dti-3177	184	7	authors	author	NOUN
dti-3177	184	8	contributed	contribute	VERB
dti-3177	184	9	to	to	ADP
dti-3177	184	10	the	the	DET
dti-3177	184	11	study	study	NOUN
dti-3177	184	12	conception	conception	NOUN
dti-3177	184	13	and	and	CCONJ
dti-3177	184	14	design	design	NOUN
dti-3177	184	15	.	.	PUNCT
dti-3177	185	1	material	material	NOUN
dti-3177	185	2	preparation	preparation	NOUN
dti-3177	185	3	,	,	PUNCT
dti-3177	185	4	data	datum	NOUN
dti-3177	185	5	collection	collection	NOUN
dti-3177	185	6	and	and	CCONJ
dti-3177	185	7	analysis	analysis	NOUN
dti-3177	185	8	were	be	AUX
dti-3177	185	9	performed	perform	VERB
dti-3177	185	10	by	by	ADP
dti-3177	185	11	javid	javid	PROPN
dti-3177	185	12	sadraei	sadraei	PROPN
dti-3177	185	13	,	,	PUNCT
dti-3177	185	14	firooz	firooz	NOUN
dti-3177	185	15	shahrivar	shahrivar	NOUN
dti-3177	185	16	,	,	PUNCT
dti-3177	185	17	majid	majid	PROPN
dti-3177	185	18	pirestani	pirestani	PROPN
dti-3177	185	19	,	,	PUNCT
dti-3177	185	20	and	and	CCONJ
dti-3177	185	21	ehsan	ehsan	PROPN
dti-3177	185	22	ahmadpour	ahmadpour	PROPN
dti-3177	185	23	.	.	PUNCT
dti-3177	186	1	the	the	DET
dti-3177	186	2	first	first	ADJ
dti-3177	186	3	draft	draft	NOUN
dti-3177	186	4	of	of	ADP
dti-3177	186	5	the	the	DET
dti-3177	186	6	manuscript	manuscript	NOUN
dti-3177	186	7	was	be	AUX
dti-3177	186	8	written	write	VERB
dti-3177	186	9	by	by	ADP
dti-3177	186	10	firooz	firooz	NOUN
dti-3177	186	11	shahrivar	shahrivar	NOUN
dti-3177	186	12	and	and	CCONJ
dti-3177	186	13	all	all	DET
dti-3177	186	14	authors	author	NOUN
dti-3177	186	15	commented	comment	VERB
dti-3177	186	16	on	on	ADP
dti-3177	186	17	previous	previous	ADJ
dti-3177	186	18	versions	version	NOUN
dti-3177	186	19	of	of	ADP
dti-3177	186	20	the	the	DET
dti-3177	186	21	manuscript	manuscript	NOUN
dti-3177	186	22	.	.	PUNCT
dti-3177	187	1	all	all	DET
dti-3177	187	2	authors	author	NOUN
dti-3177	187	3	read	read	VERB
dti-3177	187	4	and	and	CCONJ
dti-3177	187	5	approved	approve	VERB
dti-3177	187	6	the	the	DET
dti-3177	187	7	final	final	ADJ
dti-3177	187	8	manuscript	manuscript	NOUN
dti-3177	187	9	.	.	PUNCT
dti-3177	188	1	data	datum	NOUN
dti-3177	188	2	availability	availability	NOUN
dti-3177	188	3	declaration	declaration	NOUN
dti-3177	188	4	:	:	PUNCT
dti-3177	188	5	the	the	DET
dti-3177	188	6	authors	author	NOUN
dti-3177	188	7	declare	declare	VERB
dti-3177	188	8	that	that	SCONJ
dti-3177	188	9	data	datum	NOUN
dti-3177	188	10	would	would	AUX
dti-3177	188	11	be	be	AUX
dti-3177	188	12	available	available	ADJ
dti-3177	188	13	if	if	SCONJ
dti-3177	188	14	any	any	DET
dti-3177	188	15	formal	formal	ADJ
dti-3177	188	16	request	request	NOUN
dti-3177	188	17	is	be	AUX
dti-3177	188	18	sent	send	VERB
dti-3177	188	19	to	to	ADP
dti-3177	188	20	the	the	DET
dti-3177	188	21	corresponding	corresponding	ADJ
dti-3177	188	22	author	author	NOUN
dti-3177	188	23	.	.	PUNCT
dti-3177	189	1	funding	funding	NOUN
dti-3177	189	2	:	:	PUNCT
dti-3177	189	3	this	this	DET
dti-3177	189	4	study	study	NOUN
dti-3177	189	5	was	be	AUX
dti-3177	189	6	funded	fund	VERB
dti-3177	189	7	by	by	ADP
dti-3177	189	8	tarbiat	tarbiat	PROPN
dti-3177	189	9	modares	modares	PROPN
dti-3177	189	10	university	university	PROPN
dti-3177	189	11	,	,	PUNCT
dti-3177	189	12	tehran	tehran	PROPN
dti-3177	189	13	,	,	PUNCT
dti-3177	189	14	iran	iran	PROPN
dti-3177	189	15	(	(	PUNCT
dti-3177	189	16	med	med	PROPN
dti-3177	189	17	87201	87201	NUM
dti-3177	189	18	)	)	PUNCT
dti-3177	189	19	.	.	PUNCT
dti-3177	190	1	conflict	conflict	NOUN
dti-3177	190	2	of	of	ADP
dti-3177	190	3	interest	interest	NOUN
dti-3177	190	4	:	:	PUNCT
dti-3177	190	5	the	the	DET
dti-3177	190	6	authors	author	NOUN
dti-3177	190	7	declare	declare	VERB
dti-3177	190	8	that	that	SCONJ
dti-3177	190	9	they	they	PRON
dti-3177	190	10	have	have	VERB
dti-3177	190	11	no	no	DET
dti-3177	190	12	conflict	conflict	NOUN
dti-3177	190	13	of	of	ADP
dti-3177	190	14	interest	interest	NOUN
dti-3177	190	15	.	.	PUNCT
dti-3177	191	1	ethical	ethical	ADJ
dti-3177	191	2	approval	approval	NOUN
dti-3177	191	3	:	:	PUNCT
dti-3177	191	4	this	this	DET
dti-3177	191	5	study	study	NOUN
dti-3177	191	6	was	be	AUX
dti-3177	191	7	performed	perform	VERB
dti-3177	191	8	in	in	ADP
dti-3177	191	9	line	line	NOUN
dti-3177	191	10	with	with	ADP
dti-3177	191	11	the	the	DET
dti-3177	191	12	principles	principle	NOUN
dti-3177	191	13	of	of	ADP
dti-3177	191	14	the	the	DET
dti-3177	191	15	declaration	declaration	NOUN
dti-3177	191	16	of	of	ADP
dti-3177	191	17	helsinki	helsinki	PROPN
dti-3177	191	18	.	.	PUNCT
dti-3177	192	1	approval	approval	NOUN
dti-3177	192	2	was	be	AUX
dti-3177	192	3	granted	grant	VERB
dti-3177	192	4	by	by	ADP
dti-3177	192	5	the	the	DET
dti-3177	192	6	ethics	ethic	NOUN
dti-3177	192	7	committee	committee	PROPN
dti-3177	192	8	of	of	ADP
dti-3177	192	9	tarbiat	tarbiat	PROPN
dti-3177	192	10	modares	modares	PROPN
dti-3177	192	11	university	university	PROPN
dti-3177	192	12	(	(	PUNCT
dti-3177	192	13	ir.modares	ir.modare	NOUN
dti-3177	192	14	.	.	PUNCT
dti-3177	192	15	rec.1400.128	rec.1400.128	PROPN
dti-3177	192	16	)	)	PUNCT
dti-3177	192	17	.	.	PUNCT
dti-3177	193	1	consent	consent	VERB
dti-3177	193	2	to	to	PART
dti-3177	193	3	publish	publish	VERB
dti-3177	193	4	/	/	SYM
dti-3177	193	5	participate	participate	NOUN
dti-3177	193	6	:	:	PUNCT
dti-3177	193	7	the	the	DET
dti-3177	193	8	authors	author	NOUN
dti-3177	193	9	affirm	affirm	VERB
dti-3177	193	10	that	that	SCONJ
dti-3177	193	11	no	no	DET
dti-3177	193	12	patient/	patient/	NUM
dti-3177	193	13	participant	participant	ADJ
dti-3177	193	14	consent	consent	NOUN
dti-3177	193	15	was	be	AUX
dti-3177	193	16	required	require	VERB
dti-3177	193	17	for	for	ADP
dti-3177	193	18	publishing	publishing	NOUN
dti-3177	193	19	;	;	PUNCT
dti-3177	193	20	meanwhile	meanwhile	ADV
dti-3177	193	21	,	,	PUNCT
dti-3177	193	22	there	there	PRON
dti-3177	193	23	is	be	VERB
dti-3177	193	24	no	no	DET
dti-3177	193	25	conflict	conflict	NOUN
dti-3177	193	26	or	or	CCONJ
dti-3177	193	27	opposition	opposition	NOUN
dti-3177	193	28	for	for	ADP
dti-3177	193	29	publishing	publish	VERB
dti-3177	193	30	the	the	DET
dti-3177	193	31	data	datum	NOUN
dti-3177	193	32	.	.	PUNCT
dti-3177	194	1	references	reference	NOUN
dti-3177	194	2	1	1	NUM
dti-3177	194	3	.	.	PUNCT
dti-3177	194	4	flegr	flegr	PROPN
dti-3177	194	5	j	j	PROPN
dti-3177	194	6	,	,	PUNCT
dti-3177	194	7	prandota	prandota	PROPN
dti-3177	194	8	j	j	PROPN
dti-3177	194	9	,	,	PUNCT
dti-3177	194	10	sovičková	sovičková	PROPN
dti-3177	194	11	m	m	PROPN
dti-3177	194	12	,	,	PUNCT
dti-3177	194	13	israili	israili	PROPN
dti-3177	194	14	zh	zh	PROPN
dti-3177	194	15	.	.	PUNCT
dti-3177	194	16	toxoplasmosis	toxoplasmosis	PROPN
dti-3177	194	17	–	–	PUNCT
dti-3177	194	18	a	a	DET
dti-3177	194	19	global	global	ADJ
dti-3177	194	20	threat	threat	NOUN
dti-3177	194	21	.	.	PUNCT
dti-3177	195	1	correlation	correlation	NOUN
dti-3177	195	2	of	of	ADP
dti-3177	195	3	latent	latent	ADJ
dti-3177	195	4	toxoplasmosis	toxoplasmosis	NOUN
dti-3177	195	5	with	with	ADP
dti-3177	195	6	specific	specific	ADJ
dti-3177	195	7	disease	disease	NOUN
dti-3177	195	8	burden	burden	NOUN
dti-3177	195	9	in	in	ADP
dti-3177	195	10	a	a	DET
dti-3177	195	11	set	set	NOUN
dti-3177	195	12	of	of	ADP
dti-3177	195	13	88	88	NUM
dti-3177	195	14	countries	country	NOUN
dti-3177	195	15	.	.	PUNCT
dti-3177	196	1	plos	plos	PROPN
dti-3177	196	2	one	one	NUM
dti-3177	196	3	.	.	PUNCT
dti-3177	197	1	2014;9(3	2014;9(3	NUM
dti-3177	197	2	):	):	PUNCT
dti-3177	198	1	e90203	e90203	PROPN
dti-3177	198	2	.	.	PUNCT
dti-3177	199	1	crossref	crossref	PROPN
dti-3177	199	2	pubmed	pubmed	PROPN
dti-3177	199	3	2	2	NUM
dti-3177	199	4	.	.	PUNCT
dti-3177	200	1	dubey	dubey	PROPN
dti-3177	200	2	jp	jp	PROPN
dti-3177	200	3	.	.	PUNCT
dti-3177	201	1	history	history	NOUN
dti-3177	201	2	of	of	ADP
dti-3177	201	3	the	the	DET
dti-3177	201	4	discovery	discovery	NOUN
dti-3177	201	5	of	of	ADP
dti-3177	201	6	the	the	DET
dti-3177	201	7	life	life	NOUN
dti-3177	201	8	cycle	cycle	NOUN
dti-3177	201	9	of	of	ADP
dti-3177	201	10	toxoplasma	toxoplasma	NOUN
dti-3177	201	11	gondii	gondii	NOUN
dti-3177	201	12	.	.	PUNCT
dti-3177	202	1	int	int	NOUN
dti-3177	202	2	j	j	PROPN
dti-3177	202	3	parasitol	parasitol	NOUN
dti-3177	202	4	.	.	PUNCT
dti-3177	203	1	2009;39(8):877	2009;39(8):877	NUM
dti-3177	203	2	-	-	PUNCT
dti-3177	203	3	882	882	NUM
dti-3177	203	4	.	.	PUNCT
dti-3177	204	1	crossref	crossref	PROPN
dti-3177	204	2	pubmed	pubmed	PROPN
dti-3177	204	3	3	3	PROPN
dti-3177	204	4	.	.	PUNCT
dti-3177	205	1	attias	attias	PROPN
dti-3177	205	2	m	m	PROPN
dti-3177	205	3	,	,	PUNCT
dti-3177	205	4	teixeira	teixeira	PROPN
dti-3177	205	5	de	de	PROPN
dti-3177	205	6	,	,	PUNCT
dti-3177	205	7	benchimol	benchimol	PROPN
dti-3177	205	8	m	m	PROPN
dti-3177	205	9	,	,	PUNCT
dti-3177	205	10	vommaro	vommaro	PROPN
dti-3177	205	11	rc	rc	PROPN
dti-3177	205	12	,	,	PUNCT
dti-3177	205	13	crepaldi	crepaldi	NOUN
dti-3177	205	14	ph	ph	VERB
dti-3177	205	15	,	,	PUNCT
dti-3177	205	16	de	de	PROPN
dti-3177	205	17	souza	souza	PROPN
dti-3177	205	18	w.	w.	PROPN
dti-3177	205	19	the	the	DET
dti-3177	205	20	life	life	NOUN
dti-3177	205	21	-	-	PUNCT
dti-3177	205	22	cycle	cycle	NOUN
dti-3177	205	23	of	of	ADP
dti-3177	205	24	toxoplasma	toxoplasma	NOUN
dti-3177	205	25	gondii	gondii	NOUN
dti-3177	205	26	reviewed	review	VERB
dti-3177	205	27	using	use	VERB
dti-3177	205	28	animations	animation	NOUN
dti-3177	205	29	.	.	PUNCT
dti-3177	206	1	parasit	parasit	NOUN
dti-3177	206	2	vectors	vector	NOUN
dti-3177	206	3	.	.	PUNCT
dti-3177	207	1	2020;13(1):588	2020;13(1):588	NUM
dti-3177	207	2	.	.	PUNCT
dti-3177	208	1	crossref	crossref	PROPN
dti-3177	208	2	pubmed	pubmed	PROPN
dti-3177	208	3	4	4	PROPN
dti-3177	208	4	.	.	PUNCT
dti-3177	208	5	stelzer	stelzer	PROPN
dti-3177	208	6	s	s	PART
dti-3177	208	7	,	,	PUNCT
dti-3177	208	8	basso	basso	PROPN
dti-3177	208	9	w	w	PROPN
dti-3177	208	10	,	,	PUNCT
dti-3177	208	11	benavides	benavides	PROPN
dti-3177	208	12	silván	silván	PROPN
dti-3177	208	13	j	j	PROPN
dti-3177	208	14	,	,	PUNCT
dti-3177	208	15	et	et	PROPN
dti-3177	208	16	al	al	PROPN
dti-3177	208	17	.	.	PUNCT
dti-3177	209	1	toxoplasma	toxoplasma	PROPN
dti-3177	209	2	gondii	gondii	NOUN
dti-3177	209	3	infection	infection	NOUN
dti-3177	209	4	and	and	CCONJ
dti-3177	209	5	toxoplasmosis	toxoplasmosis	NOUN
dti-3177	209	6	in	in	ADP
dti-3177	209	7	farm	farm	NOUN
dti-3177	209	8	animals	animal	NOUN
dti-3177	209	9	:	:	PUNCT
dti-3177	209	10	risk	risk	NOUN
dti-3177	209	11	factors	factor	NOUN
dti-3177	209	12	and	and	CCONJ
dti-3177	209	13	economic	economic	ADJ
dti-3177	209	14	impact	impact	NOUN
dti-3177	209	15	.	.	PUNCT
dti-3177	210	1	food	food	NOUN
dti-3177	210	2	waterborne	waterborne	VERB
dti-3177	210	3	parasitol	parasitol	NOUN
dti-3177	210	4	.	.	PUNCT
dti-3177	211	1	2019;15	2019;15	NUM
dti-3177	211	2	:	:	PUNCT
dti-3177	211	3	e00037	e00037	NOUN
dti-3177	211	4	.	.	PUNCT
dti-3177	212	1	crossref	crossref	PROPN
dti-3177	212	2	pubmed	pubmed	PROPN
dti-3177	212	3	5	5	NUM
dti-3177	212	4	.	.	PUNCT
dti-3177	213	1	dubey	dubey	PROPN
dti-3177	213	2	jp	jp	PROPN
dti-3177	213	3	.	.	PUNCT
dti-3177	214	1	the	the	DET
dti-3177	214	2	history	history	NOUN
dti-3177	214	3	and	and	CCONJ
dti-3177	214	4	life	life	NOUN
dti-3177	214	5	cycle	cycle	NOUN
dti-3177	214	6	of	of	ADP
dti-3177	214	7	toxoplasma	toxoplasma	NOUN
dti-3177	214	8	gondii	gondii	NOUN
dti-3177	214	9	.	.	PUNCT
dti-3177	215	1	in	in	ADP
dti-3177	215	2	:	:	PUNCT
dti-3177	215	3	weiss	weiss	PROPN
dti-3177	215	4	lm	lm	PROPN
dti-3177	215	5	,	,	PUNCT
dti-3177	215	6	kim	kim	PROPN
dti-3177	215	7	k	k	PROPN
dti-3177	215	8	,	,	PUNCT
dti-3177	215	9	eds	eds	PROPN
dti-3177	215	10	.	.	PUNCT
dti-3177	216	1	toxoplasma	toxoplasma	NOUN
dti-3177	216	2	gondii	gondii	NOUN
dti-3177	216	3	.	.	PUNCT
dti-3177	217	1	elsevier	elsevier	NOUN
dti-3177	217	2	2020	2020	NUM
dti-3177	217	3	;	;	PUNCT
dti-3177	217	4	1	1	NUM
dti-3177	217	5	-	-	SYM
dti-3177	217	6	19	19	NUM
dti-3177	217	7	.	.	PUNCT
dti-3177	218	1	crossref	crossref	PROPN
dti-3177	218	2	6	6	NUM
dti-3177	218	3	.	.	PUNCT
dti-3177	219	1	hanahan	hanahan	PROPN
dti-3177	219	2	d	d	PROPN
dti-3177	219	3	,	,	PUNCT
dti-3177	219	4	weinberg	weinberg	PROPN
dti-3177	219	5	ra	ra	PROPN
dti-3177	219	6	.	.	PUNCT
dti-3177	220	1	hallmarks	hallmark	NOUN
dti-3177	220	2	of	of	ADP
dti-3177	220	3	cancer	cancer	NOUN
dti-3177	220	4	:	:	PUNCT
dti-3177	220	5	the	the	DET
dti-3177	220	6	next	next	ADJ
dti-3177	220	7	generation	generation	NOUN
dti-3177	220	8	.	.	PUNCT
dti-3177	221	1	cell	cell	NOUN
dti-3177	221	2	.	.	PUNCT
dti-3177	222	1	2011	2011	NUM
dti-3177	222	2	mar	mar	PROPN
dti-3177	222	3	4;144(5):646	4;144(5):646	PROPN
dti-3177	222	4	-	-	PUNCT
dti-3177	222	5	74	74	PROPN
dti-3177	222	6	.	.	PUNCT
dti-3177	223	1	crossref	crossref	PROPN
dti-3177	223	2	pubmed	pubmed	PROPN
dti-3177	223	3	7	7	PROPN
dti-3177	223	4	.	.	X
dti-3177	224	1	callejas	callejas	PROPN
dti-3177	224	2	be	be	AUX
dti-3177	224	3	,	,	PUNCT
dti-3177	224	4	martínez	martínez	PROPN
dti-3177	224	5	-	-	PUNCT
dti-3177	224	6	saucedo	saucedo	PROPN
dti-3177	224	7	d	d	PROPN
dti-3177	224	8	,	,	PUNCT
dti-3177	224	9	terrazas	terrazas	PROPN
dti-3177	224	10	li	li	PROPN
dti-3177	224	11	.	.	PROPN
dti-3177	224	12	parasites	parasite	NOUN
dti-3177	224	13	as	as	ADP
dti-3177	224	14	negative	negative	ADJ
dti-3177	224	15	regulators	regulator	NOUN
dti-3177	224	16	of	of	ADP
dti-3177	224	17	cancer	cancer	NOUN
dti-3177	224	18	.	.	PUNCT
dti-3177	225	1	biosci	biosci	PROPN
dti-3177	225	2	rep	rep	PROPN
dti-3177	225	3	.	.	PROPN
dti-3177	225	4	2018;38(5):bsr20180935	2018;38(5):bsr20180935	PROPN
dti-3177	225	5	.	.	PUNCT
dti-3177	226	1	crossref	crossref	PROPN
dti-3177	226	2	pubmed	pubmed	PROPN
dti-3177	226	3	8	8	PROPN
dti-3177	226	4	.	.	PUNCT
dti-3177	227	1	sung	sung	PROPN
dti-3177	227	2	h	h	NOUN
dti-3177	227	3	,	,	PUNCT
dti-3177	227	4	ferlay	ferlay	PROPN
dti-3177	227	5	j	j	PROPN
dti-3177	227	6	,	,	PUNCT
dti-3177	227	7	siegel	siegel	PROPN
dti-3177	227	8	rl	rl	PROPN
dti-3177	227	9	,	,	PUNCT
dti-3177	227	10	et	et	PROPN
dti-3177	227	11	al	al	PROPN
dti-3177	227	12	.	.	PUNCT
dti-3177	228	1	global	global	ADJ
dti-3177	228	2	cancer	cancer	NOUN
dti-3177	228	3	statistics	statistic	NOUN
dti-3177	228	4	2020	2020	NUM
dti-3177	228	5	:	:	PUNCT
dti-3177	228	6	globocan	globocan	PROPN
dti-3177	228	7	estimates	estimate	NOUN
dti-3177	228	8	of	of	ADP
dti-3177	228	9	incidence	incidence	NOUN
dti-3177	228	10	and	and	CCONJ
dti-3177	228	11	mortality	mortality	NOUN
dti-3177	228	12	worldwide	worldwide	ADV
dti-3177	228	13	for	for	ADP
dti-3177	228	14	36	36	NUM
dti-3177	228	15	cancers	cancer	NOUN
dti-3177	228	16	in	in	ADP
dti-3177	228	17	185	185	NUM
dti-3177	228	18	countries	country	NOUN
dti-3177	228	19	.	.	PUNCT
dti-3177	229	1	ca	can	AUX
dti-3177	229	2	cancer	cancer	PROPN
dti-3177	229	3	j	j	PROPN
dti-3177	229	4	clin	clin	PROPN
dti-3177	229	5	.	.	PUNCT
dti-3177	230	1	2021;71(3):209249	2021;71(3):209249	PROPN
dti-3177	230	2	.	.	PUNCT
dti-3177	231	1	crossref	crossref	PROPN
dti-3177	231	2	pubmed	pubmed	PROPN
dti-3177	231	3	9	9	PROPN
dti-3177	231	4	.	.	PUNCT
dti-3177	232	1	knoll	knoll	PROPN
dti-3177	232	2	lj	lj	PROPN
dti-3177	232	3	,	,	PUNCT
dti-3177	232	4	hogan	hogan	PROPN
dti-3177	232	5	da	da	PROPN
dti-3177	232	6	,	,	PUNCT
dti-3177	232	7	leong	leong	PROPN
dti-3177	232	8	jm	jm	PROPN
dti-3177	232	9	,	,	PUNCT
dti-3177	232	10	heitman	heitman	PROPN
dti-3177	232	11	j	j	PROPN
dti-3177	232	12	,	,	PUNCT
dti-3177	232	13	condit	condit	PROPN
dti-3177	232	14	rc	rc	PROPN
dti-3177	232	15	.	.	PUNCT
dti-3177	232	16	pearls	pearl	NOUN
dti-3177	232	17	collections	collection	NOUN
dti-3177	232	18	:	:	PUNCT
dti-3177	232	19	what	what	PRON
dti-3177	232	20	we	we	PRON
dti-3177	232	21	can	can	AUX
dti-3177	232	22	learn	learn	VERB
dti-3177	232	23	about	about	ADP
dti-3177	232	24	infectious	infectious	ADJ
dti-3177	232	25	disease	disease	NOUN
dti-3177	232	26	and	and	CCONJ
dti-3177	232	27	cancer	cancer	NOUN
dti-3177	232	28	.	.	PUNCT
dti-3177	233	1	public	public	ADJ
dti-3177	233	2	library	library	NOUN
dti-3177	233	3	of	of	ADP
dti-3177	233	4	science	science	PROPN
dti-3177	233	5	san	san	PROPN
dti-3177	233	6	francisco	francisco	PROPN
dti-3177	233	7	2018	2018	NUM
dti-3177	233	8	;	;	PUNCT
dti-3177	233	9	e1006915	e1006915	VERB
dti-3177	233	10	.	.	NOUN
dti-3177	233	11	10	10	NUM
dti-3177	233	12	.	.	PUNCT
dti-3177	234	1	bahadory	bahadory	NOUN
dti-3177	234	2	s	s	PART
dti-3177	234	3	,	,	PUNCT
dti-3177	234	4	sadraei	sadraei	PROPN
dti-3177	234	5	j	j	PROPN
dti-3177	234	6	,	,	PUNCT
dti-3177	234	7	zibaei	zibaei	PROPN
dti-3177	234	8	m	m	PROPN
dti-3177	234	9	,	,	PUNCT
dti-3177	234	10	pirestani	pirestani	PROPN
dti-3177	234	11	m	m	PROPN
dti-3177	234	12	,	,	PUNCT
dti-3177	234	13	dalimi	dalimi	VERB
dti-3177	234	14	a.	a.	NOUN
dti-3177	234	15	in	in	ADP
dti-3177	234	16	vitro	vitro	X
dti-3177	234	17	anti	anti	ADJ
dti-3177	234	18	-	-	ADJ
dti-3177	234	19	gastrointestinal	gastrointestinal	ADJ
dti-3177	234	20	cancer	cancer	NOUN
dti-3177	234	21	activity	activity	NOUN
dti-3177	234	22	of	of	ADP
dti-3177	234	23	toxocara	toxocara	ADJ
dti-3177	234	24	canis	canis	NOUN
dti-3177	234	25	-	-	PUNCT
dti-3177	234	26	derived	derive	VERB
dti-3177	234	27	peptide	peptide	NOUN
dti-3177	234	28	:	:	PUNCT
dti-3177	234	29	analyzing	analyze	VERB
dti-3177	234	30	the	the	DET
dti-3177	234	31	expression	expression	NOUN
dti-3177	234	32	level	level	NOUN
dti-3177	234	33	of	of	ADP
dti-3177	234	34	factors	factor	NOUN
dti-3177	234	35	related	relate	VERB
dti-3177	234	36	to	to	ADP
dti-3177	234	37	cell	cell	NOUN
dti-3177	234	38	proliferation	proliferation	NOUN
dti-3177	234	39	and	and	CCONJ
dti-3177	234	40	tumor	tumor	NOUN
dti-3177	234	41	growth	growth	NOUN
dti-3177	234	42	.	.	PUNCT
dti-3177	235	1	front	front	ADJ
dti-3177	235	2	pharmacol	pharmacol	PROPN
dti-3177	235	3	.	.	PUNCT
dti-3177	236	1	2022;13:878724	2022;13:878724	X
dti-3177	236	2	.	.	PUNCT
dti-3177	237	1	crossref	crossref	PROPN
dti-3177	237	2	pubmed	pubmed	PROPN
dti-3177	237	3	11	11	NUM
dti-3177	237	4	.	.	PUNCT
dti-3177	238	1	fox	fox	PROPN
dti-3177	238	2	ba	ba	PROPN
dti-3177	238	3	,	,	PUNCT
dti-3177	238	4	butler	butler	PROPN
dti-3177	238	5	kl	kl	PROPN
dti-3177	238	6	,	,	PUNCT
dti-3177	238	7	guevara	guevara	PROPN
dti-3177	238	8	rb	rb	PROPN
dti-3177	238	9	,	,	PUNCT
dti-3177	238	10	bzik	bzik	NOUN
dti-3177	238	11	dj	dj	PROPN
dti-3177	238	12	.	.	PUNCT
dti-3177	238	13	cancer	cancer	NOUN
dti-3177	238	14	therapy	therapy	NOUN
dti-3177	238	15	in	in	ADP
dti-3177	238	16	a	a	DET
dti-3177	238	17	microbial	microbial	ADJ
dti-3177	238	18	bottle	bottle	NOUN
dti-3177	238	19	:	:	PUNCT
dti-3177	238	20	uncorking	uncork	VERB
dti-3177	238	21	the	the	DET
dti-3177	238	22	novel	novel	ADJ
dti-3177	238	23	biology	biology	NOUN
dti-3177	238	24	of	of	ADP
dti-3177	238	25	the	the	DET
dti-3177	238	26	protozoan	protozoan	NOUN
dti-3177	238	27	toxoplasma	toxoplasma	NOUN
dti-3177	238	28	gondii	gondii	NOUN
dti-3177	238	29	.	.	PUNCT
dti-3177	239	1	plos	plos	PROPN
dti-3177	239	2	pathog	pathog	PROPN
dti-3177	239	3	.	.	PUNCT
dti-3177	240	1	2017;13(9):e1006523	2017;13(9):e1006523	NUM
dti-3177	240	2	.	.	PUNCT
dti-3177	241	1	crossref	crossref	PROPN
dti-3177	241	2	pubmed	pubmed	PROPN
dti-3177	241	3	12	12	NUM
dti-3177	241	4	.	.	PUNCT
dti-3177	242	1	soleimani	soleimani	PROPN
dti-3177	242	2	m	m	PROPN
dti-3177	242	3	,	,	PUNCT
dti-3177	242	4	nadri	nadri	PROPN
dti-3177	242	5	s.	s.	PROPN
dti-3177	242	6	a	a	DET
dti-3177	242	7	protocol	protocol	NOUN
dti-3177	242	8	for	for	ADP
dti-3177	242	9	isolation	isolation	NOUN
dti-3177	242	10	and	and	CCONJ
dti-3177	242	11	culture	culture	NOUN
dti-3177	242	12	of	of	ADP
dti-3177	242	13	mesenchymal	mesenchymal	NOUN
dti-3177	242	14	stem	stem	NOUN
dti-3177	242	15	cells	cell	NOUN
dti-3177	242	16	from	from	ADP
dti-3177	242	17	mouse	mouse	NOUN
dti-3177	242	18	bone	bone	NOUN
dti-3177	242	19	marrow	marrow	NOUN
dti-3177	242	20	.	.	PUNCT
dti-3177	243	1	nat	nat	PROPN
dti-3177	243	2	protoc	protoc	VERB
dti-3177	243	3	.	.	PUNCT
dti-3177	244	1	2009;4(1):102	2009;4(1):102	NUM
dti-3177	244	2	-	-	SYM
dti-3177	244	3	106	106	NUM
dti-3177	244	4	.	.	PUNCT
dti-3177	245	1	crossref	crossref	PROPN
dti-3177	245	2	pubmed	pubmed	PROPN
dti-3177	245	3	13	13	NUM
dti-3177	245	4	.	.	PUNCT
dti-3177	246	1	kumar	kumar	PROPN
dti-3177	246	2	p	p	PROPN
dti-3177	246	3	,	,	PUNCT
dti-3177	246	4	nagarajan	nagarajan	NOUN
dti-3177	246	5	a	a	DET
dti-3177	246	6	,	,	PUNCT
dti-3177	246	7	uchil	uchil	PROPN
dti-3177	246	8	pd	pd	PROPN
dti-3177	246	9	.	.	PROPN
dti-3177	246	10	analysis	analysis	NOUN
dti-3177	246	11	of	of	ADP
dti-3177	246	12	cell	cell	NOUN
dti-3177	246	13	viability	viability	NOUN
dti-3177	246	14	by	by	ADP
dti-3177	246	15	the	the	DET
dti-3177	246	16	mtt	mtt	NOUN
dti-3177	246	17	assay	assay	VERB
dti-3177	246	18	.	.	PUNCT
dti-3177	247	1	cold	cold	ADJ
dti-3177	247	2	spring	spring	NOUN
dti-3177	247	3	harb	harb	PROPN
dti-3177	247	4	protoc	protoc	VERB
dti-3177	247	5	.	.	PUNCT
dti-3177	248	1	2018;2018(6):pdb	2018;2018(6):pdb	ADJ
dti-3177	248	2	.	.	PUNCT
dti-3177	249	1	prot095505	prot095505	PROPN
dti-3177	249	2	.	.	PUNCT
dti-3177	250	1	crossref	crossref	PROPN
dti-3177	250	2	pubmed	pubmed	PROPN
dti-3177	250	3	14	14	PROPN
dti-3177	250	4	.	.	PUNCT
dti-3177	251	1	pan	pan	PROPN
dti-3177	251	2	w	w	PROPN
dti-3177	251	3	,	,	PUNCT
dti-3177	251	4	yang	yang	PROPN
dti-3177	251	5	j	j	PROPN
dti-3177	251	6	,	,	PUNCT
dti-3177	251	7	wei	wei	PROPN
dti-3177	251	8	j	j	PROPN
dti-3177	251	9	,	,	PUNCT
dti-3177	251	10	et	et	PROPN
dti-3177	251	11	al	al	PROPN
dti-3177	251	12	.	.	PROPN
dti-3177	252	1	functional	functional	ADJ
dti-3177	252	2	bcl-2	bcl-2	ADJ
dti-3177	252	3	regulatory	regulatory	ADJ
dti-3177	252	4	genetic	genetic	ADJ
dti-3177	252	5	variants	variant	NOUN
dti-3177	252	6	contribute	contribute	VERB
dti-3177	252	7	to	to	ADP
dti-3177	252	8	susceptibility	susceptibility	NOUN
dti-3177	252	9	of	of	ADP
dti-3177	252	10	esophageal	esophageal	ADJ
dti-3177	252	11	squamous	squamous	ADJ
dti-3177	252	12	cell	cell	NOUN
dti-3177	252	13	carcinoma	carcinoma	NOUN
dti-3177	252	14	.	.	PUNCT
dti-3177	253	1	sci	sci	PROPN
dti-3177	253	2	rep	rep	PROPN
dti-3177	253	3	.	.	PROPN
dti-3177	253	4	2015;5(1):11833	2015;5(1):11833	NUM
dti-3177	253	5	.	.	PUNCT
dti-3177	253	6	crossref	crossref	PROPN
dti-3177	253	7	pubmed	pubmed	PROPN
dti-3177	253	8	15	15	PROPN
dti-3177	253	9	.	.	PUNCT
dti-3177	254	1	shang	shang	PROPN
dti-3177	254	2	j	j	PROPN
dti-3177	254	3	,	,	PUNCT
dti-3177	254	4	yang	yang	PROPN
dti-3177	254	5	f	f	PROPN
dti-3177	254	6	,	,	PUNCT
dti-3177	254	7	wang	wang	PROPN
dti-3177	254	8	y	y	PROPN
dti-3177	254	9	,	,	PUNCT
dti-3177	254	10	et	et	PROPN
dti-3177	254	11	al	al	PROPN
dti-3177	254	12	.	.	PUNCT
dti-3177	255	1	microrna-23a	microrna-23a	PROPN
dti-3177	255	2	antisense	antisense	NOUN
dti-3177	255	3	enhances	enhance	VERB
dti-3177	255	4	5	5	NUM
dti-3177	255	5	-	-	PUNCT
dti-3177	255	6	fluorouracil	fluorouracil	NOUN
dti-3177	255	7	chemosensitivity	chemosensitivity	NOUN
dti-3177	255	8	through	through	ADP
dti-3177	255	9	apaf-1/	apaf-1/	NOUN
dti-3177	255	10	caspase-9	caspase-9	PROPN
dti-3177	255	11	apoptotic	apoptotic	ADJ
dti-3177	255	12	pathway	pathway	NOUN
dti-3177	255	13	in	in	ADP
dti-3177	255	14	colorectal	colorectal	ADJ
dti-3177	255	15	cancer	cancer	NOUN
dti-3177	255	16	cells	cell	NOUN
dti-3177	255	17	.	.	PUNCT
dti-3177	256	1	j	j	PROPN
dti-3177	256	2	cell	cell	PROPN
dti-3177	256	3	biochem	biochem	PROPN
dti-3177	256	4	.	.	PUNCT
dti-3177	257	1	2014;115(4):772	2014;115(4):772	X
dti-3177	257	2	-	-	PUNCT
dti-3177	257	3	784	784	NUM
dti-3177	257	4	.	.	PUNCT
dti-3177	258	1	crossref	crossref	PROPN
dti-3177	258	2	pubmed	pubmed	PROPN
dti-3177	258	3	16	16	NUM
dti-3177	258	4	.	.	PUNCT
dti-3177	259	1	mckinnon	mckinnon	PROPN
dti-3177	259	2	km	km	PROPN
dti-3177	259	3	.	.	PUNCT
dti-3177	260	1	flow	flow	NOUN
dti-3177	260	2	cytometry	cytometry	NOUN
dti-3177	260	3	:	:	PUNCT
dti-3177	260	4	an	an	DET
dti-3177	260	5	overview	overview	NOUN
dti-3177	260	6	.	.	PUNCT
dti-3177	261	1	curr	curr	PROPN
dti-3177	261	2	protoc	protoc	PROPN
dti-3177	261	3	immunol	immunol	NOUN
dti-3177	261	4	.	.	PUNCT
dti-3177	262	1	2018;120(1):5.1.1	2018;120(1):5.1.1	ADJ
dti-3177	262	2	-	-	PUNCT
dti-3177	262	3	5.1.11	5.1.11	NUM
dti-3177	262	4	.	.	PUNCT
dti-3177	263	1	crossref	crossref	PROPN
dti-3177	263	2	17	17	NUM
dti-3177	263	3	.	.	PUNCT
dti-3177	264	1	lin	lin	PROPN
dti-3177	264	2	sr	sr	PROPN
dti-3177	264	3	,	,	PUNCT
dti-3177	264	4	chang	chang	PROPN
dti-3177	264	5	ch	ch	PROPN
dti-3177	264	6	,	,	PUNCT
dti-3177	264	7	hsu	hsu	PROPN
dti-3177	264	8	cf	cf	PROPN
dti-3177	264	9	,	,	PUNCT
dti-3177	264	10	et	et	PROPN
dti-3177	264	11	al	al	PROPN
dti-3177	264	12	.	.	PROPN
dti-3177	264	13	natural	natural	ADJ
dti-3177	264	14	compounds	compound	NOUN
dti-3177	264	15	as	as	ADP
dti-3177	264	16	potential	potential	ADJ
dti-3177	264	17	adjuvants	adjuvant	NOUN
dti-3177	264	18	to	to	ADP
dti-3177	264	19	cancer	cancer	NOUN
dti-3177	264	20	therapy	therapy	NOUN
dti-3177	264	21	:	:	PUNCT
dti-3177	264	22	preclinical	preclinical	ADJ
dti-3177	264	23	evidence	evidence	NOUN
dti-3177	264	24	.	.	PUNCT
dti-3177	265	1	br	br	PROPN
dti-3177	265	2	j	j	PROPN
dti-3177	265	3	pharmacol	pharmacol	PROPN
dti-3177	265	4	.	.	PUNCT
dti-3177	266	1	2020;177(6):1409	2020;177(6):1409	NUM
dti-3177	266	2	-	-	SYM
dti-3177	266	3	1423	1423	NUM
dti-3177	266	4	.	.	PUNCT
dti-3177	267	1	crossref	crossref	PROPN
dti-3177	267	2	pubmed	pubmed	PROPN
dti-3177	267	3	18	18	NUM
dti-3177	267	4	.	.	PUNCT
dti-3177	268	1	zheng	zheng	PROPN
dti-3177	268	2	h	h	PROPN
dti-3177	268	3	-	-	PUNCT
dti-3177	268	4	c.	c.	NOUN
dti-3177	268	5	the	the	DET
dti-3177	268	6	molecular	molecular	ADJ
dti-3177	268	7	mechanisms	mechanism	NOUN
dti-3177	268	8	of	of	ADP
dti-3177	268	9	chemoresistance	chemoresistance	NOUN
dti-3177	268	10	in	in	ADP
dti-3177	268	11	cancers	cancer	NOUN
dti-3177	268	12	.	.	PUNCT
dti-3177	269	1	oncotarget	oncotarget	NOUN
dti-3177	269	2	.	.	PUNCT
dti-3177	270	1	2017;8(35):59950	2017;8(35):59950	NUM
dti-3177	270	2	-	-	SYM
dti-3177	270	3	59964	59964	NUM
dti-3177	270	4	.	.	PUNCT
dti-3177	271	1	crossref	crossref	PROPN
dti-3177	271	2	pubmed	pubmed	PROPN
dti-3177	271	3	19	19	NUM
dti-3177	271	4	.	.	PUNCT
dti-3177	272	1	chen	chen	PROPN
dti-3177	272	2	m	m	PROPN
dti-3177	272	3	-	-	PROPN
dti-3177	272	4	l	l	PROPN
dti-3177	272	5	,	,	PUNCT
dti-3177	272	6	lai	lai	PROPN
dti-3177	272	7	c	c	PROPN
dti-3177	272	8	-	-	PUNCT
dti-3177	272	9	j	j	PROPN
dti-3177	272	10	,	,	PUNCT
dti-3177	272	11	lin	lin	PROPN
dti-3177	272	12	y	y	PROPN
dti-3177	272	13	-	-	PUNCT
dti-3177	272	14	n	n	CCONJ
dti-3177	272	15	,	,	PUNCT
dti-3177	272	16	huang	huang	PROPN
dti-3177	272	17	c	c	PROPN
dti-3177	272	18	-	-	PUNCT
dti-3177	272	19	m	m	PROPN
dti-3177	272	20	,	,	PUNCT
dti-3177	272	21	lin	lin	PROPN
dti-3177	272	22	y	y	PROPN
dti-3177	272	23	-	-	PUNCT
dti-3177	272	24	h.	h.	PROPN
dti-3177	272	25	multifunctional	multifunctional	ADJ
dti-3177	272	26	nanoparticles	nanoparticle	NOUN
dti-3177	272	27	for	for	ADP
dti-3177	272	28	targeting	target	VERB
dti-3177	272	29	the	the	DET
dti-3177	272	30	tumor	tumor	NOUN
dti-3177	272	31	microenvironment	microenvironment	NOUN
dti-3177	272	32	to	to	PART
dti-3177	272	33	improve	improve	VERB
dti-3177	272	34	synergistic	synergistic	ADJ
dti-3177	272	35	drug	drug	NOUN
dti-3177	272	36	combinations	combination	NOUN
dti-3177	272	37	and	and	CCONJ
dti-3177	272	38	cancer	cancer	NOUN
dti-3177	272	39	treatment	treatment	NOUN
dti-3177	272	40	effects	effect	NOUN
dti-3177	272	41	.	.	PUNCT
dti-3177	273	1	j	j	PROPN
dti-3177	273	2	mater	mater	PROPN
dti-3177	273	3	chem	chem	PROPN
dti-3177	273	4	b.	b.	PROPN
dti-3177	274	1	2020;8(45):10416	2020;8(45):10416	NUM
dti-3177	274	2	-	-	SYM
dti-3177	274	3	10427	10427	NUM
dti-3177	274	4	.	.	PUNCT
dti-3177	275	1	crossref	crossref	PROPN
dti-3177	275	2	pubmed	pubmed	PROPN
dti-3177	275	3	https://doi.org/10.1371/journal.pone.0090203	https://doi.org/10.1371/journal.pone.0090203	PROPN
dti-3177	275	4	https://www.ncbi.nlm.nih.gov/pubmed/24662942	https://www.ncbi.nlm.nih.gov/pubmed/24662942	NUM
dti-3177	275	5	https://doi.org/10.1016/j.ijpara.2009.01.005	https://doi.org/10.1016/j.ijpara.2009.01.005	PROPN
dti-3177	275	6	https://www.ncbi.nlm.nih.gov/pubmed/19630138	https://www.ncbi.nlm.nih.gov/pubmed/19630138	X
dti-3177	275	7	https://doi.org/10.1186/s13071-020-04445-z	https://doi.org/10.1186/s13071-020-04445-z	PROPN
dti-3177	275	8	https://www.ncbi.nlm.nih.gov/pubmed/33228743	https://www.ncbi.nlm.nih.gov/pubmed/33228743	PROPN
dti-3177	275	9	https://doi.org/10.1016/j.fawpar.2019.e00037	https://doi.org/10.1016/j.fawpar.2019.e00037	PROPN
dti-3177	275	10	https://www.ncbi.nlm.nih.gov/pubmed/32095611	https://www.ncbi.nlm.nih.gov/pubmed/32095611	AUX
dti-3177	275	11	https://doi.org/10.1016/b978-0-12-815041-2.00001-3	https://doi.org/10.1016/b978-0-12-815041-2.00001-3	VERB
dti-3177	275	12	https://doi.org/10.1016/j.cell.2011.02.013	https://doi.org/10.1016/j.cell.2011.02.013	NOUN
dti-3177	275	13	https://pubmed.ncbi.nlm.nih.gov/21376230/	https://pubmed.ncbi.nlm.nih.gov/21376230/	PROPN
dti-3177	275	14	https://doi.org/10.1042/bsr20180935	https://doi.org/10.1042/bsr20180935	ADV
dti-3177	275	15	https://www.ncbi.nlm.nih.gov/pubmed/30266743	https://www.ncbi.nlm.nih.gov/pubmed/30266743	NUM
dti-3177	275	16	https://doi.org/10.3322/caac.21660	https://doi.org/10.3322/caac.21660	X
dti-3177	275	17	https://www.ncbi.nlm.nih.gov/pubmed/33538338	https://www.ncbi.nlm.nih.gov/pubmed/33538338	NUM
dti-3177	275	18	https://doi.org/10.3389/fphar.2022.878724	https://doi.org/10.3389/fphar.2022.878724	PROPN
dti-3177	275	19	https://www.ncbi.nlm.nih.gov/pubmed/36204226	https://www.ncbi.nlm.nih.gov/pubmed/36204226	NOUN
dti-3177	275	20	https://doi.org/10.1371/journal.ppat.1006523	https://doi.org/10.1371/journal.ppat.1006523	NOUN
dti-3177	275	21	https://www.ncbi.nlm.nih.gov/pubmed/28910406	https://www.ncbi.nlm.nih.gov/pubmed/28910406	NUM
dti-3177	275	22	https://doi.org/10.1038/nprot.2008.221	https://doi.org/10.1038/nprot.2008.221	PROPN
dti-3177	275	23	https://www.ncbi.nlm.nih.gov/pubmed/19131962	https://www.ncbi.nlm.nih.gov/pubmed/19131962	PUNCT
dti-3177	275	24	https://doi.org/10.1101/pdb.prot095505	https://doi.org/10.1101/pdb.prot095505	PROPN
dti-3177	275	25	https://www.ncbi.nlm.nih.gov/pubmed/29858338	https://www.ncbi.nlm.nih.gov/pubmed/29858338	NUM
dti-3177	275	26	https://doi.org/10.1038/srep11833	https://doi.org/10.1038/srep11833	PROPN
dti-3177	275	27	https://www.ncbi.nlm.nih.gov/pubmed/26132559	https://www.ncbi.nlm.nih.gov/pubmed/26132559	PROPN
dti-3177	275	28	https://doi.org/10.1002/jcb.24721	https://doi.org/10.1002/jcb.24721	PROPN
dti-3177	275	29	https://www.ncbi.nlm.nih.gov/pubmed/24249161	https://www.ncbi.nlm.nih.gov/pubmed/24249161	X
dti-3177	275	30	https://doi.org/10.1002/cpim.40	https://doi.org/10.1002/cpim.40	X
dti-3177	275	31	https://doi.org/10.1111/bph.14816	https://doi.org/10.1111/bph.14816	PROPN
dti-3177	275	32	https://www.ncbi.nlm.nih.gov/pubmed/31368509	https://www.ncbi.nlm.nih.gov/pubmed/31368509	NUM
dti-3177	275	33	https://doi.org/10.18632/oncotarget.19048	https://doi.org/10.18632/oncotarget.19048	NOUN
dti-3177	275	34	https://www.ncbi.nlm.nih.gov/pubmed/28938696	https://www.ncbi.nlm.nih.gov/pubmed/28938696	NUM
dti-3177	275	35	https://doi.org/10.1039/d0tb01733	https://doi.org/10.1039/d0tb01733	NOUN
dti-3177	275	36	g	g	PROPN
dti-3177	275	37	https://www.ncbi.nlm.nih.gov/pubmed/33112350	https://www.ncbi.nlm.nih.gov/pubmed/33112350	PROPN
dti-3177	275	38	shahrivar	shahrivar	NOUN
dti-3177	275	39	et	et	PROPN
dti-3177	275	40	al	al	PROPN
dti-3177	275	41	drug	drug	PROPN
dti-3177	275	42	target	target	NOUN
dti-3177	275	43	insights	insight	NOUN
dti-3177	275	44	2024	2024	NUM
dti-3177	275	45	;	;	PUNCT
dti-3177	275	46	18	18	NUM
dti-3177	275	47	:	:	SYM
dti-3177	275	48	77	77	NUM
dti-3177	275	49	©	©	PROPN
dti-3177	275	50	2024	2024	NUM
dti-3177	275	51	the	the	DET
dti-3177	275	52	authors	author	NOUN
dti-3177	275	53	.	.	PUNCT
dti-3177	276	1	published	publish	VERB
dti-3177	276	2	by	by	ADP
dti-3177	276	3	aboutscience	aboutscience	NOUN
dti-3177	276	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-3177	276	5	20	20	NUM
dti-3177	276	6	.	.	PUNCT
dti-3177	277	1	garcia	garcia	PROPN
dti-3177	277	2	sb	sb	PROPN
dti-3177	277	3	,	,	PUNCT
dti-3177	277	4	aranha	aranha	VERB
dti-3177	277	5	al	al	PROPN
dti-3177	277	6	,	,	PUNCT
dti-3177	277	7	garcia	garcia	PROPN
dti-3177	277	8	frb	frb	PROPN
dti-3177	277	9	,	,	PUNCT
dti-3177	277	10	et	et	PROPN
dti-3177	277	11	al	al	PROPN
dti-3177	277	12	.	.	PUNCT
dti-3177	278	1	a	a	DET
dti-3177	278	2	retrospective	retrospective	ADJ
dti-3177	278	3	study	study	NOUN
dti-3177	278	4	of	of	ADP
dti-3177	278	5	histopathological	histopathological	ADJ
dti-3177	278	6	findings	finding	NOUN
dti-3177	278	7	in	in	ADP
dti-3177	278	8	894	894	NUM
dti-3177	278	9	cases	case	NOUN
dti-3177	278	10	of	of	ADP
dti-3177	278	11	megacolon	megacolon	NOUN
dti-3177	278	12	:	:	PUNCT
dti-3177	278	13	what	what	PRON
dti-3177	278	14	is	be	AUX
dti-3177	278	15	the	the	DET
dti-3177	278	16	relationship	relationship	NOUN
dti-3177	278	17	between	between	ADP
dti-3177	278	18	megacolon	megacolon	NOUN
dti-3177	278	19	and	and	CCONJ
dti-3177	278	20	colonic	colonic	NOUN
dti-3177	278	21	cancer	cancer	NOUN
dti-3177	278	22	?	?	PUNCT
dti-3177	279	1	rev	rev	AUX
dti-3177	279	2	inst	inst	PROPN
dti-3177	279	3	med	med	PROPN
dti-3177	279	4	trop	trop	X
dti-3177	279	5	são	são	PROPN
dti-3177	279	6	paulo	paulo	PROPN
dti-3177	279	7	.	.	PUNCT
dti-3177	280	1	2003;45(2):91	2003;45(2):91	NUM
dti-3177	280	2	-	-	SYM
dti-3177	280	3	93	93	NUM
dti-3177	280	4	.	.	PUNCT
dti-3177	281	1	crossref	crossref	PROPN
dti-3177	281	2	pubmed	pubmed	PROPN
dti-3177	281	3	21	21	NUM
dti-3177	281	4	.	.	PUNCT
dti-3177	282	1	hunter	hunter	NOUN
dti-3177	282	2	ca	ca	PROPN
dti-3177	282	3	,	,	PUNCT
dti-3177	282	4	subauste	subauste	VERB
dti-3177	282	5	cs	cs	PROPN
dti-3177	282	6	,	,	PUNCT
dti-3177	282	7	van	van	PROPN
dti-3177	282	8	cleave	cleave	PROPN
dti-3177	282	9	vh	vh	PROPN
dti-3177	282	10	,	,	PUNCT
dti-3177	282	11	remington	remington	PROPN
dti-3177	282	12	js	js	PROPN
dti-3177	282	13	.	.	PUNCT
dti-3177	283	1	production	production	NOUN
dti-3177	283	2	of	of	ADP
dti-3177	283	3	gamma	gamma	PROPN
dti-3177	283	4	interferon	interferon	NOUN
dti-3177	283	5	by	by	ADP
dti-3177	283	6	natural	natural	ADJ
dti-3177	283	7	killer	killer	NOUN
dti-3177	283	8	cells	cell	NOUN
dti-3177	283	9	from	from	ADP
dti-3177	283	10	toxoplasma	toxoplasma	ADJ
dti-3177	283	11	gondii	gondii	NOUN
dti-3177	283	12	-	-	PUNCT
dti-3177	283	13	infected	infect	VERB
dti-3177	283	14	scid	scid	NOUN
dti-3177	283	15	mice	mouse	NOUN
dti-3177	283	16	:	:	PUNCT
dti-3177	283	17	regulation	regulation	NOUN
dti-3177	283	18	by	by	ADP
dti-3177	283	19	interleukin-10	interleukin-10	PROPN
dti-3177	283	20	,	,	PUNCT
dti-3177	283	21	interleukin-12	interleukin-12	PROPN
dti-3177	283	22	,	,	PUNCT
dti-3177	283	23	and	and	CCONJ
dti-3177	283	24	tumor	tumor	NOUN
dti-3177	283	25	necrosis	necrosis	NOUN
dti-3177	283	26	factor	factor	NOUN
dti-3177	283	27	alpha	alpha	NOUN
dti-3177	283	28	.	.	PUNCT
dti-3177	284	1	infect	infect	PROPN
dti-3177	284	2	immun	immun	PROPN
dti-3177	284	3	.	.	PUNCT
dti-3177	285	1	1994;62(7):2818	1994;62(7):2818	NUM
dti-3177	285	2	-	-	SYM
dti-3177	285	3	2824	2824	NUM
dti-3177	285	4	.	.	PUNCT
dti-3177	286	1	crossref	crossref	PROPN
dti-3177	286	2	pubmed	pubmed	PROPN
dti-3177	286	3	22	22	NUM
dti-3177	286	4	.	.	PUNCT
dti-3177	287	1	fosgerau	fosgerau	PROPN
dti-3177	287	2	k	k	PROPN
dti-3177	287	3	,	,	PUNCT
dti-3177	287	4	hoffmann	hoffmann	PROPN
dti-3177	287	5	t.	t.	PROPN
dti-3177	287	6	peptide	peptide	NOUN
dti-3177	287	7	therapeutics	therapeutic	NOUN
dti-3177	287	8	:	:	PUNCT
dti-3177	287	9	current	current	ADJ
dti-3177	287	10	status	status	NOUN
dti-3177	287	11	and	and	CCONJ
dti-3177	287	12	future	future	ADJ
dti-3177	287	13	directions	direction	NOUN
dti-3177	287	14	.	.	PUNCT
dti-3177	288	1	drug	drug	NOUN
dti-3177	288	2	discov	discov	PROPN
dti-3177	288	3	today	today	NOUN
dti-3177	288	4	.	.	PUNCT
dti-3177	289	1	2015;20(1):122	2015;20(1):122	NUM
dti-3177	289	2	-	-	SYM
dti-3177	289	3	128	128	NUM
dti-3177	289	4	.	.	PUNCT
dti-3177	290	1	crossref	crossref	PROPN
dti-3177	290	2	pubmed	pubmed	PROPN
dti-3177	290	3	23	23	NUM
dti-3177	290	4	.	.	PUNCT
dti-3177	291	1	lv	lv	PROPN
dti-3177	291	2	s	s	PROPN
dti-3177	291	3	,	,	PUNCT
dti-3177	291	4	sylvestre	sylvestre	NOUN
dti-3177	291	5	m	m	PROPN
dti-3177	291	6	,	,	PUNCT
dti-3177	291	7	prossnitz	prossnitz	NOUN
dti-3177	291	8	an	an	PROPN
dti-3177	291	9	,	,	PUNCT
dti-3177	291	10	yang	yang	PROPN
dti-3177	291	11	lf	lf	PROPN
dti-3177	291	12	,	,	PUNCT
dti-3177	291	13	pun	pun	PROPN
dti-3177	291	14	sh	sh	PROPN
dti-3177	291	15	.	.	PROPN
dti-3177	291	16	design	design	NOUN
dti-3177	291	17	of	of	ADP
dti-3177	291	18	polymeric	polymeric	ADJ
dti-3177	291	19	carriers	carrier	NOUN
dti-3177	291	20	for	for	ADP
dti-3177	291	21	intracellular	intracellular	ADJ
dti-3177	291	22	peptide	peptide	NOUN
dti-3177	291	23	delivery	delivery	NOUN
dti-3177	291	24	in	in	ADP
dti-3177	291	25	oncology	oncology	NOUN
dti-3177	291	26	applications	application	NOUN
dti-3177	291	27	.	.	PUNCT
dti-3177	292	1	chem	chem	PROPN
dti-3177	292	2	rev	rev	VERB
dti-3177	292	3	.	.	PROPN
dti-3177	292	4	2021;121(18):11653	2021;121(18):11653	NUM
dti-3177	292	5	-	-	SYM
dti-3177	292	6	11698	11698	NUM
dti-3177	292	7	.	.	PUNCT
dti-3177	293	1	crossref	crossref	PROPN
dti-3177	293	2	pubmed	pubmed	PROPN
dti-3177	293	3	24	24	NUM
dti-3177	293	4	.	.	PUNCT
dti-3177	294	1	gogvadze	gogvadze	NOUN
dti-3177	294	2	v	v	ADP
dti-3177	294	3	,	,	PUNCT
dti-3177	294	4	orrenius	orrenius	PROPN
dti-3177	294	5	s	s	PROPN
dti-3177	294	6	,	,	PUNCT
dti-3177	294	7	zhivotovsky	zhivotovsky	PROPN
dti-3177	294	8	b.	b.	PROPN
dti-3177	295	1	multiple	multiple	ADJ
dti-3177	295	2	pathways	pathway	NOUN
dti-3177	295	3	of	of	ADP
dti-3177	295	4	cytochrome	cytochrome	NOUN
dti-3177	295	5	c	c	NOUN
dti-3177	295	6	release	release	NOUN
dti-3177	295	7	from	from	ADP
dti-3177	295	8	mitochondria	mitochondria	NOUN
dti-3177	295	9	in	in	ADP
dti-3177	295	10	apoptosis	apoptosis	NOUN
dti-3177	295	11	.	.	PUNCT
dti-3177	296	1	biochim	biochim	PROPN
dti-3177	296	2	biophys	biophy	NOUN
dti-3177	296	3	acta	acta	PROPN
dti-3177	296	4	.	.	PUNCT
dti-3177	297	1	2006;1757(5	2006;1757(5	X
dti-3177	297	2	-	-	PUNCT
dti-3177	297	3	6):639	6):639	PROPN
dti-3177	297	4	-	-	PUNCT
dti-3177	297	5	647	647	NUM
dti-3177	297	6	.	.	PUNCT
dti-3177	298	1	crossref	crossref	PROPN
dti-3177	298	2	pubmed	pubmed	PROPN
dti-3177	298	3	25	25	NUM
dti-3177	298	4	.	.	PUNCT
dti-3177	299	1	brunelle	brunelle	PROPN
dti-3177	299	2	jk	jk	PROPN
dti-3177	299	3	,	,	PUNCT
dti-3177	299	4	letai	letai	PROPN
dti-3177	299	5	a.	a.	NOUN
dti-3177	299	6	control	control	NOUN
dti-3177	299	7	of	of	ADP
dti-3177	299	8	mitochondrial	mitochondrial	ADJ
dti-3177	299	9	apoptosis	apoptosis	NOUN
dti-3177	299	10	by	by	ADP
dti-3177	299	11	the	the	DET
dti-3177	299	12	bcl-2	bcl-2	ADJ
dti-3177	299	13	family	family	NOUN
dti-3177	299	14	.	.	PUNCT
dti-3177	300	1	j	j	PROPN
dti-3177	300	2	cell	cell	PROPN
dti-3177	300	3	sci	sci	PROPN
dti-3177	300	4	.	.	PUNCT
dti-3177	301	1	2009;122(pt	2009;122(pt	NUM
dti-3177	301	2	4):437	4):437	NUM
dti-3177	301	3	-	-	SYM
dti-3177	301	4	441	441	NUM
dti-3177	301	5	.	.	PUNCT
dti-3177	302	1	crossref	crossref	PROPN
dti-3177	302	2	pubmed	pubmed	PROPN
dti-3177	302	3	26	26	NUM
dti-3177	302	4	.	.	PUNCT
dti-3177	303	1	shakeri	shakeri	ADJ
dti-3177	303	2	r	r	NOUN
dti-3177	303	3	,	,	PUNCT
dti-3177	303	4	kheirollahi	kheirollahi	NOUN
dti-3177	303	5	a	a	PRON
dti-3177	303	6	,	,	PUNCT
dti-3177	303	7	davoodi	davoodi	ADV
dti-3177	303	8	j.	j.	PROPN
dti-3177	303	9	apaf-1	apaf-1	PROPN
dti-3177	303	10	:	:	PUNCT
dti-3177	303	11	regulation	regulation	NOUN
dti-3177	303	12	and	and	CCONJ
dti-3177	303	13	function	function	NOUN
dti-3177	303	14	in	in	ADP
dti-3177	303	15	cell	cell	NOUN
dti-3177	303	16	death	death	NOUN
dti-3177	303	17	.	.	PUNCT
dti-3177	304	1	biochimie	biochimie	PROPN
dti-3177	304	2	.	.	PUNCT
dti-3177	305	1	2017;135:111	2017;135:111	X
dti-3177	305	2	-	-	SYM
dti-3177	305	3	125	125	NUM
dti-3177	305	4	.	.	PUNCT
dti-3177	306	1	crossref	crossref	PROPN
dti-3177	306	2	pubmed	pubmed	PROPN
dti-3177	306	3	27	27	NUM
dti-3177	306	4	.	.	PUNCT
dti-3177	307	1	tang	tang	PROPN
dti-3177	308	1	d	d	PROPN
dti-3177	308	2	,	,	PUNCT
dti-3177	308	3	kang	kang	PROPN
dti-3177	308	4	r	r	PROPN
dti-3177	308	5	,	,	PUNCT
dti-3177	308	6	berghe	berghe	NOUN
dti-3177	308	7	tv	tv	NOUN
dti-3177	308	8	,	,	PUNCT
dti-3177	308	9	vandenabeele	vandenabeele	NOUN
dti-3177	308	10	p	p	NOUN
dti-3177	308	11	,	,	PUNCT
dti-3177	308	12	kroemer	kroemer	PROPN
dti-3177	308	13	g.	g.	PROPN
dti-3177	308	14	the	the	DET
dti-3177	308	15	molecular	molecular	ADJ
dti-3177	308	16	machinery	machinery	NOUN
dti-3177	308	17	of	of	ADP
dti-3177	308	18	regulated	regulated	ADJ
dti-3177	308	19	cell	cell	NOUN
dti-3177	308	20	death	death	NOUN
dti-3177	308	21	.	.	PUNCT
dti-3177	309	1	cell	cell	NOUN
dti-3177	309	2	res	re	NOUN
dti-3177	309	3	.	.	PUNCT
dti-3177	309	4	2019	2019	NUM
dti-3177	309	5	;	;	PUNCT
dti-3177	309	6	29(5):347	29(5):347	NUM
dti-3177	309	7	-	-	SYM
dti-3177	309	8	364	364	NUM
dti-3177	309	9	.	.	PUNCT
dti-3177	310	1	crossref	crossref	PROPN
dti-3177	310	2	pubmed	pubmed	PROPN
dti-3177	310	3	28	28	PROPN
dti-3177	310	4	.	.	PUNCT
dti-3177	311	1	d’arcy	d’arcy	PROPN
dti-3177	311	2	ms	ms	PROPN
dti-3177	311	3	.	.	PROPN
dti-3177	311	4	cell	cell	NOUN
dti-3177	311	5	death	death	NOUN
dti-3177	311	6	:	:	PUNCT
dti-3177	311	7	a	a	DET
dti-3177	311	8	review	review	NOUN
dti-3177	311	9	of	of	ADP
dti-3177	311	10	the	the	DET
dti-3177	311	11	major	major	ADJ
dti-3177	311	12	forms	form	NOUN
dti-3177	311	13	of	of	ADP
dti-3177	311	14	apoptosis	apoptosis	NOUN
dti-3177	311	15	,	,	PUNCT
dti-3177	311	16	necrosis	necrosis	NOUN
dti-3177	311	17	and	and	CCONJ
dti-3177	311	18	autophagy	autophagy	NOUN
dti-3177	311	19	.	.	PUNCT
dti-3177	312	1	cell	cell	NOUN
dti-3177	312	2	biol	biol	PROPN
dti-3177	312	3	int	int	NOUN
dti-3177	312	4	.	.	PUNCT
dti-3177	313	1	2019;43(6):582	2019;43(6):582	NUM
dti-3177	313	2	-	-	SYM
dti-3177	313	3	592	592	NUM
dti-3177	313	4	.	.	PUNCT
dti-3177	314	1	crossref	crossref	PROPN
dti-3177	314	2	pubmed	pubmed	PROPN
dti-3177	314	3	29	29	NUM
dti-3177	314	4	.	.	PUNCT
dti-3177	315	1	robles	robles	PROPN
dti-3177	315	2	ai	ai	VERB
dti-3177	315	3	,	,	PUNCT
dti-3177	315	4	bemmels	bemmel	VERB
dti-3177	315	5	na	na	PROPN
dti-3177	315	6	,	,	PUNCT
dti-3177	315	7	foraker	foraker	PROPN
dti-3177	315	8	ab	ab	PROPN
dti-3177	315	9	,	,	PUNCT
dti-3177	315	10	harris	harris	PROPN
dti-3177	315	11	cc	cc	PROPN
dti-3177	315	12	.	.	PROPN
dti-3177	316	1	apaf-1	apaf-1	NUM
dti-3177	316	2	is	be	AUX
dti-3177	316	3	a	a	DET
dti-3177	316	4	transcriptional	transcriptional	ADJ
dti-3177	316	5	target	target	NOUN
dti-3177	316	6	of	of	ADP
dti-3177	316	7	p53	p53	NOUN
dti-3177	316	8	in	in	ADP
dti-3177	316	9	dna	dna	PROPN
dti-3177	316	10	damage	damage	NOUN
dti-3177	316	11	-	-	PUNCT
dti-3177	316	12	induced	induce	VERB
dti-3177	316	13	apoptosis	apoptosis	NOUN
dti-3177	316	14	.	.	PUNCT
dti-3177	317	1	cancer	cancer	NOUN
dti-3177	317	2	research	research	NOUN
dti-3177	317	3	.	.	PUNCT
dti-3177	318	1	2001	2001	NUM
dti-3177	318	2	sep	sep	NOUN
dti-3177	318	3	15;61(18):6660	15;61(18):6660	NUM
dti-3177	318	4	-	-	SYM
dti-3177	318	5	4	4	NUM
dti-3177	318	6	.	.	NOUN
dti-3177	318	7	30	30	NUM
dti-3177	318	8	.	.	PUNCT
dti-3177	319	1	liu	liu	PROPN
dti-3177	319	2	l	l	PROPN
dti-3177	319	3	,	,	PUNCT
dti-3177	319	4	yuan	yuan	NOUN
dti-3177	319	5	g	g	PROPN
dti-3177	319	6	,	,	PUNCT
dti-3177	319	7	cheng	cheng	PROPN
dti-3177	319	8	z	z	PROPN
dti-3177	319	9	,	,	PUNCT
dti-3177	319	10	zhang	zhang	PROPN
dti-3177	319	11	g	g	PROPN
dti-3177	319	12	,	,	PUNCT
dti-3177	319	13	liu	liu	PROPN
dti-3177	319	14	x	x	PROPN
dti-3177	319	15	,	,	PUNCT
dti-3177	319	16	zhang	zhang	PROPN
dti-3177	319	17	h.	h.	PROPN
dti-3177	319	18	identification	identification	NOUN
dti-3177	319	19	of	of	ADP
dti-3177	319	20	the	the	DET
dti-3177	319	21	mrna	mrna	PROPN
dti-3177	319	22	expression	expression	NOUN
dti-3177	319	23	status	status	NOUN
dti-3177	319	24	of	of	ADP
dti-3177	319	25	the	the	DET
dti-3177	319	26	dopamine	dopamine	NOUN
dti-3177	319	27	d2	d2	NOUN
dti-3177	319	28	receptor	receptor	NOUN
dti-3177	319	29	and	and	CCONJ
dti-3177	319	30	dopamine	dopamine	NOUN
dti-3177	319	31	transporter	transporter	NOUN
dti-3177	319	32	in	in	ADP
dti-3177	319	33	peripheral	peripheral	ADJ
dti-3177	319	34	blood	blood	NOUN
dti-3177	319	35	lymphocytes	lymphocyte	NOUN
dti-3177	319	36	of	of	ADP
dti-3177	319	37	schizophrenia	schizophrenia	NOUN
dti-3177	319	38	patients	patient	NOUN
dti-3177	319	39	.	.	PUNCT
dti-3177	320	1	plos	plos	PROPN
dti-3177	320	2	one	one	NUM
dti-3177	320	3	.	.	PUNCT
dti-3177	321	1	2013;8(9):e75259	2013;8(9):e75259	X
dti-3177	321	2	.	.	PUNCT
dti-3177	322	1	crossref	crossref	PROPN
dti-3177	322	2	pubmed	pubmed	PROPN
dti-3177	322	3	https://doi.org/10.1590/s0036-46652003000200007	https://doi.org/10.1590/s0036-46652003000200007	PROPN
dti-3177	322	4	https://www.ncbi.nlm.nih.gov/pubmed/12754574	https://www.ncbi.nlm.nih.gov/pubmed/12754574	PROPN
dti-3177	323	1	https://doi.org/10.1128/iai.62.7.2818-2824.1994	https://doi.org/10.1128/iai.62.7.2818-2824.1994	PROPN
dti-3177	323	2	https://www.ncbi.nlm.nih.gov/pubmed/7911785	https://www.ncbi.nlm.nih.gov/pubmed/7911785	PUNCT
dti-3177	323	3	https://doi.org/10.1016/j.drudis.2014.10.003	https://doi.org/10.1016/j.drudis.2014.10.003	PROPN
dti-3177	323	4	https://www.ncbi.nlm.nih.gov/pubmed/25450771	https://www.ncbi.nlm.nih.gov/pubmed/25450771	PRON
dti-3177	324	1	https://doi.org/10.1021/acs.chemrev.0c00963	https://doi.org/10.1021/acs.chemrev.0c00963	PROPN
dti-3177	324	2	https://www.ncbi.nlm.nih.gov/pubmed/33566580	https://www.ncbi.nlm.nih.gov/pubmed/33566580	NUM
dti-3177	324	3	https://doi.org/10.1016/j.bbabio.2006.03.016	https://doi.org/10.1016/j.bbabio.2006.03.016	PROPN
dti-3177	324	4	https://www.ncbi.nlm.nih.gov/pubmed/16678785	https://www.ncbi.nlm.nih.gov/pubmed/16678785	NUM
dti-3177	324	5	https://doi.org/10.1242/jcs.031682	https://doi.org/10.1242/jcs.031682	ADV
dti-3177	324	6	https://www.ncbi.nlm.nih.gov/pubmed/19193868	https://www.ncbi.nlm.nih.gov/pubmed/19193868	NUM
dti-3177	324	7	https://doi.org/10.1016/j.biochi.2017.02.001	https://doi.org/10.1016/j.biochi.2017.02.001	PROPN
dti-3177	324	8	https://www.ncbi.nlm.nih.gov/pubmed/28192157	https://www.ncbi.nlm.nih.gov/pubmed/28192157	PROPN
dti-3177	324	9	https://doi.org/10.1038/s41422-019-0164-5	https://doi.org/10.1038/s41422-019-0164-5	NOUN
dti-3177	324	10	https://www.ncbi.nlm.nih.gov/pubmed/30948788	https://www.ncbi.nlm.nih.gov/pubmed/30948788	NUM
dti-3177	324	11	https://doi.org/10.1002/cbin.11137	https://doi.org/10.1002/cbin.11137	X
dti-3177	324	12	https://www.ncbi.nlm.nih.gov/pubmed/30958602	https://www.ncbi.nlm.nih.gov/pubmed/30958602	X
dti-3177	324	13	https://doi.org/10.1371/journal.pone.0075259	https://doi.org/10.1371/journal.pone.0075259	NOUN
dti-3177	324	14	https://www.ncbi.nlm.nih.gov/pubmed/24086483	https://www.ncbi.nlm.nih.gov/pubmed/24086483	PROPN